id,target_id,drug,act_value,act_type,action_type,smiles,cmpd_chemblid
1,11838,elobixibat,9.275724,IC50,INHIBITOR,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=C(C=C(OCC(=O)N[C@@H](C(=O)NCC(O)=O)C3=CC=CC=C3)C(SC)=C2)S(=O)(=O)C1,CHEMBL3039515
2,3299,tezacaftor,,,PHARMACOLOGICAL CHAPERONE,CC(C)(CO)C1=CC2=C(C=C(F)C(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C2)N1C[C@@H](O)CO,CHEMBL3544914
3,6977,macimorelin,7.81,IC50,AGONIST,[H]C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@@H](CC1=CC2=C(N1)C=CC=C2)NC(=O)C(C)(C)N,CHEMBL278623
4,13260,copanlisib,9.30103016,IC50,INHIBITOR,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,CHEMBL3218576
5,13069,copanlisib,9.1549015,IC50,INHIBITOR,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,CHEMBL3218576
6,3144,abemaciclib,9.22184875,Ki,INHIBITOR,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,CHEMBL3301610
7,3145,abemaciclib,8.61978876,Ki,INHIBITOR,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1,CHEMBL3301610
8,12942,latanoprostene bunod,8.6,Ki,AGONIST,[H][C@]1(CC[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@H](O)[C@]1([H])C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O,CHEMBL1050
9,8668,benralizumab,10.95860731,Kd,ANTIBODY BINDING,,CHEMBL1742991
10,7044,semaglutide,9.4202164,IC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CO)C(=O)NC(CO)C(=O)NC(CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)[C@H](CCC(O)=O)NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NC(CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(C)C)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,CHEMBL2108724
11,14788,netarsudil,8.376751,Ki,INHIBITOR,CC1=CC=C(C(=O)OCC2=CC=C(C=C2)[C@@H](CN)C(=O)NC2=CC3=C(C=C2)C=NC=C3)C(C)=C1,CHEMBL3545126
12,11810,rucaparib,8.5,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,CHEMBL1173055
13,11683,rucaparib,7.55000019,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,CHEMBL1173055
14,11684,rucaparib,6.38999987,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,CHEMBL1173055
15,12769,crisaborole,6.30980396,IC50,INHIBITOR,OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12,CHEMBL484785
16,12770,crisaborole,6.30980396,IC50,INHIBITOR,OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12,CHEMBL484785
17,12628,crisaborole,6.30980396,IC50,INHIBITOR,OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12,CHEMBL484785
18,12629,crisaborole,6.30980396,IC50,INHIBITOR,OB1OCC2=CC(OC3=CC=C(C=C3)C#N)=CC=C12,CHEMBL484785
19,8267,baricitinib,8.22914791,IC50,INHIBITOR,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2,CHEMBL2105759
20,8242,baricitinib,8.24412537,IC50,INHIBITOR,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2,CHEMBL2105759
21,4969,icotinib,8.69896984,IC50,INHIBITOR,C#CC1=CC=CC(NC2=NC=NC3=C2C=C2OCCOCCOCCOC2=C3)=C1,CHEMBL2087361
22,4969,olmutinib,8.03621197,IC50,INHIBITOR,CN1CCN(CC1)C1=CC=C(NC2=NC3=C(SC=C3)C(OC3=CC=CC(NC(=O)C=C)=C3)=N2)C=C1,CHEMBL3786343
23,6942,plecanatide,6.72124624,EC50,AGONIST,[H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C)C(C)C,CHEMBL2103867
24,3507,cobicistat,6.02733421,Ki,INHIBITOR,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,CHEMBL2095208
25,4226,cobicistat,6.02733421,Ki,INHIBITOR,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,CHEMBL2095208
26,3246,cobicistat,6.02733421,Ki,INHIBITOR,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,CHEMBL2095208
27,4225,cobicistat,6.02733421,Ki,INHIBITOR,CC(C)C1=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)CC2=CC=CC=C2)=CS1,CHEMBL2095208
28,469,radotinib,7.51427841,IC50,INHIBITOR,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F,
29,18451,apatinib,9.0,IC50,INHIBITOR,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,CHEMBL3186534
30,150,methanthelinium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2,CHEMBL1200988
31,151,methanthelinium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2,CHEMBL1200988
32,431,methanthelinium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2,CHEMBL1200988
33,42,methanthelinium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2,CHEMBL1200988
34,430,methanthelinium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2,CHEMBL1200988
35,1679,verapamil,,,BLOCKER,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL6966
36,547,landiolol,,,ANTAGONIST,CC1(C)OC[C@@H](COC(=O)CCC2=CC=C(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)C=C2)O1,CHEMBL1742466
37,13316,piketoprofen,,,INHIBITOR,CC(C(=O)NC1=CC(C)=CC=N1)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL2106966
38,12865,piketoprofen,,,INHIBITOR,CC(C(=O)NC1=CC(C)=CC=N1)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL2106966
39,12948,olaratumab,10.4,Kd,ANTIBODY BINDING,,CHEMBL1743049
40,8632,brodalumab,9.19999981,Kd,ANTIBODY BINDING,,CHEMBL1742996
41,8631,brodalumab,9.19999981,Kd,ANTIBODY BINDING,,CHEMBL1742996
42,8562,lifitegrast,8.04575729,IC50,ANTAGONIST,[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O,CHEMBL2048028
43,8559,lifitegrast,8.04575729,IC50,ANTAGONIST,[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O,CHEMBL2048028
44,27,lorcaserin,7.88605642,Ki,AGONIST,C[C@H]1CNCCC2=CC=C(Cl)C=C12,CHEMBL360328
45,2357,muromonab-CD3,,,ANTIBODY BINDING,,CHEMBL1201608
46,2436,muromonab-CD3,,,ANTIBODY BINDING,,CHEMBL1201608
47,2985,muromonab-CD3,,,ANTIBODY BINDING,,CHEMBL1201608
48,7509,bilastine,7.19382,Ki,ANTAGONIST,CCOCCN1C(=NC2=C1C=CC=C2)C1CCN(CCC2=CC=C(C=C2)C(C)(C)C(O)=O)CC1,CHEMBL1742423
49,483,enalapril,4.3,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,CHEMBL578
50,483,enalaprilat,7.5,IC50,INHIBITOR,C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,CHEMBL577
51,17750,eltrombopag,7.42,EC50,AGONIST,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC(=CC=C2)C(O)=O)=C1O)C1=CC(C)=C(C)C=C1,CHEMBL461101
52,8481,peginterferon beta-1a,,,AGONIST,,CHEMBL2108677
53,8217,peginterferon beta-1a,,,AGONIST,,CHEMBL2108677
54,8481,interferon beta-1a,,,AGONIST,,CHEMBL1201562
55,8217,interferon beta-1a,,,AGONIST,,CHEMBL1201562
56,8481,interferon beta-1b,,,AGONIST,,CHEMBL1201563
57,8217,interferon beta-1b,,,AGONIST,,CHEMBL1201563
58,13391,alteplase,,,ACTIVATOR,,CHEMBL1201593
59,104,pimavanserin,9.30000019,Ki,INVERSE AGONIST,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,CHEMBL2111101
60,3216,opicapone,9.0,Ki,INHIBITOR,CC1=C(C2=NOC(=N2)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,
61,12621,atezolizumab,,,ANTIBODY BINDING,,CHEMBL3707227
62,9138,choriogonadotropin alfa,,,AGONIST,,CHEMBL1201464
63,558,migalastat,7.1500001,IC50,PHARMACOLOGICAL CHAPERONE,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,CHEMBL110458
64,1326,venetoclax,11.0,Ki,INHIBITOR,CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1,CHEMBL3137309
65,4816,rotigotine,10.22,Ki,AGONIST,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,CHEMBL1303
66,13783,quingestanol acetate,,,AGONIST,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(OC4CCCC4)=CC3=CC[C@@]21[H],CHEMBL2105291
67,1535,dexrabeprazole,,,INHIBITOR,COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C,CHEMBL1615209
68,1158,dexrabeprazole,,,INHIBITOR,COCCCOC1=CC=NC(C[S@@](=O)C2=NC3=C(N2)C=CC=C3)=C1C,CHEMBL1615209
69,1535,ilaprazole,,,INHIBITOR,COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC(=C3)N2C=CC=C2)=C1C,CHEMBL2106370
70,1158,ilaprazole,,,INHIBITOR,COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC(=C3)N2C=CC=C2)=C1C,CHEMBL2106370
71,2123,cilnidipine,,,BLOCKER,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1,CHEMBL452076
72,1677,cilnidipine,,,BLOCKER,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC\C=C\C1=CC=CC=C1,CHEMBL452076
73,2123,dexniguldipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL2051956
74,1677,dexniguldipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL2051956
75,144,distigmine,,,INHIBITOR,CN(CCCCCCN(C)C(=O)OC1=C[N+](C)=CC=C1)C(=O)OC1=C[N+](C)=CC=C1,CHEMBL1098285
76,2123,manidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1085699
77,1677,manidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1085699
78,2123,nilvadipine,,,BLOCKER,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,CHEMBL517427
79,1677,nilvadipine,,,BLOCKER,COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N,CHEMBL517427
80,11526,mifamurtide,,,ACTIVATOR,CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC,CHEMBL2107354
81,2123,levamlodipine,,,BLOCKER,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=C(Cl)C=CC=C1)C(=O)OC,CHEMBL2107350
82,1677,levamlodipine,,,BLOCKER,CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C1=C(Cl)C=CC=C1)C(=O)OC,CHEMBL2107350
83,13391,tenecteplase,,,ACTIVATOR,,CHEMBL2108791
84,13819,ixazomib,8.46852112,IC50,INHIBITOR,[H][C@@](CC(C)C)(NC(=O)CNC(=O)C1=C(Cl)C=CC(Cl)=C1)B(O)O,CHEMBL2141296
85,16580,brivaracetam,7.0999999,Ki,MODULATOR,[H][C@@](CC)(N1C[C@]([H])(CCC)CC1=O)C(N)=O,CHEMBL607400
86,2356,daratumumab,8.22,Kd,ANTIBODY BINDING,,CHEMBL1743007
87,4969,necitumumab,,,ANTIBODY BINDING,,CHEMBL1743047
88,7509,setastine,,,ANTAGONIST,CC(OCCN1CCCCCC1)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,CHEMBL1742452
89,7509,talastine,,,ANTAGONIST,CN(C)CCN1N=C(CC2=CC=CC=C2)C2=C(C=CC=C2)C1=O,CHEMBL1742439
90,7509,moxastine,,,ANTAGONIST,CN(C)CCOC(C)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1742465
91,1028,pheniprazine,,,INHIBITOR,CC(CC1=CC=CC=C1)NN,CHEMBL22498
92,756,pheniprazine,,,INHIBITOR,CC(CC1=CC=CC=C1)NN,CHEMBL22498
93,1028,mebanazine,,,INHIBITOR,CC(NN)C1=CC=CC=C1,CHEMBL1909283
94,756,mebanazine,,,INHIBITOR,CC(NN)C1=CC=CC=C1,CHEMBL1909283
95,15538,phenytoin,,,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
96,15251,phenytoin,,,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
97,15540,phenytoin,,,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
98,15541,phenytoin,,,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
99,16301,elotuzumab,,,ANTIBODY BINDING,,CHEMBL1743010
100,18598,levomenthol,4.6,EC50,ACTIVATOR,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,CHEMBL256087
101,14497,alectinib,8.31875896,IC50,INHIBITOR,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,CHEMBL1738797
102,13203,selexipag,7.69896984,Ki,AGONIST,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=CN=C(C2=CC=CC=C2)C(=N1)C1=CC=CC=C1,CHEMBL238804
103,1028,pirlindole,7.40893555,Ki,INHIBITOR,CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13,CHEMBL32350
104,10328,cobimetinib,9.04575729,IC50,INHIBITOR,[H][C@]1(CCCCN1)C1(O)CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1,CHEMBL2146883
105,13566,saroglitazar,9.18708706,EC50,AGONIST,CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O,
106,13436,saroglitazar,8.52287865,EC50,AGONIST,CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O,
107,7756,pitolisant,9.79588032,Ki,INVERSE AGONIST,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1,CHEMBL462605
108,4816,aripiprazole lauroxil,9.46852112,Ki,PARTIAL AGONIST,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,CHEMBL2219425
109,443,aripiprazole lauroxil,8.76955128,Ki,PARTIAL AGONIST,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,CHEMBL2219425
110,104,aripiprazole lauroxil,8.46852112,Ki,ANTAGONIST,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,CHEMBL2219425
111,7509,emedastine,8.8860569,Ki,ANTAGONIST,CCOCCN1C(=NC2=C1C=CC=C2)N1CCCN(C)CC1,CHEMBL594
112,4923,omarigliptin,9.09691048,Ki,INHIBITOR,CS(=O)(=O)N1C=C2CN(CC2=N1)[C@H]1CO[C@@H]([C@@H](N)C1)C1=C(F)C=CC(F)=C1,CHEMBL2105762
113,8077,insulin glulisine,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1201613
114,443,flibanserin,9.0,Ki,AGONIST,FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,CHEMBL231068
115,104,flibanserin,7.30980396,Ki,ANTAGONIST,FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,CHEMBL231068
116,4816,haloperidol decanoate,9.34,Ki,INVERSE AGONIST,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,CHEMBL1200986
117,8311,chlorzoxazone,4.52287865,EC50,OPENER,ClC1=CC2=C(OC(=O)N2)C=C1,CHEMBL1371
118,8056,oprelvekin,,,AGONIST,,CHEMBL1201573
119,7880,oprelvekin,,,AGONIST,,CHEMBL1201573
120,11575,rolapitant,9.18045616,Ki,ANTAGONIST,[H][C@](C)(OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,CHEMBL3707330
121,3844,sargramostim,8.30103016,Kd,AGONIST,,CHEMBL1201670
122,8667,sargramostim,8.30103016,Kd,AGONIST,,CHEMBL1201670
123,2855,mogamulizumab,,,ANTIBODY BINDING,,CHEMBL1743041
124,12559,alirocumab,9.42,Kd,INHIBITOR,,CHEMBL2109540
125,7796,anakinra,7.82000017,Kd,ANTAGONIST,[H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O,CHEMBL1201570
126,8206,anakinra,7.82000017,Kd,ANTAGONIST,[H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O,CHEMBL1201570
127,7510,niperotidine,,,ANTAGONIST,CN(C)CC1=CC=C(CSCCNC(NCC2=CC3=C(OCO3)C=C2)=C[N+]([O-])=O)O1,CHEMBL1909284
128,16966,hydroxyamfetamine,5.52870846,EC50,AGONIST,CC(N)CC1=CC=C(O)C=C1,CHEMBL1546
129,4815,pergolide,6.46999979,Ki,AGONIST,[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1,CHEMBL531
130,11328,sacubitril,,,INHIBITOR,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C1=CC=CC=C1)NC(=O)CCC(O)=O,CHEMBL3137301
131,4923,trelagliptin,8.39793968,IC50,INHIBITOR,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=CC(F)=CC=C2C#N)C1=O,CHEMBL1650443
132,3216,tolcapone,9.56863594,Ki,INHIBITOR,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,CHEMBL1324
133,3216,entacapone,9.52287865,Ki,INHIBITOR,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,CHEMBL953
134,6343,incadronic acid,7.52287865,IC50,INHIBITOR,OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O,CHEMBL53950
135,4816,brexpiprazole,9.52287865,Ki,AGONIST,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,CHEMBL2105760
136,443,brexpiprazole,9.92081833,Ki,AGONIST,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,CHEMBL2105760
137,104,brexpiprazole,9.32790184,Ki,ANTAGONIST,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,CHEMBL2105760
138,6834,pegvisomant,,,ANTAGONIST,,CHEMBL1201515
139,4856,gimeracil,6.63827229,Ki,INHIBITOR,OC1=CC(=O)NC=C1Cl,CHEMBL1730601
140,19085,oteracil,,,INHIBITOR,OC(=O)C1=NC(=O)NC(=O)N1,CHEMBL181932
141,547,arbutamine,,,AGONIST,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1,CHEMBL1200385
142,17391,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
143,16765,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
144,16764,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
145,16763,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
146,17077,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
147,16987,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
148,17297,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
149,16762,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
150,17076,trastuzumab emtansine,,,INHIBITOR,,CHEMBL1743082
151,5479,trastuzumab emtansine,,,ANTIBODY BINDING,,CHEMBL1743082
152,3649,lipegfilgrastim,,,ACTIVATOR,,CHEMBL2105765
153,1535,vonoprazan,8.0,Ki,INHIBITOR,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,
154,1158,vonoprazan,8.0,Ki,INHIBITOR,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,
155,150,aclatonium,,,AGONIST,CC(OC(C)=O)C(=O)OCC[N+](C)(C)C,CHEMBL2106580
156,151,aclatonium,,,AGONIST,CC(OC(C)=O)C(=O)OCC[N+](C)(C)C,CHEMBL2106580
157,431,aclatonium,,,AGONIST,CC(OC(C)=O)C(=O)OCC[N+](C)(C)C,CHEMBL2106580
158,42,aclatonium,,,AGONIST,CC(OC(C)=O)C(=O)OCC[N+](C)(C)C,CHEMBL2106580
159,430,aclatonium,,,AGONIST,CC(OC(C)=O)C(=O)OCC[N+](C)(C)C,CHEMBL2106580
160,5364,epoetin alfa,11.15,IC50,AGONIST,,CHEMBL1201565
161,17618,etoposide,7.3,IC50,INHIBITOR,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,CHEMBL44657
162,17750,romiplostim,,,AGONIST,,CHEMBL1201832
163,12006,eluxadoline,8.76955128,Ki,AGONIST,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,CHEMBL2159122
164,12187,eluxadoline,8.8860569,Ki,ANTAGONIST,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O,CHEMBL2159122
165,8077,insulin lispro,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1201538
166,8077,insulin human,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1201641
167,12865,parecoxib,8.30103016,IC50,INHIBITOR,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C1=C(C)ON=C1C1=CC=CC=C1,CHEMBL296913
168,13783,hydroxyprogesterone caproate,7.66354036,IC50,AGONIST,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1062
169,3649,pegfilgrastim,,,ACTIVATOR,,CHEMBL1201568
170,3649,filgrastim,,,ACTIVATOR,,CHEMBL1201567
171,6487,triamcinolone hexacetonide,,,AGONIST,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200878
172,6490,nitric oxide,,,ACTIVATOR,,CHEMBL1200689
173,6792,nitric oxide,,,ACTIVATOR,,CHEMBL1200689
174,7026,nitric oxide,,,ACTIVATOR,,CHEMBL1200689
175,6793,nitric oxide,,,ACTIVATOR,,CHEMBL1200689
176,8329,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
177,8328,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
178,8318,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
179,8775,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
180,8777,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
181,8162,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
182,8776,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
183,8163,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
184,8781,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
185,9447,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
186,8417,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
187,8314,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
188,8600,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
189,8165,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
190,8783,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
191,8779,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
192,8766,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
193,8332,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
194,8402,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
195,8317,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
196,8400,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
197,8333,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
198,8780,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
199,8330,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
200,8167,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
201,8782,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
202,8778,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
203,9450,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
204,8320,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
205,9446,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
206,8418,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
207,8166,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
208,8784,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
209,8785,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
210,8399,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
211,8316,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
212,8786,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
213,8401,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
214,9449,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
215,8319,guanidine,,,BLOCKER,NC(N)=N,CHEMBL821
216,243,fomepizole,,,INHIBITOR,CC1=CNN=C1,CHEMBL1308
217,244,fomepizole,,,INHIBITOR,CC1=CNN=C1,CHEMBL1308
218,242,fomepizole,,,INHIBITOR,CC1=CNN=C1,CHEMBL1308
219,1677,bepridil,,,BLOCKER,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,CHEMBL1008
220,2123,bepridil,,,BLOCKER,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,CHEMBL1008
221,1951,gabapentin enacarbil,,,MODULATOR,[H]C(C)(OC(=O)NCC1(CC(O)=O)CCCCC1)OC(=O)C(C)C,CHEMBL1628502
222,2119,gabapentin enacarbil,,,MODULATOR,[H]C(C)(OC(=O)NCC1(CC(O)=O)CCCCC1)OC(=O)C(C)C,CHEMBL1628502
223,13819,carfilzomib,8.22184849,IC50,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,CHEMBL451887
224,7335,chidamide,7.0222764,IC50,INHIBITOR,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1,
225,7336,chidamide,6.79587984,IC50,INHIBITOR,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1,
226,7425,chidamide,7.1739254,IC50,INHIBITOR,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1,
227,7136,chidamide,7.10790539,IC50,INHIBITOR,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1,
228,17391,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
229,16765,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
230,16764,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
231,16763,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
232,17077,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
233,16987,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
234,17297,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
235,16762,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
236,17076,docetaxel,6.69899988,ID50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL92
237,17391,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
238,16765,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
239,16764,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
240,16763,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
241,17077,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
242,16987,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
243,17297,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
244,16762,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
245,17076,paclitaxel,8.05,EC50,INHIBITOR,[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL428647
246,17391,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
247,16765,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
248,16764,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
249,16763,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
250,17077,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
251,16987,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
252,17297,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
253,16762,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
254,17076,brentuximab vedotin,,,INHIBITOR,,CHEMBL1742994
255,17391,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
256,16765,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
257,16764,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
258,16763,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
259,17077,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
260,16987,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
261,17297,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
262,16762,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
263,17076,eribulin,8.22999954,IC50,INHIBITOR,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,CHEMBL1683544
264,17391,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
265,16765,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
266,16764,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
267,16763,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
268,17077,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
269,16987,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
270,17297,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
271,16762,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
272,17076,vinblastine,9.0,IC50,INHIBITOR,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL159
273,17391,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
274,16765,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
275,16764,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
276,16763,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
277,17077,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
278,16987,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
279,17297,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
280,16762,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
281,17076,vinorelbine,,,INHIBITOR,[H][C@@]12N(C)C3=C(C=C(C(OC)=C3)[C@]3(C[C@@]4([H])C[N@](CC(CC)=C4)CC4=C3NC3=C4C=CC=C3)C(=O)OC)[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H],CHEMBL553025
282,17391,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
283,16765,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
284,16764,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
285,16763,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
286,17077,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
287,16987,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
288,17297,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
289,16762,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
290,17076,vincristine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=CC(=C(OC)C=C4N(C=O)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])C[N@](C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,CHEMBL90555
291,17391,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
292,16765,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
293,16764,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
294,16763,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
295,17077,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
296,16987,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
297,17297,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
298,16762,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
299,17076,ixabepilone,,,INHIBITOR,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,CHEMBL1201752
300,17391,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
301,16765,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
302,16764,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
303,16763,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
304,17077,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
305,16987,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
306,17297,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
307,16762,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
308,17076,vinflunine,,,INHIBITOR,[H][C@@]12N3CC[C@@]11C4=C(C=C(OC)C(=C4)[C@]4(C[C@]5([H])C[C@H](C[N@@](C5)CC5=C4NC4=C5C=CC=C4)C(C)(F)F)C(=O)OC)N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC,CHEMBL2105629
309,3144,palbociclib,7.9586072,IC50,INHIBITOR,CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O,CHEMBL189963
310,3145,palbociclib,7.82390881,IC50,INHIBITOR,CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O,CHEMBL189963
311,19095,lenvatinib,7.65757751,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
312,18451,lenvatinib,8.39793968,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
313,19096,lenvatinib,8.28399658,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
314,5845,lenvatinib,7.33724213,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
315,12948,lenvatinib,7.29242992,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
316,8988,lenvatinib,7.0,IC50,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
317,14497,lenvatinib,8.82,Ki,INHIBITOR,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,CHEMBL1289601
318,430,pilocarpine,6.96999979,EC50,AGONIST,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,CHEMBL550
319,8691,mycophenolate mofetil,8.1549015,Ki,INHIBITOR,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1,CHEMBL1456
320,8690,mycophenolate mofetil,7.48148584,Ki,INHIBITOR,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1,CHEMBL1456
321,756,safinamide,6.34678745,Ki,INHIBITOR,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O,CHEMBL48582
322,12841,nivolumab,9.14,Kd,ANTIBODY BINDING,,CHEMBL2108738
323,42,glycopyrronium bromide,9.68999958,Ki,ANTAGONIST,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,CHEMBL1201027
324,150,glycopyrronium bromide,9.25,Ki,ANTAGONIST,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,CHEMBL1201027
325,430,glycopyrronium bromide,9.64000034,Ki,ANTAGONIST,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,CHEMBL1201027
326,151,glycopyrronium bromide,9.06000042,Ki,ANTAGONIST,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,CHEMBL1201027
327,431,glycopyrronium bromide,8.90999985,Ki,ANTAGONIST,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,CHEMBL1201027
328,18599,zucapsaicin,7.71000004,EC50,OPENER,COC1=CC(CNC(=O)CCCC\C=C/C(C)C)=CC=C1O,CHEMBL313971
329,3117,blinatumomab,9.0,Kd,ANTIBODY BINDING,,CHEMBL1742992
330,2357,blinatumomab,7.0,Kd,ANTIBODY BINDING,,CHEMBL1742992
331,2436,blinatumomab,7.0,Kd,ANTIBODY BINDING,,CHEMBL1742992
332,2985,blinatumomab,7.0,Kd,ANTIBODY BINDING,,CHEMBL1742992
333,79,reproterol,,,AGONIST,CN1C2=C(N(CCCNCC(O)C3=CC(O)=CC(O)=C3)C=N2)C(=O)N(C)C1=O,CHEMBL1095607
334,547,etilefrine,,,AGONIST,CCNCC(O)C1=CC(O)=CC=C1,CHEMBL86882
335,547,etilefrine pivalate,,,AGONIST,CCNCC(O)C1=CC(OC(=O)C(C)(C)C)=CC=C1,CHEMBL2105571
336,3354,cinalukast,,,ANTAGONIST,CCC(CC)(CC(=O)NC1=CC=CC(\C=C\C2=NC(=CS2)C2CCC2)=C1)C(O)=O,CHEMBL283754
337,3354,pranlukast,10.0,IC50,ANTAGONIST,O=C(NC1=CC=CC2=C1OC(=CC2=O)C1=NN=NN1)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1,CHEMBL21333
338,204,tetracosactide,8.26760578,Ki,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,CHEMBL2103784
339,204,seractide,8.0087738,Ki,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL1201489
340,15019,hydralazine,,,BLOCKER,NNC1=NN=CC2=CC=CC=C12,CHEMBL276832
341,15103,benzocaine,3.49484992,ED50,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
342,15538,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
343,15101,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
344,15251,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
345,15102,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
346,15539,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
347,15540,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
348,15541,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
349,15104,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
350,15105,benzocaine,,,BLOCKER,CCOC(=O)C1=CC=C(N)C=C1,CHEMBL278172
351,4816,lurasidone,9.00261402,Ki,ANTAGONIST,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O,CHEMBL1237021
352,104,lurasidone,9.32790184,Ki,ANTAGONIST,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@@]1([H])CN1CCN(CC1)C1=NSC3=C1C=CC=C3)C2=O,CHEMBL1237021
353,7044,dulaglutide,,,AGONIST,,CHEMBL2108027
354,6487,methylprednisolone acetate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,CHEMBL1200844
355,12865,aceclofenac,,,INHIBITOR,OC(=O)COC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,CHEMBL93645
356,5171,methotrexate,8.92,Ki,INHIBITOR,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,CHEMBL34259
357,79,tulobuterol,,,AGONIST,CC(C)(C)NCC(O)C1=C(Cl)C=CC=C1,CHEMBL1159717
358,12768,olprinone,,,INHIBITOR,CC1=C(C=C(C#N)C(=O)N1)C1=CN2C=CN=C2C=C1,CHEMBL1474900
359,12843,olprinone,,,INHIBITOR,CC1=C(C=C(C#N)C(=O)N1)C1=CN2C=CN=C2C=C1,CHEMBL1474900
360,9099,cetilistat,8.22548294,IC50,INHIBITOR,CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1,CHEMBL2103825
361,19194,topiroxostat,8.27572441,IC50,INHIBITOR,N#CC1=NC=CC(=C1)C1=NNC(=N1)C1=CC=NC=C1,
362,15515,ipragliflozin,8.1319437,IC50,INHIBITOR,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC3=C(S2)C=CC=C3)=C(F)C=C1,
363,15515,luseogliflozin,8.64589119,IC50,INHIBITOR,CCOC1=CC=C(CC2=C(C)C=C(OC)C(=C2)[C@@H]2S[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,
364,15515,tofogliflozin,8.53760242,IC50,INHIBITOR,CCC1=CC=C(CC2=CC3=C(CO[C@]33O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C2)C=C1,CHEMBL2105711
365,18299,tipiracil,7.69896984,IC50,INHIBITOR,ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,CHEMBL65375
366,4923,teneligliptin,9.43179798,IC50,INHIBITOR,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1,CHEMBL2147777
367,4923,anagliptin,8.42021656,IC50,INHIBITOR,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,CHEMBL1929387
368,6942,linaclotide,8.90657806,Ki,AGONIST,[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O,CHEMBL3301675
369,12145,suvorexant,9.25963688,Ki,ANTAGONIST,C[C@@H]1CCN(CCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,CHEMBL1083659
370,12265,suvorexant,9.45593166,Ki,ANTAGONIST,C[C@@H]1CCN(CCN1C(=O)C1=CC(C)=CC=C1N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2,CHEMBL1083659
371,3633,thalidomide,6.3929739,EC50,MODULATOR,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=C1C=CC=C2,CHEMBL468
372,3633,lenalidomide,6.52739,EC50,MODULATOR,NC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1,CHEMBL848
373,3633,pomalidomide,6.57708216,EC50,MODULATOR,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,CHEMBL43452
374,332,mirabegron,7.64975214,EC50,AGONIST,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,CHEMBL2095212
375,253,ceritinib,9.69896984,IC50,INHIBITOR,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,CHEMBL2403108
376,12886,vorapaxar,8.09151459,Ki,ANTAGONIST,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC,CHEMBL493982
377,4923,gemigliptin,7.79587984,IC50,INHIBITOR,N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCC2=C(N=C(N=C2C1)C(F)(F)F)C(F)(F)F,CHEMBL3707235
378,2647,eliglustat,6.8268137,IC50,INHIBITOR,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1,CHEMBL2103853
379,15089,levomilnacipran,7.95078182,Ki,INHIBITOR,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1,CHEMBL99946
380,15387,levomilnacipran,7.03526926,Ki,INHIBITOR,CCN(CC)C(=O)[C@]1(C[C@H]1CN)C1=CC=CC=C1,CHEMBL99946
381,12629,apremilast,7.1307683,IC50,INHIBITOR,CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,CHEMBL514800
382,15515,empagliflozin,7.24412537,Kd,INHIBITOR,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C(Cl)C=C1,CHEMBL2107830
383,12942,travoprost,7.28399658,Ki,AGONIST,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC(=CC=C1)C(F)(F)F,CHEMBL1200799
384,10909,tasimelteon,9.44999981,Ki,AGONIST,[H][C@@]1(CNC(=O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1,CHEMBL2103822
385,10723,tasimelteon,9.80000019,Ki,AGONIST,[H][C@@]1(CNC(=O)CC)C[C@@]1([H])C1=C2CCOC2=CC=C1,CHEMBL2103822
386,79,olodaterol,9.14000034,Ki,ANTAGONIST,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,CHEMBL605846
387,7044,lixisenatide,8.84466362,IC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O,CHEMBL2108336
388,430,umeclidinium,10.22184849,Ki,ANTAGONIST,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,CHEMBL523299
389,105,vortioxetine,8.43179798,Ki,ANTAGONIST,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
390,111,vortioxetine,7.72124624,Ki,ANTAGONIST,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
391,444,vortioxetine,7.48148584,Ki,AGONIST,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
392,443,vortioxetine,7.82390881,Ki,AGONIST,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
393,15089,vortioxetine,8.79588032,Ki,INHIBITOR,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
394,6793,riociguat,7.52287865,MEC,POSITIVE ALLOSTERIC MODULATOR,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=NC=CC=C12,CHEMBL2107834
395,5092,macitentan,9.30103016,IC50,ANTAGONIST,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,CHEMBL2103873
396,5005,macitentan,6.40782309,IC50,ANTAGONIST,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,CHEMBL2103873
397,12630,avanafil,8.28399658,IC50,INHIBITOR,COC1=C(Cl)C=C(CNC2=NC(=NC=C2C(=O)NCC2=NC=CC=N2)N2CCC[C@H]2CO)C=C1,CHEMBL1963681
398,12006,tapentadol,7.01772881,Ki,AGONIST,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,CHEMBL1201776
399,15387,tapentadol,6.31875896,Ki,INHIBITOR,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1,CHEMBL1201776
400,6487,fluorometholone acetate,8.34679985,Ki,AGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,CHEMBL1201064
401,18451,cabozantinib,10.45593166,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
402,9664,cabozantinib,8.8860569,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
403,14497,cabozantinib,8.28399658,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
404,17476,cabozantinib,7.8446641,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
405,6240,cabozantinib,7.94692135,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
406,8988,cabozantinib,8.33724213,IC50,INHIBITOR,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,CHEMBL2103868
407,469,ponatinib,9.43179798,IC50,INHIBITOR,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,CHEMBL1171837
408,3299,crofelemer,5.15490198,IC50,INHIBITOR,,CHEMBL2108184
409,1220,crofelemer,5.18708658,IC50,INHIBITOR,,CHEMBL2108184
410,16282,pentazocine,8.76,EC50,MODULATOR,[H]C12CC3=CC=C(O)C=C3C(C)(CCN1CC=C(C)C)C2C,CHEMBL560
411,5055,cilastatin,6.9586,Ki,INHIBITOR,[H][C@@]1(CC1(C)C)C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,CHEMBL766
412,14054,alitretinoin,7.13,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
413,14054,tretinoin,6.7,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,CHEMBL38
414,147,varenicline,9.3979,Ki,AGONIST,[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1,CHEMBL1396
415,422,varenicline,9.3979,Ki,AGONIST,[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1,CHEMBL1396
416,426,trimetaphan,,,ANTAGONIST,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,CHEMBL1245
417,215,trimetaphan,,,ANTAGONIST,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,CHEMBL1245
418,147,nicotine,8.56,Ki,AGONIST,CN1CCC[C@H]1C1=CC=CN=C1,CHEMBL3
419,422,nicotine,8.56,Ki,AGONIST,CN1CCC[C@H]1C1=CC=CN=C1,CHEMBL3
420,426,mecamylamine,6.2218,Ki,NEGATIVE ALLOSTERIC MODULATOR,[H]C12CCC([H])(C1)C(C)(NC)C2(C)C,CHEMBL267936
421,215,mecamylamine,6.2218,Ki,NEGATIVE ALLOSTERIC MODULATOR,[H]C12CCC([H])(C1)C(C)(NC)C2(C)C,CHEMBL267936
422,10283,trametinib,9.036212,IC50,INHIBITOR,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1,CHEMBL2103875
423,10328,trametinib,8.744727,IC50,INHIBITOR,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1,CHEMBL2103875
424,15515,canagliflozin,8.6575775,IC50,INHIBITOR,CC1=C(CC2=CC=C(S2)C2=CC=C(F)C=C2)C=C(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL2048484
425,10908,lomitapide,8.09691,IC50,INHIBITOR,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=C1C=CC=C2,CHEMBL354541
426,7044,liraglutide,10.2,EC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,CHEMBL1201866
427,7695,nitisinone,7.398,IC50,INHIBITOR,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,CHEMBL1337
428,15018,dantrolene,6.757,Ki,ANTAGONIST,[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,CHEMBL928
429,4923,sitagliptin,7.774,Ki,INHIBITOR,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1,CHEMBL1422
430,14497,sunitinib,8.8,IC50,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
431,1625,dabrafenib,9.1549015,IC50,INHIBITOR,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,CHEMBL2028663
432,12942,bimatoprost,5.3,Ki,AGONIST,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,CHEMBL1200963
433,15722,probenecid,,,INHIBITOR,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,CHEMBL897
434,8691,thioguanine,,,INHIBITOR,NC1=NC2=C(NC=N2)C(=S)N1,CHEMBL727
435,2647,miglustat,5.13,Ki,INHIBITOR,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL1029
436,14456,aliskiren,9.22,IC50,INHIBITOR,[H][C@@](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)(CC1=CC(OCCCOC)=C(OC)C=C1)C(C)C,CHEMBL1639
437,13607,bortezomib,9.2076,Ki,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,CHEMBL325041
438,10291,acarbose,5.6968,IC50,INHIBITOR,[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL404271
439,12782,alprostadil,8.0,EC50,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,CHEMBL495
440,9099,orlistat,8.9,IC50,INHIBITOR,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,CHEMBL175247
441,12769,theophylline,4.11,Ki,INHIBITOR,CN1C2=C(N=CN2)C(=O)N(C)C1=O,CHEMBL190
442,15104,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
443,15104,orphenadrine,5.2007,IC50,BLOCKER,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
444,5092,ambrisentan,9.65,Ki,ANTAGONIST,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1111
445,1816,mitotane,,,INHIBITOR,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1,CHEMBL1670
446,19094,colecalciferol,9.68,EC50,AGONIST,[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CCC\C2=C/C=C1/C[C@@H](O)CCC1=C,CHEMBL1042
447,19094,ergocalciferol,,,AGONIST,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,CHEMBL1536
448,19094,paricalcitol,8.7,EC50,AGONIST,C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1,CHEMBL1200622
449,19094,calcitriol,8.4,EC50,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O,CHEMBL846
450,14092,alitretinoin,7.3,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
451,14092,tretinoin,6.7,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,CHEMBL38
452,15016,alitretinoin,6.66,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
453,15716,alitretinoin,6.7,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
454,15182,alitretinoin,6.5,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
455,12630,vardenafil,9.1549,IC50,INHIBITOR,CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1,CHEMBL1339
456,12630,sildenafil,9.0,IC50,INHIBITOR,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,CHEMBL192
457,13436,troglitazone,6.27,EC50,AGONIST,[H]C1(CC2=CC=C(OCC3(C)CCC4=C(C)C(O)=C(C)C(C)=C4O3)C=C2)SC(=O)NC1=O,CHEMBL408
458,13436,rosiglitazone,7.04,EC50,AGONIST,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,CHEMBL121
459,13436,pioglitazone,6.23,EC50,AGONIST,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,CHEMBL595
460,18515,tolvaptan,9.0,Ki,ANTAGONIST,CC1=C(C=CC=C1)C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCCC(O)C2=CC(Cl)=CC=C12,CHEMBL344159
461,17616,topotecan,,,INHIBITOR,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O,CHEMBL84
462,4969,erlotinib,9.22,IC50,INHIBITOR,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,CHEMBL553
463,862,candesartan cilexetil,,,ANTAGONIST,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,CHEMBL1014
464,11328,racecadotril,9.0,IC50,INHIBITOR,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,CHEMBL10247
465,469,dasatinib,9.6,IC50,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
466,10723,ramelteon,10.39,Ki,AGONIST,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,CHEMBL1218
467,10909,ramelteon,10.9,Ki,AGONIST,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,CHEMBL1218
468,17559,ximelagatran,6.4318,Ki,INHIBITOR,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO,CHEMBL266349
469,17559,argatroban,7.39794,Ki,INHIBITOR,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,CHEMBL1166
470,12712,propylthiouracil,5.06,IC50,INHIBITOR,CCCC1=CC(=O)NC(=S)N1,CHEMBL1518
471,12712,thiamazole,5.57,IC50,INHIBITOR,CN1C=CNC1=S,CHEMBL1515
472,8938,sulfasalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,CHEMBL421
473,8938,meclofenamic acid,4.33,IC50,INHIBITOR,CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl,CHEMBL509
474,6711,triptorelin,9.025,EC50,AGONIST,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,CHEMBL1200554
475,6711,nafarelin,9.699,Kd,AGONIST,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,CHEMBL1200671
476,6711,leuprorelin,9.5229,IC50,AGONIST,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,CHEMBL1200775
477,13203,iloprost,7.75,EC50,AGONIST,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O,CHEMBL494
478,13203,epoprostenol,7.8,Ki,AGONIST,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,CHEMBL962
479,577,disulfiram,,,INHIBITOR,CCN(CC)C(=S)SSC(=S)N(CC)CC,CHEMBL964
480,2740,dichlorphenamide,7.301,Ki,INHIBITOR,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,CHEMBL17
481,12157,ticlopidine,,,ANTAGONIST,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1,CHEMBL833
482,12157,clopidogrel,6.9,Ki,ANTAGONIST,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C1=C(Cl)C=CC=C1,CHEMBL1771
483,70,pentostatin,10.8,IC50,INHIBITOR,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1NC=NC[C@H]2O,CHEMBL1580
484,3446,testolactone,4.46,Ki,INHIBITOR,[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])CC[C@]1(C)OC(=O)CC[C@@]21[H],CHEMBL1571
485,3446,letrozole,8.22,IC50,INHIBITOR,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,CHEMBL1444
486,3446,exemestane,5.6925,IC50,INHIBITOR,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,CHEMBL1200374
487,3446,anastrozole,6.2218,IC50,INHIBITOR,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,CHEMBL1399
488,3446,aminoglutethimide,5.11,IC50,INHIBITOR,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,CHEMBL488
489,4851,fludarabine phosphate,,,INHIBITOR,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]3O)C2=NC(F)=N1,CHEMBL1568
490,4851,clofarabine,,,INHIBITOR,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1,CHEMBL1750
491,18527,tetrabenazine,7.0,Ki,INHIBITOR,[H][C@@]12CC(=O)[C@@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1,CHEMBL117785
492,18527,reserpine,7.9,Ki,INHIBITOR,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,CHEMBL772
493,11519,felbamate,4.284,IC50,ANTAGONIST,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,CHEMBL1094
494,521,tolrestat,8.5086,IC50,INHIBITOR,COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O,CHEMBL436
495,521,epalrestat,7.6778,IC50,INHIBITOR,C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1,CHEMBL56337
496,19194,febuxostat,9.22,Ki,INHIBITOR,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,CHEMBL1164729
497,19101,warfarin,7.0,IC50,INHIBITOR,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,CHEMBL1464
498,19101,phenindione,,,INHIBITOR,O=C1C(C(=O)C2=C1C=CC=C2)C1=CC=CC=C1,CHEMBL711
499,5666,raloxifene,8.0,EC50,MODULATOR,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,CHEMBL81
500,5666,fulvestrant,8.74,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],CHEMBL1358
501,8690,thioguanine,,,INHIBITOR,NC1=NC2=C(NC=N2)C(=S)N1,CHEMBL727
502,8690,ribavirin,6.0,IC50,INHIBITOR,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL1643
503,5044,decitabine,,,INHIBITOR,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,CHEMBL1201129
504,1678,mibefradil,6.6021,IC50,BLOCKER,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C,CHEMBL45816
505,1678,bepridil,5.1487,Ki,BLOCKER,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,CHEMBL1008
506,16563,octreotide,8.5229,IC50,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O,CHEMBL1680
507,16804,octreotide,8.3,Ki,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O,CHEMBL1680
508,16803,octreotide,10.699,EC50,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O,CHEMBL1680
509,144,tacrine,7.14,Ki,INHIBITOR,NC1=C2CCCCC2=NC2=CC=CC=C12,CHEMBL95
510,144,neostigmine,7.59,IC50,INHIBITOR,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,CHEMBL278020
511,144,donepezil,7.8,Ki,INHIBITOR,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,CHEMBL502
512,12187,nalbuphine,6.0,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O,CHEMBL895
513,12187,naltrexone,7.99,Ki,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,CHEMBL19019
514,447,metoclopramide,6.0,EC50,AGONIST,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,CHEMBL86
515,5171,pemetrexed,5.1805,IC50,INHIBITOR,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,CHEMBL225072
516,7742,simvastatin,7.77,IC50,INHIBITOR,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,CHEMBL1064
517,7742,pitavastatin,8.1675,IC50,INHIBITOR,O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=C(C=CC=C2)N=C1C1CC1)CC(O)=O,CHEMBL1201753
518,7742,lovastatin,7.67,IC50,INHIBITOR,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,CHEMBL503
519,7742,cerivastatin,8.0,IC50,INHIBITOR,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C,CHEMBL1477
520,7742,atorvastatin,8.0,IC50,INHIBITOR,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1=CC=C(F)C=C1)C1=CC=CC=C1,CHEMBL393220
521,13783,progesterone,9.8761,ED50,AGONIST,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL103
522,13783,norgestimate,,,AGONIST,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CC\C(C=C3CC[C@@]21[H])=N/O,CHEMBL1200934
523,13783,norethindrone acetate,11.2596,ED50,AGONIST,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1201146
524,13783,norethisterone,11.2596,ED50,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1162
525,13783,norelgestromin,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO,CHEMBL1200807
526,13783,mifepristone,8.74,Ki,ANTAGONIST,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],CHEMBL1276308
527,13783,medroxyprogesterone,9.59,EC50,AGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,CHEMBL717
528,13783,levonorgestrel,12.7959,ED50,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1389
529,13783,etonogestrel,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1531
530,13783,etynodiol,,,AGONIST,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CC[C@H](OC(C)=O)C=C3CC[C@@]21[H],CHEMBL1200624
531,13783,drospirenone,10.5,EC50,AGONIST,[H][C@@]12[C@@H]3C[C@@H]3[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H]2C[C@H]2C2=CC(=O)CC[C@]12C,CHEMBL1509
532,13783,desogestrel,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],CHEMBL1533
533,13783,danazol,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,CHEMBL1479
534,2123,nifedipine,7.7,IC50,GATING INHIBITOR,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,CHEMBL193
535,2123,isradipine,9.3,IC50,GATING INHIBITOR,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,CHEMBL1648
536,2123,felodipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,CHEMBL1480
537,2123,clevidipine,,,BLOCKER,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,CHEMBL1237132
538,2123,amlodipine,7.0,Ki,BLOCKER,[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC,CHEMBL1491
539,14053,alitretinoin,6.52,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,CHEMBL705
540,14053,tretinoin,6.7,EC50,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,CHEMBL38
541,1951,pregabalin,7.0969,IC50,MODULATOR,CC(C)C[C@H](CN)CC(O)=O,CHEMBL1059
542,1951,gabapentin,7.26,IC50,MODULATOR,NCC1(CC(O)=O)CCCCC1,CHEMBL940
543,1977,dichlorphenamide,8.301,IC50,INHIBITOR,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,CHEMBL17
544,18619,pemetrexed,6.4685,IC50,INHIBITOR,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,CHEMBL225072
545,18619,capecitabine,,,INHIBITOR,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,CHEMBL1773
546,18619,fluorouracil,,,INHIBITOR,FC1=CNC(=O)NC1=O,CHEMBL185
547,15619,dutasteride,8.49,IC50,INHIBITOR,[H][C@@]12CC[C@H](C(=O)NC3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,CHEMBL1200969
548,15225,finasteride,8.26,IC50,INHIBITOR,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,CHEMBL710
549,15225,dutasteride,9.2,IC50,INHIBITOR,[H][C@@]12CC[C@H](C(=O)NC3=C(C=CC(=C3)C(F)(F)F)C(F)(F)F)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,CHEMBL1200969
550,2126,trimethadione,,,BLOCKER,CN1C(=O)OC(C)(C)C1=O,CHEMBL695
551,2126,ethosuximide,,,BLOCKER,CCC1(C)CC(=O)NC1=O,CHEMBL696
552,875,testosterone,9.2,EC50,AGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL386630
553,875,oxymetholone,,,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)\C(C[C@]12C)=C/O,CHEMBL1200585
554,875,nandrolone phenpropionate,9.5,EC50,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1200412
555,5154,ospemifene,6.0824943,IC50,MODULATOR,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,CHEMBL2105395
556,5154,toremifene,,,MODULATOR,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,CHEMBL1655
557,5154,fulvestrant,9.62,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],CHEMBL1358
558,5154,ethinylestradiol,9.83,Kd,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL691
559,5154,estradiol,10.3,EC50,AGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL135
560,11518,memantine,,,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
561,17618,valrubicin,,,INHIBITOR,[H][C@@]1(C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=C(OC)C=CC=C3C(=O)C1=C2O)C(=O)COC(=O)CCCC,CHEMBL1096885
562,17618,teniposide,,,INHIBITOR,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@]1([H])O[C@]2([H])CO[C@H](O[C@@]2([H])[C@H](O)[C@H]1O)C1=CC=CS1,CHEMBL452231
563,17618,mitoxantrone,5.9586,IC90,INHIBITOR,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,CHEMBL58
564,17618,idarubicin,,,INHIBITOR,[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=CC=CC=C1C3=O)C(C)=O,CHEMBL1117
565,17618,daunorubicin,,,INHIBITOR,[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(C)=O,CHEMBL178
566,1677,verapamil,6.0,IC50,BLOCKER,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL6966
567,1677,isradipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,CHEMBL1648
568,1677,felodipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,CHEMBL1480
569,1677,diltiazem,7.3188,IC50,BLOCKER,COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,CHEMBL23
570,1677,clevidipine,,,BLOCKER,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,CHEMBL1237132
571,1677,amlodipine,,,BLOCKER,[H]C1(C2=C(Cl)C=CC=C2)C(C(=O)OC)=C(C)NC(COCCN)=C1C(=O)OCC,CHEMBL1491
572,15187,trichlormethiazide,7.0,A2,INHIBITOR,NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl,CHEMBL1054
573,15187,polythiazide,9.09,A2,INHIBITOR,CN1C(CSCC(F)(F)F)NC2=C(C=C(C(Cl)=C2)S(N)(=O)=O)S1(=O)=O,CHEMBL1587
574,15187,indapamide,7.54,A2,INHIBITOR,[H]C1(C)CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,CHEMBL406
575,15187,hydroflumethiazide,7.37,A2,INHIBITOR,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1C(F)(F)F,CHEMBL1763
576,15187,hydrochlorothiazide,7.01,A2,INHIBITOR,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,CHEMBL435
577,15187,chlorothiazide,5.43,A2,INHIBITOR,NS(=O)(=O)C1=C(Cl)C=C2N=CNS(=O)(=O)C2=C1,CHEMBL842
578,15187,benzthiazide,8.17,A2,INHIBITOR,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=C(CSCC1=CC=CC=C1)NS2(=O)=O,CHEMBL1201039
579,15187,bendroflumethiazide,8.3,A2,INHIBITOR,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,CHEMBL1684
580,9891,spironolactone,9.8844,IC50,ANTAGONIST,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)SC(C)=O,CHEMBL1393
581,9891,eplerenone,7.0,IC50,ANTAGONIST,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC,CHEMBL1095097
582,9891,drospirenone,10.5,IC50,ANTAGONIST,[H][C@@]12[C@@H]3C[C@@H]3[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@H]2C[C@H]2C2=CC(=O)CC[C@]12C,CHEMBL1509
583,9891,desoxycorticosterone pivalate,11.0,EC50,AGONIST,[H][C@@]12CC[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200592
584,13879,ciclosporin,8.0458,IC50,MODULATOR,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,CHEMBL160
585,5857,tacrolimus,9.398,Kd,INHIBITOR,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC,CHEMBL269732
586,5857,sirolimus,8.96,Kd,INHIBITOR,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,CHEMBL413
587,5857,pimecrolimus,9.0,Kd,INHIBITOR,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@H](C)[C@@H](O)CC(=O)[C@H](CC)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC,CHEMBL1200686
588,5857,everolimus,8.25964,IC50,INHIBITOR,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OCCO)[C@@H](C1)OC)[C@]1([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,CHEMBL1908360
589,12188,oxymorphone,6.8297,Ki,AGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O,CHEMBL963
590,12188,nalbuphine,8.0,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O,CHEMBL895
591,12188,naltrexone,8.93,Ki,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,CHEMBL19019
592,12188,dezocine,,,ANTAGONIST,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N,CHEMBL1685
593,12188,buprenorphine,9.01,Ki,ANTAGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O,CHEMBL511142
594,539,terazosin,9.08,Ki,ANTAGONIST,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1,CHEMBL611
595,539,phenylephrine,6.9,Ki,AGONIST,CNC[C@H](O)C1=CC(O)=CC=C1,CHEMBL1215
596,539,doxazosin,9.1,Ki,ANTAGONIST,[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1,CHEMBL707
597,539,bunazosin,,,ANTAGONIST,CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1,CHEMBL188185
598,105,ondansetron,7.8,Ki,ANTAGONIST,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,CHEMBL46
599,105,metoclopramide,6.699,Ki,ANTAGONIST,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,CHEMBL86
600,105,granisetron,8.7,Ki,ANTAGONIST,[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2,CHEMBL289469
601,63,terazosin,9.2,Ki,ANTAGONIST,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1,CHEMBL611
602,63,phenylephrine,5.9,IC50,AGONIST,CNC[C@H](O)C1=CC(O)=CC=C1,CHEMBL1215
603,63,methoxamine,4.9,EC50,AGONIST,COC1=CC(C(O)C(C)N)=C(OC)C=C1,CHEMBL524
604,63,doxazosin,8.85,Ki,ANTAGONIST,[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1,CHEMBL707
605,2741,dichlorphenamide,7.4202,Ki,INHIBITOR,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,CHEMBL17
606,12770,pentoxifylline,,,INHIBITOR,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,CHEMBL628
607,12770,diprophylline,,,INHIBITOR,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,CHEMBL221190
608,38,caffeine,4.77,Ki,ANTAGONIST,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,CHEMBL113
609,38,adenosine,4.6198,EC50,AGONIST,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,CHEMBL477
610,37,adenosine,6.5086,EC50,AGONIST,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,CHEMBL477
611,15088,armodafinil,5.4975,IC50,INHIBITOR,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1201192
612,15088,sibutramine,6.0255,Ki,INHIBITOR,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,CHEMBL1419
613,15088,phenmetrazine,6.8827,EC50,INHIBITOR,CC1NCCOC1C1=CC=CC=C1,CHEMBL1200483
614,15088,dexamfetamine,6.68,Ki,RELEASING AGENT,C[C@H](N)CC1=CC=CC=C1,CHEMBL612
615,15088,bupropion,6.28,Kd,INHIBITOR,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,CHEMBL894
616,1226,heparin,7.85,Kd,ACTIVATOR,,CHEMBL1201513
617,12781,alprostadil,6.8,EC50,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,CHEMBL495
618,15541,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
619,15541,orphenadrine,4.7645,IC50,BLOCKER,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
620,15541,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
621,15540,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
622,15540,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
623,15102,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
624,15102,orphenadrine,5.6576,Ki,BLOCKER,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
625,15102,mexiletine,4.38,IC50,BLOCKER,CC(N)COC1=C(C)C=CC=C1C,CHEMBL558
626,15102,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
627,15102,etidocaine,,,BLOCKER,CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C,CHEMBL492
628,15102,bupivacaine,6.0,IC50,BLOCKER,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1098
629,15102,levobupivacaine,,,BLOCKER,CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1200749
630,15251,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
631,15251,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
632,15101,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
633,15101,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
634,15538,zonisamide,,,BLOCKER,NS(=O)(=O)CC1=NOC2=CC=CC=C12,CHEMBL750
635,15538,ropivacaine,,,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
636,15538,orphenadrine,4.8894,IC50,BLOCKER,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
637,15538,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
638,15028,torsemide,6.4,IC50,INHIBITOR,CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC(C)=CC=C1,CHEMBL1148
639,15028,furosemide,6.2,IC50,INHIBITOR,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl,CHEMBL35
640,15028,ethacrynic acid,,,INHIBITOR,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,CHEMBL456
641,15028,bumetanide,7.6,Ki,INHIBITOR,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,CHEMBL1072
642,540,tolazoline,5.43,Ki,ANTAGONIST,C(C1=NCCN1)C1=CC=CC=C1,CHEMBL770
643,540,tizanidine,,,AGONIST,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,CHEMBL1079
644,540,dipivefrine,,,AGONIST,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,CHEMBL1200833
645,540,clonidine,6.7,EC50,AGONIST,ClC1=CC=CC(Cl)=C1NC1=NCCN1,CHEMBL134
646,540,brimonidine,8.4685,EC50,AGONIST,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,CHEMBL844
647,103,zolmitriptan,8.9,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2,CHEMBL1185
648,103,rizatriptan,7.9,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,CHEMBL905
649,103,naratriptan,8.7959,EC50,AGONIST,CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1,CHEMBL1278
650,103,almotriptan,7.5,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,CHEMBL1505
651,444,zolmitriptan,7.7,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(C[C@H]1COC(=O)N1)C=C2,CHEMBL1185
652,444,rizatriptan,6.9,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,CHEMBL905
653,444,almotriptan,8.0,Ki,AGONIST,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,CHEMBL1505
654,6487,triamcinolone acetonide,9.3,EC50,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,CHEMBL1504
655,6487,prednisone,8.0,EC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL635
656,6487,prednisolone,7.8,EC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL131
657,6487,mifepristone,9.0,IC50,ANTAGONIST,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],CHEMBL1276308
658,6487,methylprednisolone,8.5,EC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,CHEMBL650
659,6487,hydrocortisone,8.5,EC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL389621
660,6487,fluticasone propionate,10.74,EC50,AGONIST,[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CC)C(=O)SCF,CHEMBL1473
661,6487,flunisolide,9.1,EC50,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,CHEMBL1512
662,6487,dexamethasone,8.88,EC50,AGONIST,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL384467
663,6487,cortisone acetate,6.02,Kd,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL111861
664,6487,ciclesonide,7.43,Ki,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,CHEMBL2040682
665,6487,budesonide,10.3,EC50,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(CCC)O2)C(=O)CO,CHEMBL1370
666,6487,betamethasone,8.07,IC50,AGONIST,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL632
667,483,trandolapril,8.12,IC50,INHIBITOR,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,CHEMBL1519
668,483,ramipril,8.3418,Ki,INHIBITOR,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,CHEMBL1168
669,483,lisinopril,8.92,IC50,INHIBITOR,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,CHEMBL419213
670,483,cilazapril,8.7,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,CHEMBL515606
671,483,captopril,8.7,Ki,INHIBITOR,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,CHEMBL1560
672,483,benazepril,6.51,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O,CHEMBL838
673,12843,theophylline,3.85,Ki,INHIBITOR,CN1C2=C(N=CN2)C(=O)N(C)C1=O,CHEMBL190
674,12843,cilostazol,6.7,IC50,INHIBITOR,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,CHEMBL799
675,12843,amrinone,4.78,IC50,INHIBITOR,NC1=CC(=CNC1=O)C1=CC=NC=C1,CHEMBL12856
676,430,fesoterodine,6.2706,Ki,ANTAGONIST,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,CHEMBL1201764
677,430,trospium,,,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,CHEMBL1888176
678,430,tiotropium bromide,11.1,Ki,ANTAGONIST,[H][C@]1(C[C@H]2[C@@H]3O[C@@H]3[C@@H](C1)[N+]2(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,CHEMBL1182657
679,430,ipratropium,9.2924,Ki,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,CHEMBL1464005
680,430,hyoscyamine,9.8,Ki,ANTAGONIST,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,CHEMBL1331216
681,430,cevimeline,7.3188,EC50,AGONIST,CC1OC2(CS1)CN1CCC2CC1,CHEMBL168815
682,430,carbachol,8.699,EC50,AGONIST,C[N+](C)(C)CCOC(N)=O,CHEMBL14
683,430,atropine,9.5,Ki,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C,CHEMBL517712
684,150,fesoterodine,6.401,Ki,ANTAGONIST,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,CHEMBL1201764
685,150,hyoscyamine,9.3,Ki,ANTAGONIST,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,CHEMBL1331216
686,150,atropine,8.97,Ki,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C,CHEMBL517712
687,42,scopolamine,9.0,Ki,ANTAGONIST,CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,CHEMBL1187846
688,42,oxyphenonium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1200906
689,42,hyoscyamine,9.0,Ki,ANTAGONIST,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,CHEMBL1331216
690,42,profenamine,,,ANTAGONIST,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=C1C=CC=C2,CHEMBL1206
691,42,cycrimine,,,ANTAGONIST,OC(CCN1CCCCC1)(C1CCCC1)C1=CC=CC=C1,CHEMBL1200828
692,42,cevimeline,7.6383,EC50,AGONIST,CC1OC2(CS1)CN1CCC2CC1,CHEMBL168815
693,42,benzatropine,9.6364,Ki,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,CHEMBL1200383
694,42,atropine,9.31,Ki,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(=O)C(CO)C1=CC=CC=C1)N2C,CHEMBL517712
695,7510,ranitidine,6.86,Kd,ANTAGONIST,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,CHEMBL1790041
696,7510,nizatidine,6.92,Kd,ANTAGONIST,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,CHEMBL653
697,7510,famotidine,7.93,Kd,ANTAGONIST,NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1,CHEMBL902
698,7510,cimetidine,6.14,Kd,ANTAGONIST,CNC(NCCSCC1=C(C)NC=N1)=NC#N,CHEMBL30
699,7510,betazole,,,AGONIST,NCCC1=NNC=C1,CHEMBL1200949
700,7509,propiomazine,,,ANTAGONIST,CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CC(C)N(C)C)C2=C1,CHEMBL1201068
701,7509,promethazine,9.6198,Ki,ANTAGONIST,CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C,CHEMBL643
702,7509,orphenadrine,7.9586,Ki,ANTAGONIST,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
703,7509,olopatadine,8.284,Ki,ANTAGONIST,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,CHEMBL1719
704,7509,loratadine,6.97,Ki,ANTAGONIST,CCOC(=O)N1CCC(CC1)=C1C2=CC=C(Cl)C=C2CCC2=C1N=CC=C2,CHEMBL998
705,7509,levocetirizine,7.95,Ki,ANTAGONIST,OC(=O)COCCN1CCN(CC1)[C@H](C1=CC=CC=C1)C1=CC=C(Cl)C=C1,CHEMBL1201190
706,7509,levocabastine,7.279,Ki,ANTAGONIST,[H][C@@]1(C)CN(CC[C@]1(C(O)=O)C1=CC=CC=C1)[C@@]1([H])CC[C@](CC1)(C#N)C1=CC=C(F)C=C1,CHEMBL1237102
707,7509,ketotifen,9.5086,Ki,ANTAGONIST,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2,CHEMBL534
708,7509,hydroxyzine,8.699,Ki,ANTAGONIST,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,CHEMBL896
709,7509,fexofenadine,8.0,Ki,ANTAGONIST,CC(C)(C(O)=O)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL914
710,7509,epinastine,8.9,Ki,ANTAGONIST,[H]C12CN=C(N)N1C1=C(CC3=C2C=CC=C3)C=CC=C1,CHEMBL1106
711,7509,doxepin,9.75,Ki,ANTAGONIST,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2,CHEMBL1628227
712,7509,diphenylpyraline,8.0757,Ki,ANTAGONIST,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1492
713,7509,diphenhydramine,7.81,Ki,ANTAGONIST,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL657
714,7509,desloratadine,9.4,Ki,ANTAGONIST,ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1,CHEMBL1172
715,7509,cyproheptadine,10.2218,Ki,ANTAGONIST,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL516
716,7509,clemastine,8.585,Ki,ANTAGONIST,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,CHEMBL1626
717,7509,chlorphenamine,8.15,Ki,ANTAGONIST,CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,CHEMBL505
718,7509,cetirizine,7.91,Ki,ANTAGONIST,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,CHEMBL1000
719,7509,bromazine,8.8861,Ki,ANTAGONIST,CN(C)CCOC(C1=CC=CC=C1)C1=CC=C(Br)C=C1,CHEMBL1200967
720,7509,azelastine,8.1675,Ki,ANTAGONIST,[H]C1(CCCN(C)CC1)N1N=C(CC2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C1=O,CHEMBL639
721,7509,acrivastine,7.16,IC50,ANTAGONIST,CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC(\C=C\C(O)=O)=N1,CHEMBL1224
722,7509,histamine,4.1,Ki,AGONIST,NCCC1=CN=CN1,CHEMBL90
723,7405,nicotinic acid,7.3,Ki,AGONIST,OC(=O)C1=CN=CC=C1,CHEMBL573
724,104,paliperidone,8.95860767,Ki,ANTAGONIST,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,CHEMBL1621
725,4816,paliperidone,8.47002888,Ki,ANTAGONIST,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,CHEMBL1621
726,316,xylometazoline,5.98000002,Ki,AGONIST,CC1=CC(=CC(C)=C1CC1=NCCN1)C(C)(C)C,CHEMBL312448
727,540,naphazoline,6.38999987,Ki,AGONIST,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CHEMBL761
728,316,naphazoline,6.38999987,Ki,AGONIST,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CHEMBL761
729,67,naphazoline,7.67999983,Ki,AGONIST,C(C1=NCCN1)C1=CC=CC2=CC=CC=C12,CHEMBL761
730,6320,vigabatrin,,,INHIBITOR,NC(CCC(O)=O)C=C,CHEMBL89598
731,11166,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
732,10609,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
733,155,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
734,10845,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
735,11051,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
736,10850,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
737,10848,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
738,10853,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
739,11192,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
740,11202,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
741,11052,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
742,11049,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
743,10854,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
744,11312,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
745,11050,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
746,10851,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
747,11193,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
748,10849,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
749,11313,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
750,11046,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
751,11195,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
752,11198,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
753,10610,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
754,11314,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
755,11448,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
756,11451,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
757,11842,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
758,11721,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
759,11872,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
760,11873,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
761,11722,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
762,10852,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
763,11167,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
764,11048,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
765,11053,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
766,11161,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
767,10855,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
768,11194,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
769,10846,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
770,11196,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
771,11162,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
772,11200,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
773,11164,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
774,11874,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
775,11163,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
776,11315,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
777,10847,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
778,11311,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
779,2706,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
780,11197,metformin,,,INHIBITOR,CN(C)C(=N)NC(N)=N,CHEMBL1431
781,13391,aminocaproic acid,4.4,IC50,INHIBITOR,NCCCCCC(O)=O,CHEMBL1046
782,756,tranylcypromine,7.48,IC50,INHIBITOR,N[C@@H]1C[C@H]1C1=CC=CC=C1,CHEMBL313833
783,18527,dexamfetamine,,,INHIBITOR,C[C@H](N)CC1=CC=CC=C1,CHEMBL612
784,15387,amfetamine,,,RELEASING AGENT,CC(N)CC1=CC=CC=C1,CHEMBL405
785,19194,allopurinol,5.15,Ki,INHIBITOR,OC1=NC=NC2=C1C=NN2,CHEMBL1467
786,144,pralidoxime,4.59,Kd,ACTIVATOR,C[N+]1=CC=CC=C1C=NO,CHEMBL14577
787,16802,valproic acid,,,INHIBITOR,CCCC(CCC)C(O)=O,CHEMBL433
788,430,acetylcholine,6.66,EC50,AGONIST,CC(=O)OCC[N+](C)(C)C,CHEMBL667
789,15088,trimipramine,5.42250824,Ki,INHIBITOR,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL644
790,15089,trimipramine,6.8268137,Ki,INHIBITOR,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL644
791,4816,triflupromazine,8.55284214,Ki,ANTAGONIST,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(F)(F)F,CHEMBL570
792,4816,trifluoperazine,8.84096813,Ki,ANTAGONIST,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,CHEMBL422
793,4816,thiothixene,9.34678745,Ki,ANTAGONIST,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,CHEMBL1201
794,973,phenylpropanolamine,,,AGONIST,CC(N)C(O)C1=CC=CC=C1,CHEMBL61006
795,13316,aminosalicylic acid,,,INHIBITOR,NC1=CC(O)=C(C=C1)C(O)=O,CHEMBL1169
796,12865,aminosalicylic acid,,,INHIBITOR,NC1=CC(O)=C(C=C1)C(O)=O,CHEMBL1169
797,8938,mesalazine,,,INHIBITOR,NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL704
798,2126,paramethadione,,,BLOCKER,CCC1(C)OC(=O)N(C)C1=O,CHEMBL1100
799,1678,paramethadione,,,BLOCKER,CCC1(C)OC(=O)N(C)C1=O,CHEMBL1100
800,2127,paramethadione,,,BLOCKER,CCC1(C)OC(=O)N(C)C1=O,CHEMBL1100
801,13391,tranexamic acid,5.96,Kd,INHIBITOR,NC[C@H]1CC[C@@H](CC1)C(O)=O,CHEMBL877
802,756,pargyline,5.74,Ki,INHIBITOR,CN(CC#C)CC1=CC=CC=C1,CHEMBL673
803,1028,pargyline,5.47,IC50,INHIBITOR,CN(CC#C)CC1=CC=CC=C1,CHEMBL673
804,430,methacholine,,,AGONIST,CC(C[N+](C)(C)C)OC(C)=O,CHEMBL978
805,6786,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
806,6782,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
807,6829,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
808,6478,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
809,6480,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
810,6479,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
811,6477,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
812,6778,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
813,6777,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
814,6559,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
815,6779,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
816,6783,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
817,6780,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
818,6784,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
819,6560,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
820,6789,methoxyflurane,,,POSITIVE MODULATOR,COC(F)(F)C(Cl)Cl,CHEMBL1341
821,15387,pseudoephedrine,,,RELEASING AGENT,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1,CHEMBL1590
822,144,edrophonium,8.79,Ki,INHIBITOR,CC[N+](C)(C)C1=CC=CC(O)=C1,CHEMBL1104
823,7076,desflurane,,,POSITIVE MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
824,6988,desflurane,,,POSITIVE MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
825,6786,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
826,6782,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
827,6829,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
828,6478,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
829,6480,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
830,6479,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
831,6477,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
832,6778,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
833,6777,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
834,6559,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
835,6779,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
836,6783,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
837,6780,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
838,6784,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
839,6560,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
840,6789,desflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
841,8327,desflurane,,,OPENER,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
842,8173,desflurane,,,OPENER,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
843,8323,desflurane,,,OPENER,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
844,8326,desflurane,,,OPENER,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
845,8322,desflurane,,,OPENER,FC(F)OC(F)C(F)(F)F,CHEMBL1200733
846,539,norepinephrine,4.69,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
847,540,norepinephrine,7.2,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
848,79,norepinephrine,5.4,Kd,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
849,42,procyclidine,8.33724213,Ki,ANTAGONIST,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,CHEMBL86715
850,4816,pipotiazine palmitate,9.69896984,Ki,ANTAGONIST,CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)S(=O)(=O)N(C)C)CC1,CHEMBL398880
851,316,phenoxybenzamine,8.45593166,Ki,ANTAGONIST,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,CHEMBL753
852,15088,methamphetamine,7.61083412,Ki,INHIBITOR,CN[C@@H](C)CC1=CC=CC=C1,CHEMBL1200952
853,104,mesoridazine,8.12491512,Ki,ANTAGONIST,[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C,CHEMBL1088
854,4816,mesoridazine,7.72445822,Ki,ANTAGONIST,[H]C1(CCN2C3=CC=CC=C3SC3=C2C=C(C=C3)S(C)=O)CCCCN1C,CHEMBL1088
855,4816,fluphenazine enanthate,9.26760578,Ki,ANTAGONIST,CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,CHEMBL1200951
856,4816,droperidol,9.60206032,Ki,ANTAGONIST,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2,CHEMBL1108
857,15089,clomipramine,9.70335674,Ki,INHIBITOR,CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2,CHEMBL415
858,7509,brompheniramine,8.21752739,Ki,ANTAGONIST,CN(C)CCC(C1=CC=C(Br)C=C1)C1=CC=CC=N1,CHEMBL811
859,316,apraclonidine,7.93839359,Ki,AGONIST,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,CHEMBL647
860,15088,amfetamine,6.93554211,Ki,RELEASING AGENT,CC(N)CC1=CC=CC=C1,CHEMBL405
861,15088,lisdexamfetamine,,,RELEASING AGENT,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,CHEMBL1201178
862,3683,lubiprostone,,,OPENER,[H][C@@]12CC(=O)[C@]([H])(CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC,CHEMBL1201134
863,15104,oxybuprocaine,,,BLOCKER,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,CHEMBL1200
864,436,trilostane,,,INHIBITOR,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]23O[C@@H]2C(O)=C(C[C@]13C)C#N,CHEMBL1200907
865,15538,topiramate,,,BLOCKER,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
866,12957,sapropterin,5.4,Ki,ACTIVATOR,C[C@H](O)[C@H](O)[C@H]1CNC2=C(N1)C(=O)NC(N)=N2,CHEMBL1201774
867,483,spirapril,9.1,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2,CHEMBL431
868,7076,sevoflurane,,,POSITIVE MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
869,5154,quinestrol,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC1CCCC1)C=C3,CHEMBL1201165
870,15104,proparacaine,,,BLOCKER,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,CHEMBL1196
871,15104,procaine,,,BLOCKER,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,CHEMBL569
872,15473,probenecid,,,INHIBITOR,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,CHEMBL897
873,756,phenelzine,7.82,Ki,INHIBITOR,NNCCC1=CC=CC=C1,CHEMBL1089
874,12630,pentoxifylline,,,INHIBITOR,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,CHEMBL628
875,875,oxandrolone,,,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12C,CHEMBL1200436
876,63,norepinephrine,7.4,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
877,6487,mometasone furoate,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1161
878,18843,metirosine,,,INHIBITOR,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,CHEMBL1200862
879,7076,methoxyflurane,,,AGONIST,COC(F)(F)C(Cl)Cl,CHEMBL1341
880,12865,mesalazine,,,INHIBITOR,NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL704
881,13840,mercaptopurine,,,INHIBITOR,S=C1N=CNC2=C1NC=N2,CHEMBL1425
882,973,mephentermine,,,AGONIST,CNC(C)(C)CC1=CC=CC=C1,CHEMBL1200996
883,13783,megestrol acetate,,,AGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(C)C2=CC(=O)CC[C@]12C,CHEMBL1201139
884,6487,loteprednol etabonate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200865
885,15541,lamotrigine,4.77,IC50,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
886,15540,lamotrigine,,,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
887,15251,lamotrigine,4.77,IC50,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
888,15538,lamotrigine,,,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
889,1028,isocarboxazid,,,INHIBITOR,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1,CHEMBL1201168
890,756,isocarboxazid,,,INHIBITOR,CC1=CC(=NO1)C(=O)NNCC1=CC=CC=C1,CHEMBL1201168
891,17617,irinotecan,,,INHIBITOR,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,CHEMBL481
892,15103,indecainide,,,BLOCKER,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=C1C=CC=C2,CHEMBL1200341
893,15387,guanadrel,,,SUBSTRATE,NC(=N)NCC1COC2(CCCCC2)O1,CHEMBL1037
894,15103,fosphenytoin,,,BLOCKER,OP(O)(=O)OCN1C(=O)NC(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL919
895,6487,flumetasone pivalate,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1200877
896,9891,fludrocortisone acetate,9.92,IC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1201010
897,18619,floxuridine,,,INHIBITOR,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(F)C(=O)NC1=O,CHEMBL917
898,11228,felbamate,,,ANTAGONIST,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,CHEMBL1094
899,15016,etretinate,,,AGONIST,CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(C)=C(OC)C=C1C,CHEMBL464
900,13783,dydrogesterone,6.9,Ki,AGONIST,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,CHEMBL1200853
901,15104,dyclonine,,,BLOCKER,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,CHEMBL1200478
902,875,drostanolone propionate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12C,CHEMBL1201048
903,430,diphemanil,,,ANTAGONIST,C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1200880
904,5154,dienestrol,4.88,EC50,AGONIST,C\C=C(\C(=C\C)\C1=CC=C(O)C=C1)/C1=CC=C(O)C=C1,CHEMBL1018
905,15104,cinchocaine,,,BLOCKER,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,CHEMBL1086
906,15103,cinchocaine,,,BLOCKER,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,CHEMBL1086
907,7509,dexbrompheniramine,,,ANTAGONIST,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1,CHEMBL1200638
908,144,demecarium,,,INHIBITOR,CN(CCCCCCCCCCN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,CHEMBL1200514
909,15104,chloroprocaine,,,BLOCKER,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,CHEMBL944
910,2281,ceruletide,,,AGONIST,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,CHEMBL1200755
911,4816,carfenazine,,,ANTAGONIST,CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1,CHEMBL1201328
912,17559,bivalirudin,8.6,Ki,INHIBITOR,[H]N[C@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,CHEMBL2103749
913,15387,betanidine,,,SUBSTRATE,CNC(NC)=NCC1=CC=CC=C1,CHEMBL1201260
914,7509,bepotastine,,,ANTAGONIST,OC(=O)CCCN1CCC(CC1)O[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,CHEMBL1201758
915,7509,azatadine,,,ANTAGONIST,CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2,CHEMBL946
916,430,octatropine methylbromide,,,ANTAGONIST,CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C,CHEMBL1578
917,42,octatropine methylbromide,,,ANTAGONIST,CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C,CHEMBL1578
918,18884,anisindione,,,INHIBITOR,COC1=CC=C(C=C1)C1C(=O)C2=C(C=CC=C2)C1=O,CHEMBL712
919,12843,anagrelide,7.27,IC50,INHIBITOR,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,CHEMBL760
920,18170,aminocaproic acid,,,INHIBITOR,NCCCCCC(O)=O,CHEMBL1046
921,4816,acetophenazine,,,ANTAGONIST,CC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1,CHEMBL1085
922,5044,azacitidine,,,INHIBITOR,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL1489
923,547,levdobutamine,,,AGONIST,C[C@@H](CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,CHEMBL1367478
924,79,carvedilol,9.9,Ki,ANTAGONIST,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1,CHEMBL723
925,6711,abarelix,9.49,Ki,ANTAGONIST,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,CHEMBL1252
926,4816,cabergoline,9.2,Ki,AGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,CHEMBL1201087
927,79,bupranolol,9.1,Ki,ANTAGONIST,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,CHEMBL305380
928,973,oxymetazoline,8.2,Ki,AGONIST,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,CHEMBL762
929,4816,domperidone,8.4,Ki,ANTAGONIST,ClC1=CC2=C(C=C1)N(C1CCN(CCCN3C(=O)NC4=C3C=CC=C4)CC1)C(=O)N2,CHEMBL219916
930,4816,flupentixol,8.82,Ki,ANTAGONIST,OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,CHEMBL54661
931,547,bupranolol,9.0,Ki,ANTAGONIST,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,CHEMBL305380
932,79,nadolol,8.6,Ki,ANTAGONIST,CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2,CHEMBL649
933,1677,nisoldipine,7.1,IC50,GATING INHIBITOR,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C,CHEMBL1726
934,4815,flupentixol,8.4,Ki,ANTAGONIST,OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,CHEMBL54661
935,4816,piribedil,6.9,Ki,AGONIST,C(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1,CHEMBL1256997
936,2123,nisoldipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C,CHEMBL1726
937,447,mosapride,6.9,Ki,AGONIST,CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1,CHEMBL60889
938,547,practolol,6.8,Ki,ANTAGONIST,CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1,CHEMBL6995
939,2123,nimodipine,,,BLOCKER,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,CHEMBL1428
940,316,oxymetazoline,6.2,Ki,AGONIST,CC1=CC(=C(O)C(C)=C1CC1=NCCN1)C(C)(C)C,CHEMBL762
941,37,caffeine,4.97,Ki,ANTAGONIST,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,CHEMBL113
942,430,propantheline,10.0,Ki,ANTAGONIST,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C,CHEMBL1240
943,42,propantheline,9.7,Ki,ANTAGONIST,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C,CHEMBL1240
944,430,clidinium,9.6,Ki,ANTAGONIST,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL620
945,150,propantheline,9.5,Ki,ANTAGONIST,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C,CHEMBL1240
946,547,carvedilol,9.5,Ki,ANTAGONIST,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1,CHEMBL723
947,1677,nitrendipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,CHEMBL475534
948,2122,ziconotide,,,BLOCKER,[H]N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N3)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(N)=O,CHEMBL1795072
949,430,hexocyclium,8.9,Ki,ANTAGONIST,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1,CHEMBL1201325
950,42,hexocyclium,,,ANTAGONIST,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1,CHEMBL1201325
951,17465,levothyroxine,8.52,IC50,AGONIST,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,CHEMBL42115
952,63,epinephrine,,,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
953,547,nadolol,6.9,Ki,ANTAGONIST,CC(C)(C)NCC(O)COC1=CC=CC2=C1CC(O)C(O)C2,CHEMBL649
954,1677,nimodipine,,,BLOCKER,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,CHEMBL1428
955,539,epinephrine,,,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
956,12756,misoprostol,8.1,Ki,AGONIST,[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCC(=O)OC)[C@@]1([H])\C=C\CC(C)(O)CCCC,CHEMBL606
957,104,molindone,6.5,Ki,ANTAGONIST,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,CHEMBL460
958,12942,latanoprost,6.3,Ki,AGONIST,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,CHEMBL1050
959,27,agomelatine,6.2,Ki,ANTAGONIST,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,CHEMBL10878
960,15101,etidocaine,,,BLOCKER,CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C,CHEMBL492
961,7135,ivabradine,5.7,IC50,BLOCKER,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,CHEMBL471737
962,79,ephedrine,5.6,Ki,AGONIST,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,CHEMBL211456
963,7303,ivabradine,,,BLOCKER,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,CHEMBL471737
964,7304,ivabradine,5.7,IC50,BLOCKER,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,CHEMBL471737
965,150,dexetimide,8.9,Ki,ANTAGONIST,O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C1=CC=CC=C1,CHEMBL1908364
966,15101,lidocaine,,,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
967,15103,lidocaine,4.8,Kd,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
968,15101,phenytoin,4.9,IC50,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
969,13566,bezafibrate,4.3,EC50,AGONIST,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,CHEMBL264374
970,430,bethanechol,4.2,Ki,AGONIST,CC(C[N+](C)(C)C)OC(N)=O,CHEMBL1482
971,150,bethanechol,4.0,Ki,AGONIST,CC(C[N+](C)(C)C)OC(N)=O,CHEMBL1482
972,539,methoxamine,4.0,Ki,AGONIST,COC1=CC(C(O)C(C)N)=C(OC)C=C1,CHEMBL524
973,15104,lidocaine,,,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
974,19094,doxercalciferol,,,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,CHEMBL1200810
975,103,dihydroergotamine,9.9,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,CHEMBL1732
976,316,dexmedetomidine,9.7,Ki,AGONIST,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,CHEMBL778
977,540,dexmedetomidine,9.3,Ki,AGONIST,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,CHEMBL778
978,7405,acipimox,5.6,EC50,AGONIST,CC1=CN=C(C=[N+]1[O-])C(O)=O,CHEMBL345714
979,6626,glucagon,9.0,EC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O,CHEMBL266481
980,104,terguride,8.3,Ki,AGONIST,[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC,CHEMBL73151
981,26,terguride,8.2,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC,CHEMBL73151
982,17846,taltirelin,6.5,Ki,AGONIST,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCCC1C(N)=O,CHEMBL2107016
983,547,denopamine,5.8,Ki,AGONIST,COC1=CC=C(CCNC[C@H](O)C2=CC=C(O)C=C2)C=C1OC,CHEMBL493682
984,13566,clofibrate,4.25,IC50,AGONIST,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1,CHEMBL565
985,15089,amoxapine,7.46852108,IC50,INHIBITOR,ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1,CHEMBL1113
986,15387,amoxapine,7.88605665,Ki,INHIBITOR,ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1,CHEMBL1113
987,6487,beclometasone dipropionate,8.4271284,Ki,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1586
988,42,diphenidol,7.1079054,Ki,ANTAGONIST,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL936
989,547,levobunolol,8.3990271,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1,CHEMBL1201177
990,79,levobunolol,9.26280736,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1,CHEMBL1201177
991,5154,clomifene,8.88605665,Ki,MODULATOR,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL2355051
992,7509,cyclizine,8.35261703,Ki,ANTAGONIST,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL648
993,63,dapiprazole,8.38827669,Ki,ANTAGONIST,CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1,CHEMBL1201044
994,6487,desoximetasone,8.93181414,Ki,AGONIST,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL16829
995,42,dicycloverine,9.07883395,Ki,ANTAGONIST,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,CHEMBL1123
996,430,dicycloverine,9.03292027,Ki,ANTAGONIST,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,CHEMBL1123
997,7509,dimenhydrinate,7.43179828,Ki,ANTAGONIST,CN1C2=C(N=C(Cl)N2)C(=O)N(C)C1=O.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1200406
998,12769,dipyridamole,5.80161787,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
999,104,droperidol,9.13194364,Ki,ANTAGONIST,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=C1C=CC=C2,CHEMBL1108
1000,67,epinephrine,6.55909092,Ki,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
1001,316,epinephrine,6.40120949,Ki,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
1002,540,epinephrine,6.44855,Ki,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
1003,13316,felbinac,6.04866248,IC50,INHIBITOR,OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1,CHEMBL413965
1004,6487,fluocinolone acetonide,8.84771166,Ki,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,CHEMBL989
1005,6487,fluocinonide,8.6216021,Ki,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@]([H])(F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@]([H])(O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,CHEMBL989
1006,6487,fluorometholone,8.80134291,Ki,AGONIST,[H][C@@]12CC[C@](O)(C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,CHEMBL1200600
1007,6487,fludroxycortide,8.69464863,Ki,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,CHEMBL1201012
1008,150,gallamine,6.1481304,Ki,NEGATIVE ALLOSTERIC MODULATOR,CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,CHEMBL360055
1009,547,labetalol,8.23358715,Ki,ANTAGONIST,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,CHEMBL429
1010,79,labetalol,7.95860732,Ki,ANTAGONIST,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,CHEMBL429
1011,26,lisuride,8.48945499,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,CHEMBL157138
1012,5154,mestranol,8.2823295,Ki,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC)C=C3,CHEMBL1201151
1013,4815,methylergometrine,6.26841124,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,CHEMBL1200843
1014,15088,modafinil,5.83683863,Ki,INHIBITOR,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1373
1015,13316,oxaprozin,6.06752624,IC50,INHIBITOR,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1071
1016,1028,phenelzine,6.83564714,IC50,INHIBITOR,NNCCC1=CC=CC=C1,CHEMBL1089
1017,547,propafenone,6.68824614,Ki,ANTAGONIST,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,CHEMBL631
1018,6487,triamcinolone,7.58502665,Ki,AGONIST,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1451
1019,430,tropicamide,7.52287875,Ki,ANTAGONIST,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,CHEMBL1200604
1020,67,guanabenz,7.82390874,Ki,AGONIST,NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl,CHEMBL420
1021,316,guanabenz,7.16749109,Ki,AGONIST,NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl,CHEMBL420
1022,540,guanabenz,6.79317412,Ki,AGONIST,NC(=N)N\N=C\C1=C(Cl)C=CC=C1Cl,CHEMBL420
1023,6487,clobetasol propionate,9.17914201,Ki,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1159650
1024,6487,diflorasone diacetate,8.53610701,Ki,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(C)=O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1200545
1025,6487,halcinonide,9.13548892,Ki,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CCl,CHEMBL1200845
1026,6487,betamethasone phosphate,8.42829117,Ki,AGONIST,[H][C@@]12C[C@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200762
1027,67,norepinephrine,7.18,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
1028,973,norepinephrine,5.82,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
1029,16580,levetiracetam,6.0999999,Ki,MODULATOR,CC[C@H](N1CCCC1=O)C(N)=O,CHEMBL1286
1030,7983,propylthiouracil,,,INHIBITOR,CCCC1=CC(=O)NC(=S)N1,CHEMBL1518
1031,756,rasagiline,6.15,Ki,INHIBITOR,C#CCN[C@@H]1CCC2=C1C=CC=C2,CHEMBL887
1032,6829,propofol,5.7,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1033,6480,propofol,5.7,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1034,6559,propofol,5.7,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1035,6829,propofol,5.39,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1036,6480,propofol,5.39,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1037,6479,propofol,5.39,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1038,6480,propofol,4.95,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1039,6777,propofol,4.95,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1040,6559,propofol,4.95,EC50,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1O,CHEMBL526
1041,1028,iproniazid,5.18,IC50,INHIBITOR,CC(C)NNC(=O)C1=CC=NC=C1,CHEMBL92401
1042,756,iproniazid,5.12,IC50,INHIBITOR,CC(C)NNC(=O)C1=CC=NC=C1,CHEMBL92401
1043,15104,mexiletine,4.25,IC50,BLOCKER,CC(N)COC1=C(C)C=CC=C1C,CHEMBL558
1044,15541,mexiletine,4.89,Ki,BLOCKER,CC(N)COC1=C(C)C=CC=C1C,CHEMBL558
1045,15101,mexiletine,5.54,IC50,BLOCKER,CC(N)COC1=C(C)C=CC=C1C,CHEMBL558
1046,11089,memantine,5.26,IC50,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
1047,11519,memantine,5.26,IC50,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
1048,11089,memantine,9.02,IC50,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
1049,11228,memantine,9.02,IC50,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
1050,11089,memantine,5.02,IC50,NEGATIVE ALLOSTERIC MODULATOR,CC12CC3CC(C)(C1)CC(N)(C3)C2,CHEMBL807
1051,38,theophylline,5.57,Ki,ANTAGONIST,CN1C2=C(N=CN2)C(=O)N(C)C1=O,CHEMBL190
1052,385,theophylline,9.22,Ki,ANTAGONIST,CN1C2=C(N=CN2)C(=O)N(C)C1=O,CHEMBL190
1053,37,theophylline,9.22,Ki,ANTAGONIST,CN1C2=C(N=CN2)C(=O)N(C)C1=O,CHEMBL190
1054,11400,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1055,11088,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1056,11089,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1057,11228,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1058,11519,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1059,11520,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1060,11518,acamprosate,,,ANTAGONIST,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1061,144,pyridostigmine,6.44,IC50,INHIBITOR,CN(C)C(=O)OC1=C[N+](C)=CC=C1,CHEMBL812
1062,79,epinephrine,6.2,Kd,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
1063,973,epinephrine,5.7,Ki,AGONIST,CNC[C@H](O)C1=CC=C(O)C(O)=C1,CHEMBL679
1064,144,fluostigmine,5.22,Ki,INHIBITOR,CC(C)OP(F)(=O)OC(C)C,CHEMBL1025
1065,7076,isoflurane,,,POSITIVE MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1066,6988,isoflurane,,,POSITIVE MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1067,6786,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1068,6782,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1069,6829,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1070,6478,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1071,6480,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1072,6479,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1073,6477,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1074,6778,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1075,6777,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1076,6559,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1077,6779,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1078,6783,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1079,6780,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1080,6784,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1081,6560,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1082,6789,isoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1083,8327,isoflurane,,,OPENER,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1084,8173,isoflurane,,,OPENER,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1085,8323,isoflurane,,,OPENER,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1086,8326,isoflurane,,,OPENER,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1087,8322,isoflurane,,,OPENER,FC(F)OC(Cl)C(F)(F)F,CHEMBL1256
1088,8327,enflurane,,,OPENER,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
1089,8173,enflurane,,,OPENER,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
1090,8323,enflurane,,,OPENER,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
1091,8326,enflurane,,,OPENER,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
1092,8322,enflurane,,,OPENER,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
1093,756,selegiline,7.26,Ki,INHIBITOR,C[C@H](CC1=CC=CC=C1)N(C)CC#C,CHEMBL972
1094,2126,phensuximide,,,BLOCKER,CN1C(=O)CC(C1=O)C1=CC=CC=C1,CHEMBL797
1095,1678,phensuximide,,,BLOCKER,CN1C(=O)CC(C1=O)C1=CC=CC=C1,CHEMBL797
1096,2127,phensuximide,,,BLOCKER,CN1C(=O)CC(C1=O)C1=CC=CC=C1,CHEMBL797
1097,3258,carglumic acid,,,POSITIVE ALLOSTERIC MODULATOR,NC(=O)N[C@@H](CCC(O)=O)C(O)=O,CHEMBL1201780
1098,6490,isosorbide mononitrate,,,ACTIVATOR,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,CHEMBL1311
1099,6792,isosorbide mononitrate,,,ACTIVATOR,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,CHEMBL1311
1100,7026,isosorbide mononitrate,,,ACTIVATOR,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,CHEMBL1311
1101,6793,isosorbide mononitrate,,,ACTIVATOR,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,CHEMBL1311
1102,15088,phendimetrazine,,,INHIBITOR,[H][C@@]1(C)N(C)CCO[C@@]1([H])C1=CC=CC=C1,CHEMBL1744
1103,15387,phendimetrazine,,,INHIBITOR,[H][C@@]1(C)N(C)CCO[C@@]1([H])C1=CC=CC=C1,CHEMBL1744
1104,385,caffeine,5.61,Ki,ANTAGONIST,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,CHEMBL113
1105,7076,halothane,,,POSITIVE MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1106,6988,halothane,,,POSITIVE MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1107,6786,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1108,6782,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1109,6829,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1110,6478,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1111,6480,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1112,6479,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1113,6477,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1114,6778,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1115,6777,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1116,6559,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1117,6779,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1118,6783,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1119,6780,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1120,6784,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1121,6560,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1122,6789,halothane,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)C(Cl)Br,CHEMBL931
1123,8327,halothane,,,OPENER,FC(F)(F)C(Cl)Br,CHEMBL931
1124,8173,halothane,,,OPENER,FC(F)(F)C(Cl)Br,CHEMBL931
1125,8323,halothane,,,OPENER,FC(F)(F)C(Cl)Br,CHEMBL931
1126,8326,halothane,,,OPENER,FC(F)(F)C(Cl)Br,CHEMBL931
1127,8322,halothane,,,OPENER,FC(F)(F)C(Cl)Br,CHEMBL931
1128,17637,arsenic trioxide,,,INHIBITOR,,CHEMBL1200978
1129,6786,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1130,6782,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1131,6829,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1132,6478,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1133,6480,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1134,6479,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1135,6477,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1136,6778,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1137,6777,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1138,6559,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1139,6779,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1140,6783,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1141,6780,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1142,6784,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1143,6560,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1144,6789,metharbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(CC)C(=O)NC(=O)N(C)C1=O,CHEMBL450
1145,6786,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1146,6782,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1147,6829,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1148,6478,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1149,6480,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1150,6479,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1151,6477,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1152,6778,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1153,6777,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1154,6559,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1155,6779,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1156,6783,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1157,6780,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1158,6784,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1159,6560,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1160,6789,sevoflurane,,,POSITIVE ALLOSTERIC MODULATOR,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1161,8327,sevoflurane,,,OPENER,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1162,8173,sevoflurane,,,OPENER,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1163,8323,sevoflurane,,,OPENER,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1164,8326,sevoflurane,,,OPENER,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1165,8322,sevoflurane,,,OPENER,FCOC(C(F)(F)F)C(F)(F)F,CHEMBL1200694
1166,18300,monobenzone,,,INHIBITOR,OC1=CC=C(OCC2=CC=CC=C2)C=C1,CHEMBL1388
1167,67,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1168,316,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1169,540,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1170,63,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1171,973,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1172,539,tetryzoline,,,AGONIST,[H]C1(CCCC2=CC=CC=C12)C1=NCCN1,CHEMBL1266
1173,67,dexmedetomidine,8.82,EC50,AGONIST,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1,CHEMBL778
1174,2126,methsuximide,,,BLOCKER,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,CHEMBL697
1175,1678,methsuximide,,,BLOCKER,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,CHEMBL697
1176,2127,methsuximide,,,BLOCKER,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,CHEMBL697
1177,15538,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1178,15102,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1179,15539,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1180,15103,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1181,15541,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1182,15101,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1183,15251,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1184,15105,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1185,15540,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1186,15104,ethotoin,,,BLOCKER,CCN1C(=O)NC(C1=O)C1=CC=CC=C1,CHEMBL1095
1187,15088,diethylpropion,,,INHIBITOR,CCN(CC)C(C)C(=O)C1=CC=CC=C1,CHEMBL1693
1188,15387,diethylpropion,,,INHIBITOR,CCN(CC)C(C)C(=O)C1=CC=CC=C1,CHEMBL1693
1189,10291,miglitol,6.0,Ki,INHIBITOR,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL1561
1190,10119,miglitol,6.46,IC50,INHIBITOR,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,CHEMBL1561
1191,1028,toloxatone,5.82,Ki,INHIBITOR,CCC1CN(C(=O)O1)C1=CC(C)=CC=C1,CHEMBL18116
1192,607,minoxidil,,,OPENER,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,CHEMBL802
1193,8396,minoxidil,,,OPENER,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,CHEMBL802
1194,12843,milrinone,6.36,IC50,INHIBITOR,CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1,CHEMBL189
1195,79,orciprenaline,6.3,Kd,AGONIST,CC(C)NCC(O)C1=CC(O)=CC(O)=C1,CHEMBL776
1196,79,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1197,547,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1198,67,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1199,332,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1200,316,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1201,540,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1202,63,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1203,973,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1204,539,droxidopa,,,AGONIST,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL2103827
1205,15538,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1206,15102,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1207,15539,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1208,15103,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1209,15541,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1210,15101,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1211,15251,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1212,15105,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1213,15540,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1214,15104,phenazopyridine,,,BLOCKER,NC1=NC(N)=C(C=C1)\N=N\C1=CC=CC=C1,CHEMBL1242
1215,6584,baclofen,7.46,IC50,AGONIST,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,CHEMBL701
1216,6543,baclofen,7.46,IC50,AGONIST,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,CHEMBL701
1217,6755,carmustine,5.09,IC50,INHIBITOR,ClCCNC(=O)N(CCCl)N=O,CHEMBL513
1218,15538,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1219,15102,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1220,15539,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1221,15103,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1222,15541,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1223,15101,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1224,15251,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1225,15105,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1226,15540,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1227,15104,mephenytoin,,,BLOCKER,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,CHEMBL861
1228,2741,acetazolamide,8.48,Ki,INHIBITOR,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,CHEMBL20
1229,2740,acetazolamide,8.6,Ki,INHIBITOR,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,CHEMBL20
1230,2138,acetazolamide,7.96,Ki,INHIBITOR,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,CHEMBL20
1231,1977,acetazolamide,7.92,Ki,INHIBITOR,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,CHEMBL20
1232,3446,fadrozole,10.3,Ki,INHIBITOR,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,CHEMBL9298
1233,6786,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1234,6782,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1235,6829,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1236,6478,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1237,6480,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1238,6479,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1239,6477,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1240,6778,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1241,6777,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1242,6559,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1243,6779,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1244,6783,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1245,6780,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1246,6784,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1247,6560,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1248,6789,talbutal,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL1200802
1249,4367,carbidopa,,,INHIBITOR,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,CHEMBL1200748
1250,6479,pentobarbital,4.06,IC50,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL448
1251,1816,metyrapone,7.84,IC50,INHIBITOR,CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1,CHEMBL934
1252,6490,glyceryl trinitrate,,,ACTIVATOR,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,CHEMBL730
1253,6792,glyceryl trinitrate,,,ACTIVATOR,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,CHEMBL730
1254,7026,glyceryl trinitrate,,,ACTIVATOR,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,CHEMBL730
1255,6793,glyceryl trinitrate,,,ACTIVATOR,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,CHEMBL730
1256,4722,decitabine,,,INHIBITOR,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1,CHEMBL1201129
1257,12865,nabumetone,,,INHIBITOR,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1,CHEMBL1070
1258,6786,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1259,6782,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1260,6829,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1261,6478,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1262,6480,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1263,6479,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1264,6477,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1265,6778,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1266,6777,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1267,6559,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1268,6779,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1269,6783,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1270,6780,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1271,6784,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1272,6560,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1273,6789,triclofos,,,POSITIVE MODULATOR,OP(O)(=O)OCC(Cl)(Cl)Cl,CHEMBL1200789
1274,15542,amiloride,6.7,IC50,BLOCKER,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,CHEMBL945
1275,15107,amiloride,6.7,IC50,BLOCKER,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,CHEMBL945
1276,15544,amiloride,6.7,IC50,BLOCKER,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,CHEMBL945
1277,316,clonidine,7.5,Ki,AGONIST,ClC1=CC=CC(Cl)=C1NC1=NCCN1,CHEMBL134
1278,67,clonidine,8.42,Ki,AGONIST,ClC1=CC=CC(Cl)=C1NC1=NCCN1,CHEMBL134
1279,12865,naproxen,5.6,IC50,INHIBITOR,COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O,CHEMBL154
1280,3501,aminoglutethimide,,,INHIBITOR,CCC1(CCC(=O)NC1=O)C1=CC=C(N)C=C1,CHEMBL488
1281,15088,methylphenidate,6.96,Ki,INHIBITOR,[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1,CHEMBL796
1282,15387,methylphenidate,6.18,Ki,INHIBITOR,[H]C1(CCCCN1)C(C(=O)OC)C1=CC=CC=C1,CHEMBL796
1283,15088,dexmethylphenidate,7.8,Ki,INHIBITOR,[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1,CHEMBL827
1284,15102,lidocaine,5.7,IC50,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
1285,15541,lidocaine,4.54,IC50,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
1286,15251,lidocaine,4.98,IC50,BLOCKER,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,CHEMBL79
1287,6343,pamidronic acid,7.25,Ki,INHIBITOR,NCCC(O)(P(O)(O)=O)P(O)(O)=O,CHEMBL676
1288,6490,isosorbide dinitrate,,,ACTIVATOR,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,CHEMBL6622
1289,6792,isosorbide dinitrate,,,ACTIVATOR,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,CHEMBL6622
1290,7026,isosorbide dinitrate,,,ACTIVATOR,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,CHEMBL6622
1291,6793,isosorbide dinitrate,,,ACTIVATOR,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O,CHEMBL6622
1292,15102,carbamazepine,4.28,Ki,BLOCKER,NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL108
1293,15541,carbamazepine,4.66,IC50,BLOCKER,NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL108
1294,2741,methazolamide,8.05,Ki,INHIBITOR,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,CHEMBL19
1295,1690,methazolamide,8.68,Ki,INHIBITOR,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,CHEMBL19
1296,2138,methazolamide,6.62,Ki,INHIBITOR,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,CHEMBL19
1297,1977,methazolamide,7.85,Ki,INHIBITOR,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,CHEMBL19
1298,8938,zileuton,6.52,IC50,INHIBITOR,CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2,CHEMBL93
1299,15387,viloxazine,6.81,Kd,INHIBITOR,CCOC1=CC=CC=C1OCC1CNCCO1,CHEMBL306700
1300,15538,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1301,15102,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1302,15539,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1303,15103,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1304,15541,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1305,15101,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1306,15251,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1307,15105,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1308,15540,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1309,15104,rufinamide,,,BLOCKER,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,CHEMBL1201754
1310,79,levosalbutamol,5.42,Ki,AGONIST,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,CHEMBL1002
1311,79,isoetarine,6.0,Kd,AGONIST,CCC(NC(C)C)C(O)C1=CC(O)=C(O)C=C1,CHEMBL1200920
1312,15387,benzphetamine,,,RELEASING AGENT,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,CHEMBL1201358
1313,18527,benzphetamine,,,INHIBITOR,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,CHEMBL1201358
1314,15387,bupropion,5.16,Ki,INHIBITOR,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,CHEMBL894
1315,18107,imiquimod,4.97,EC50,AGONIST,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12,CHEMBL1282
1316,7509,pheniramine,,,ANTAGONIST,[H]C(CCN(C)C)(C1=CC=CC=C1)C1=NC=CC=C1,CHEMBL1193
1317,426,pentolonium,,,ANTAGONIST,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,CHEMBL1271
1318,215,pentolonium,,,ANTAGONIST,C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1,CHEMBL1271
1319,11574,moxonidine,8.38,Ki,AGONIST,COC1=NC(C)=NC(Cl)=C1NC1=NCCN1,CHEMBL19236
1320,15387,bretylium,,,SUBSTRATE,CC[N+](C)(C)CC1=C(Br)C=CC=C1,CHEMBL1095292
1321,4851,cytarabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,CHEMBL803
1322,4731,cytarabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,CHEMBL803
1323,4733,cytarabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,CHEMBL803
1324,10909,agomelatine,10.22,Ki,AGONIST,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,CHEMBL10878
1325,10723,agomelatine,10.0,Ki,AGONIST,COC1=CC2=C(C=CC=C2CCNC(C)=O)C=C1,CHEMBL10878
1326,444,frovatriptan,7.99,Ki,AGONIST,CN[C@@H]1CCC2=C(C1)C1=CC(=CC=C1N2)C(N)=O,CHEMBL1279
1327,103,frovatriptan,8.36,Ki,AGONIST,CN[C@@H]1CCC2=C(C1)C1=CC(=CC=C1N2)C(N)=O,CHEMBL1279
1328,4722,azacitidine,,,INHIBITOR,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,CHEMBL1489
1329,540,apraclonidine,7.52,Ki,AGONIST,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,CHEMBL647
1330,67,apraclonidine,8.54,Ki,AGONIST,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,CHEMBL647
1331,607,pinacidil,6.49,Ki,OPENER,CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C,CHEMBL1159
1332,8396,pinacidil,6.49,Ki,OPENER,CC(NC(NC1=CC=NC=C1)=NC#N)C(C)(C)C,CHEMBL1159
1333,12006,dezocine,7.42,EC50,PARTIAL AGONIST,[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N,CHEMBL1685
1334,13316,loxoprofen,5.19,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,CHEMBL19299
1335,12865,loxoprofen,5.0,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(CC2CCCC2=O)C=C1,CHEMBL19299
1336,12006,pethidine,6.04,Ki,AGONIST,CCOC(=O)C1(CCN(C)CC1)C1=CC=CC=C1,CHEMBL607
1337,6343,alendronic acid,7.35,Ki,INHIBITOR,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,CHEMBL675
1338,144,rivastigmine,7.43,IC50,INHIBITOR,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,CHEMBL636
1339,3307,rivastigmine,7.52,IC50,INHIBITOR,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,CHEMBL636
1340,15102,phenytoin,4.62,Ki,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
1341,12843,diprophylline,,,INHIBITOR,CN1C2=C(N(CC(O)CO)C=N2)C(=O)N(C)C1=O,CHEMBL221190
1342,13316,dexketoprofen,8.72,IC50,INHIBITOR,C[C@H](C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL75435
1343,12865,dexketoprofen,7.57,IC50,INHIBITOR,C[C@H](C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL75435
1344,6786,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1345,6782,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1346,6829,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1347,6478,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1348,6480,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1349,6479,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1350,6477,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1351,6778,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1352,6777,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1353,6559,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1354,6779,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1355,6783,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1356,6780,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1357,6784,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1358,6560,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1359,6789,thiamylal,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=S)NC1=O,CHEMBL440
1360,15387,atomoxetine,8.69,Kd,INHIBITOR,CNCC[C@@H](OC1=C(C)C=CC=C1)C1=CC=CC=C1,CHEMBL641
1361,7509,tripelennamine,7.4,IC50,ANTAGONIST,CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1,CHEMBL1241
1362,15104,lamotrigine,4.02,IC50,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
1363,15103,lamotrigine,4.21,IC50,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
1364,15102,lamotrigine,4.77,Ki,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
1365,15101,lamotrigine,5.0,IC50,BLOCKER,NC1=NN=C(C(N)=N1)C1=C(Cl)C(Cl)=CC=C1,CHEMBL741
1366,144,echothiophate,,,INHIBITOR,CCOP(=O)(OCC)SCC[N+](C)(C)C,CHEMBL1200367
1367,12006,levorphanol,9.68,Ki,AGONIST,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2C,CHEMBL592
1368,2139,ethoxzolamide,7.6,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1369,2741,ethoxzolamide,9.31,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1370,1778,ethoxzolamide,8.6,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1371,1690,ethoxzolamide,9.15,Kd,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1372,2740,ethoxzolamide,7.66,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1373,1691,ethoxzolamide,7.47,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1374,2139,ethoxzolamide,8.7,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1375,1688,ethoxzolamide,8.7,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1376,2138,ethoxzolamide,7.03,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1377,1977,ethoxzolamide,7.85,Kd,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1378,1688,ethoxzolamide,7.72,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1379,1687,ethoxzolamide,5.3,Ki,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1380,1976,ethoxzolamide,7.89,Kd,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1381,1689,ethoxzolamide,7.48,Kd,INHIBITOR,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,CHEMBL18
1382,425,decamethonium,,,PARTIAL AGONIST,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CHEMBL1134
1383,219,decamethonium,,,PARTIAL AGONIST,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CHEMBL1134
1384,427,decamethonium,,,PARTIAL AGONIST,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CHEMBL1134
1385,218,decamethonium,,,PARTIAL AGONIST,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CHEMBL1134
1386,217,decamethonium,,,PARTIAL AGONIST,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,CHEMBL1134
1387,67,lofexidine,8.36,Ki,AGONIST,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1,CHEMBL17860
1388,15538,hexylcaine,5.15,IC50,BLOCKER,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1,CHEMBL1197
1389,15101,hexylcaine,5.15,IC50,BLOCKER,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1,CHEMBL1197
1390,15251,hexylcaine,5.15,IC50,BLOCKER,CC(CNC1CCCCC1)OC(=O)C1=CC=CC=C1,CHEMBL1197
1391,4851,gemcitabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,CHEMBL888
1392,4731,gemcitabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,CHEMBL888
1393,4733,gemcitabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,CHEMBL888
1394,12006,tramadol,5.8,Ki,AGONIST,COC1=CC=CC(=C1)[C@@]1(O)CCCC[C@@H]1CN(C)C,CHEMBL1237044
1395,15103,tetracaine,6.28,IC50,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1396,15541,tetracaine,6.3,Ki,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1397,15538,tetracaine,5.47,IC50,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1398,15101,tetracaine,5.47,IC50,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1399,15251,tetracaine,5.47,IC50,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1400,15101,tetracaine,5.96,IC50,BLOCKER,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,CHEMBL698
1401,27,mirtazapine,7.41,Ki,ANTAGONIST,[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1,CHEMBL654
1402,104,mirtazapine,7.16,Ki,ANTAGONIST,[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=N1,CHEMBL654
1403,7509,antazoline,,,ANTAGONIST,C(N(CC1=CC=CC=C1)C1=CC=CC=C1)C1=NCCN1,CHEMBL1305
1404,10119,voglibose,7.15,IC50,INHIBITOR,OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL476960
1405,4816,apomorphine,9.21,Ki,AGONIST,[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23,CHEMBL53
1406,5154,diethylstilbestrol,9.66,Ki,AGONIST,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,CHEMBL411
1407,1028,moclobemide,8.3,Ki,INHIBITOR,ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1,CHEMBL86304
1408,14018,leflunomide,5.0,IC50,INHIBITOR,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,CHEMBL960
1409,5154,estrone,9.15,EC50,AGONIST,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL1405
1410,7509,doxylamine,,,ANTAGONIST,CN(C)CCOC(C)(C1=CC=CC=C1)C1=NC=CC=C1,CHEMBL1004
1411,6343,zoledronic acid,10.15,Ki,INHIBITOR,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,CHEMBL924
1412,12865,carprofen,7.0,IC50,INHIBITOR,CC(C(O)=O)C1=CC2=C(C=C1)C1=CC(Cl)=CC=C1N2,CHEMBL1316
1413,144,physostigmine,9.37,IC50,INHIBITOR,[H][C@]12N(C)CC[C@@]1(C)C1=CC(OC(=O)NC)=CC=C1N2C,CHEMBL94
1414,875,flutamide,5.89,Ki,ANTAGONIST,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,CHEMBL806
1415,38,pentoxifylline,5.29,Ki,ANTAGONIST,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C,CHEMBL628
1416,7509,triprolidine,9.9,Ki,ANTAGONIST,CC1=CC=C(C=C1)C(=C/CN1CCCC1)\C1=CC=CC=N1,CHEMBL855
1417,42,diphemanil,,,ANTAGONIST,C[N+]1(C)CCC(CC1)=C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1200880
1418,105,ramosetron,10.22,Ki,ANTAGONIST,CN1C=C(C(=O)[C@@H]2CCC3=C(C2)NC=N3)C2=CC=CC=C12,CHEMBL1643895
1419,539,phentolamine,7.32,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1420,316,phentolamine,8.12,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1421,540,phentolamine,8.08,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1422,63,phentolamine,7.71,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1423,67,phentolamine,8.77,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1424,973,phentolamine,8.39,Ki,ANTAGONIST,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,CHEMBL597
1425,6343,risedronic acid,9.44,Ki,INHIBITOR,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,CHEMBL923
1426,12006,levallorphan,9.32,Ki,ANTAGONIST,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13[H])CCN2CC=C,CHEMBL1254682
1427,15538,articaine,4.29,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,CHEMBL1093
1428,15101,articaine,4.29,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,CHEMBL1093
1429,15251,articaine,4.29,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,CHEMBL1093
1430,15088,mazindol,8.0,Ki,INHIBITOR,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,CHEMBL781
1431,15387,mazindol,9.3,Kd,INHIBITOR,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,CHEMBL781
1432,15089,mazindol,7.3,Ki,INHIBITOR,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,CHEMBL781
1433,12006,hydromorphone,9.55,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3O,CHEMBL398707
1434,7509,mepyramine,9.1,Ki,ANTAGONIST,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1,CHEMBL511
1435,144,galantamine,7.21,Ki,INHIBITOR,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=CC=C(OC)C(O2)=C13,CHEMBL659
1436,12865,etodolac,5.7,IC50,INHIBITOR,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(O)=O,CHEMBL622
1437,875,ethylestrenol,,,AGONIST,[H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],CHEMBL1200623
1438,13566,ciprofibrate,6.05,EC50,AGONIST,CC(C)(OC1=CC=C(C=C1)C1CC1(Cl)Cl)C(O)=O,CHEMBL557555
1439,15187,quinethazone,,,INHIBITOR,CCC1NC(=O)C2=CC(=C(Cl)C=C2N1)S(N)(=O)=O,CHEMBL1532
1440,425,suxamethonium,,,AGONIST,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CHEMBL703
1441,219,suxamethonium,,,AGONIST,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CHEMBL703
1442,427,suxamethonium,,,AGONIST,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CHEMBL703
1443,218,suxamethonium,,,AGONIST,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CHEMBL703
1444,217,suxamethonium,,,AGONIST,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CHEMBL703
1445,7509,carbinoxamine,,,ANTAGONIST,[H]C(OCCN(C)C)(C1=CC=C(Cl)C=C1)C1=CC=CC=N1,CHEMBL864
1446,14787,fasudil,7.0,Ki,INHIBITOR,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2,CHEMBL38380
1447,14788,fasudil,7.11,Kd,INHIBITOR,O=S(=O)(N1CCCNCC1)C1=CC=CC2=C1C=CN=C2,CHEMBL38380
1448,430,cyclopentolate,,,ANTAGONIST,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,CHEMBL1200473
1449,12865,lumiracoxib,6.49,Ki,INHIBITOR,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1,CHEMBL404108
1450,105,alosetron,9.3,Ki,ANTAGONIST,CN1C2=C(C3=C1C=CC=C3)C(=O)N(CC1=C(C)N=CN1)CC2,CHEMBL1110
1451,15538,propoxycaine,4.62,IC50,BLOCKER,CCCOC1=C(C=CC(N)=C1)C(=O)OCCN(CC)CC,CHEMBL1195
1452,15101,propoxycaine,4.62,IC50,BLOCKER,CCCOC1=C(C=CC(N)=C1)C(=O)OCCN(CC)CC,CHEMBL1195
1453,15251,propoxycaine,4.62,IC50,BLOCKER,CCCOC1=C(C=CC(N)=C1)C(=O)OCCN(CC)CC,CHEMBL1195
1454,15538,proparacaine,5.72,IC50,BLOCKER,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,CHEMBL1196
1455,15101,proparacaine,5.72,IC50,BLOCKER,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,CHEMBL1196
1456,15251,proparacaine,5.72,IC50,BLOCKER,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,CHEMBL1196
1457,444,sumatriptan,8.26,Ki,AGONIST,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,CHEMBL128
1458,103,sumatriptan,8.92,Ki,AGONIST,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,CHEMBL128
1459,105,palonosetron,10.5,Ki,ANTAGONIST,[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@]1([H])CN4CCC1CC4)=C23,CHEMBL1720
1460,7509,methdilazine,,,ANTAGONIST,CN1CCC(CN2C3=CC=CC=C3SC3=C2C=CC=C3)C1,CHEMBL1200532
1461,15387,duloxetine,8.22,Ki,INHIBITOR,CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1,CHEMBL1175
1462,15089,duloxetine,9.62,Ki,INHIBITOR,CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1,CHEMBL1175
1463,12769,amlexanox,,,INHIBITOR,CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1,CHEMBL1096
1464,12770,amlexanox,,,INHIBITOR,CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1,CHEMBL1096
1465,12628,amlexanox,,,INHIBITOR,CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1,CHEMBL1096
1466,12629,amlexanox,,,INHIBITOR,CC(C)C1=CC=C2OC3=C(C=C(C(O)=O)C(N)=N3)C(=O)C2=C1,CHEMBL1096
1467,13783,norethynodrel,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])CC(=O)CC3,CHEMBL1387
1468,7509,alimemazine,,,ANTAGONIST,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=CC=C2,CHEMBL829
1469,12006,hydrocodone,8.02,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CCC2=O)=CC=C3OC,CHEMBL1457
1470,12006,codeine,6.14,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3OC,CHEMBL485
1471,14092,isotretinoin,,,INHIBITOR,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,CHEMBL547
1472,12187,oxymorphone,7.3,Ki,AGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O,CHEMBL963
1473,12006,dihydrocodeine,,,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5([H])CC[C@@H]2O)=CC=C3OC,CHEMBL1595
1474,447,tegaserod,8.4,Ki,PARTIAL AGONIST,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2,CHEMBL76370
1475,42,trihexyphenidyl,8.89,IC50,ANTAGONIST,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1092
1476,8938,olsalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL425
1477,13436,olsalazine,,,AGONIST,OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL425
1478,13316,olsalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL425
1479,12865,olsalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL425
1480,6779,flumazenil,8.7,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1481,4923,vildagliptin,8.52,Ki,INHIBITOR,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,CHEMBL142703
1482,2138,dichlorphenamide,7.02,Ki,INHIBITOR,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,CHEMBL17
1483,18599,capsaicin,8.22,Ki,OPENER,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,CHEMBL294199
1484,4815,fenoldopam,7.55,Kd,AGONIST,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12,CHEMBL588
1485,15089,sertraline,9.54,Kd,INHIBITOR,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,CHEMBL809
1486,13316,phenylbutazone,5.52,IC50,INHIBITOR,CCCCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL101
1487,15538,oxybuprocaine,5.54,IC50,BLOCKER,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,CHEMBL1200
1488,15101,oxybuprocaine,5.54,IC50,BLOCKER,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,CHEMBL1200
1489,15251,oxybuprocaine,5.54,IC50,BLOCKER,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,CHEMBL1200
1490,547,metipranolol,,,ANTAGONIST,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,CHEMBL1291
1491,79,metipranolol,,,ANTAGONIST,CC(C)NCC(O)COC1=C(C)C(C)=C(OC(C)=O)C(C)=C1,CHEMBL1291
1492,42,metixene,,,ANTAGONIST,CN1CCCC(CC2C3=CC=CC=C3SC3=C2C=CC=C3)C1,CHEMBL1200426
1493,27,metixene,,,ANTAGONIST,CN1CCCC(CC2C3=CC=CC=C3SC3=C2C=CC=C3)C1,CHEMBL1200426
1494,187,tolazamide,,,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,CHEMBL817
1495,8396,tolazamide,,,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,CHEMBL817
1496,15020,dantrolene,,,ANTAGONIST,[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,CHEMBL928
1497,3552,dronabinol,8.54,Ki,AGONIST,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21,CHEMBL465
1498,4923,saxagliptin,9.22,Ki,INHIBITOR,[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2,CHEMBL385517
1499,4816,chlorprothixene,8.53,Ki,ANTAGONIST,CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,CHEMBL908
1500,875,nilutamide,8.05,IC50,ANTAGONIST,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,CHEMBL1274
1501,42,methscopolamine,9.9,Ki,ANTAGONIST,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,CHEMBL376897
1502,430,tridihexethyl,,,ANTAGONIST,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1200771
1503,42,tridihexethyl,,,ANTAGONIST,CC[N+](CC)(CC)CCC(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1200771
1504,6343,ibandronic acid,8.44,Ki,INHIBITOR,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,CHEMBL997
1505,3501,mitotane,,,INHIBITOR,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1,CHEMBL1670
1506,8691,mycophenolic acid,4.7,IC50,INHIBITOR,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,CHEMBL866
1507,8690,mycophenolic acid,4.7,IC50,INHIBITOR,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,CHEMBL866
1508,13316,oxyphenbutazone,,,INHIBITOR,CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1,CHEMBL1228
1509,12865,oxyphenbutazone,,,INHIBITOR,CCCCC1C(=O)N(N(C1=O)C1=CC=C(O)C=C1)C1=CC=CC=C1,CHEMBL1228
1510,316,tolazoline,5.5,Ki,ANTAGONIST,C(C1=NCCN1)C1=CC=CC=C1,CHEMBL770
1511,316,tizanidine,,,AGONIST,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,CHEMBL1079
1512,316,dipivefrine,,,AGONIST,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,CHEMBL1200833
1513,316,brimonidine,7.2596,EC50,AGONIST,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,CHEMBL844
1514,973,terazosin,8.95,Ki,ANTAGONIST,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N1CCN(CC1)C(=O)C1CCCO1,CHEMBL611
1515,973,tolazoline,5.5,Ki,ANTAGONIST,C(C1=NCCN1)C1=CC=CC=C1,CHEMBL770
1516,973,phenylephrine,5.3,Ki,AGONIST,CNC[C@H](O)C1=CC(O)=CC=C1,CHEMBL1215
1517,973,phenoxybenzamine,7.27,IC50,ANTAGONIST,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,CHEMBL753
1518,973,midodrine,,,AGONIST,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,CHEMBL1200461
1519,973,methoxamine,5.1,EC50,AGONIST,COC1=CC(C(O)C(C)N)=C(OC)C=C1,CHEMBL524
1520,973,metaraminol,,,AGONIST,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1,CHEMBL1201319
1521,973,doxazosin,8.8,Ki,ANTAGONIST,[H]C1(COC2=C(O1)C=CC=C2)C(=O)N1CCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1,CHEMBL707
1522,973,dapiprazole,,,ANTAGONIST,CC1=C(C=CC=C1)N1CCN(CCC2=NN=C3CCCCN23)CC1,CHEMBL1201044
1523,973,bunazosin,,,ANTAGONIST,CCCC(=O)N1CCCN(CC1)C1=NC2=CC(OC)=C(OC)C=C2C(N)=N1,CHEMBL188185
1524,27,trazodone,6.65,Ki,ANTAGONIST,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,CHEMBL621
1525,104,asenapine,9.61,Ki,ANTAGONIST,[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1,CHEMBL1201756
1526,104,iloperidone,9.8594,Ki,ANTAGONIST,COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O,CHEMBL14376
1527,104,ziprasidone,9.4,Ki,ANTAGONIST,ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2,CHEMBL708
1528,104,trazodone,7.35,Ki,ANTAGONIST,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,CHEMBL621
1529,104,risperidone,9.3643,Ki,ANTAGONIST,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,CHEMBL85
1530,104,quetiapine,7.1311,IC50,ANTAGONIST,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,CHEMBL716
1531,104,promazine,7.7959,Ki,ANTAGONIST,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2,CHEMBL564
1532,104,olanzapine,8.3188,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,CHEMBL715
1533,104,nefazodone,8.0,Ki,ANTAGONIST,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,CHEMBL623
1534,104,cyclobenzaprine,7.5409,Ki,ANTAGONIST,CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL669
1535,104,clozapine,8.3,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2,CHEMBL42
1536,104,aripiprazole,7.9,Ki,ANTAGONIST,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,CHEMBL1112
1537,443,buspirone,7.25,EC50,PARTIAL AGONIST,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,CHEMBL49
1538,443,aripiprazole,8.15,Ki,PARTIAL AGONIST,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,CHEMBL1112
1539,15387,desvenlafaxine,6.2747,Ki,INHIBITOR,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,CHEMBL1118
1540,15387,venlafaxine,5.9747,Kd,INHIBITOR,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,CHEMBL637
1541,15387,trimipramine,5.61,Ki,INHIBITOR,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL644
1542,15387,sibutramine,5.2635,Ki,INHIBITOR,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,CHEMBL1419
1543,15387,protriptyline,8.39,Ki,INHIBITOR,CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL668
1544,15387,phentermine,,,INHIBITOR,CC(C)(N)CC1=CC=CC=C1,CHEMBL1574
1545,15387,phenmetrazine,7.2976,EC50,INHIBITOR,CC1NCCOC1C1=CC=CC=C1,CHEMBL1200483
1546,15387,nortriptyline,8.3595,Kd,INHIBITOR,CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL445
1547,15387,nefazodone,6.4437,Kd,INHIBITOR,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,CHEMBL623
1548,15387,milnacipran,7.6,Ki,INHIBITOR,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,CHEMBL259209
1549,15387,maprotiline,8.27,Kd,INHIBITOR,CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1,CHEMBL21731
1550,15387,imipramine,7.4318,Kd,INHIBITOR,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL11
1551,15387,guanethidine,,,SUBSTRATE,NC(=N)NCCN1CCCCCCC1,CHEMBL765
1552,15387,doxepin,7.53,Kd,INHIBITOR,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2,CHEMBL1628227
1553,15387,dexmethylphenidate,,,INHIBITOR,[H][C@@]1(CCCCN1)[C@H](C(=O)OC)C1=CC=CC=C1,CHEMBL827
1554,15387,desipramine,9.0809,Kd,INHIBITOR,CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL72
1555,15387,amitriptyline,7.4559,Kd,INHIBITOR,CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL629
1556,15089,desvenlafaxine,7.3251,Ki,INHIBITOR,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,CHEMBL1118
1557,15089,venlafaxine,8.0506,Kd,INHIBITOR,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,CHEMBL637
1558,15089,trazodone,6.8,Kd,INHIBITOR,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,CHEMBL621
1559,15089,sibutramine,6.5257,Ki,INHIBITOR,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,CHEMBL1419
1560,15089,protriptyline,7.34,Ki,INHIBITOR,CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL668
1561,15089,nortriptyline,7.34,Ki,INHIBITOR,CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL445
1562,15089,nefazodone,6.699,Kd,INHIBITOR,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,CHEMBL623
1563,15089,milnacipran,7.29,Ki,INHIBITOR,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1,CHEMBL259209
1564,15089,imipramine,8.8539,Kd,INHIBITOR,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL11
1565,15089,fluvoxamine,8.51,Ki,INHIBITOR,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,CHEMBL814
1566,15089,fluoxetine,9.0915,Kd,INHIBITOR,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,CHEMBL41
1567,15089,escitalopram,8.9586,Ki,INHIBITOR,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,CHEMBL1508
1568,15089,citalopram,8.9355,Kd,INHIBITOR,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,CHEMBL549
1569,15089,chlorphentermine,6.4711,Ki,SUBSTRATE,CC(C)(N)CC1=CC=C(Cl)C=C1,CHEMBL1200595
1570,15089,amitriptyline,8.3665,Kd,INHIBITOR,CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,CHEMBL629
1571,8165,sotalol,4.0,Ki,BLOCKER,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,CHEMBL471
1572,8165,amiodarone,5.0,IC50,BLOCKER,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,CHEMBL633
1573,67,tolazoline,6.64,Ki,ANTAGONIST,C(C1=NCCN1)C1=CC=CC=C1,CHEMBL770
1574,67,tizanidine,,,AGONIST,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,CHEMBL1079
1575,67,phenoxybenzamine,6.28,IC50,ANTAGONIST,CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1,CHEMBL753
1576,67,methyldopa,,,AGONIST,C[C@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL459
1577,67,guanfacine,7.1642,EC50,AGONIST,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,CHEMBL862
1578,67,dipivefrine,,,AGONIST,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,CHEMBL1200833
1579,67,brimonidine,8.3872,EC50,AGONIST,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,CHEMBL844
1580,385,regadenoson,5.8861,EC50,AGONIST,CNC(=O)C1=CN(N=C1)C1=NC(N)=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=N1,CHEMBL317052
1581,385,adenosine,6.1549,EC50,AGONIST,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,CHEMBL477
1582,4816,asenapine,8.75,Ki,ANTAGONIST,[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1,CHEMBL1201756
1583,4816,iloperidone,8.9687,Ki,ANTAGONIST,COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O,CHEMBL14376
1584,4816,ziprasidone,8.32,Ki,ANTAGONIST,ClC1=CC2=C(CC(=O)N2)C=C1CCN1CCN(CC1)C1=NSC2=C1C=CC=C2,CHEMBL708
1585,4816,thioridazine,7.4,IC50,ANTAGONIST,[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C,CHEMBL479
1586,4816,thiethylperazine,8.699,Ki,ANTAGONIST,CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1,CHEMBL1378
1587,4816,risperidone,8.49,Ki,ANTAGONIST,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,CHEMBL85
1588,4816,quetiapine,6.4828,IC50,ANTAGONIST,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,CHEMBL716
1589,4816,promazine,6.7037,Ki,ANTAGONIST,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2,CHEMBL564
1590,4816,prochlorperazine,8.7642,Ki,ANTAGONIST,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,CHEMBL728
1591,4816,pramipexole,6.6,EC50,AGONIST,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,CHEMBL301265
1592,4816,pimozide,8.8623,Ki,ANTAGONIST,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1,CHEMBL1423
1593,4816,perphenazine,9.32,Ki,ANTAGONIST,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1,CHEMBL567
1594,4816,pergolide,8.3,EC50,AGONIST,[H][C@]1(CSC)CN(CCC)[C@]2([H])CC3=CNC4=C3C(=CC=C4)[C@@]2([H])C1,CHEMBL531
1595,4816,olanzapine,8.5229,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,CHEMBL715
1596,4816,molindone,6.1568,IC50,ANTAGONIST,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,CHEMBL460
1597,4816,metoclopramide,7.1938,Ki,ANTAGONIST,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,CHEMBL86
1598,4816,haloperidol,9.15,Ki,INVERSE AGONIST,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,CHEMBL54
1599,4816,fluphenazine,9.269,Ki,ANTAGONIST,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,CHEMBL726
1600,4816,clozapine,6.86,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2,CHEMBL42
1601,4816,chlorpromazine,8.15,Ki,ANTAGONIST,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,CHEMBL71
1602,4816,bromocriptine,9.7,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C,CHEMBL493
1603,4816,aripiprazole,8.71,Ki,PARTIAL AGONIST,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,CHEMBL1112
1604,12006,methylnaltrexone,7.55,Ki,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CC[N+](C)(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,CHEMBL1186579
1605,12006,sufentanil,8.13,EC50,AGONIST,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1,CHEMBL658
1606,12006,remifentanil,,,AGONIST,CCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC(=O)OC)CC1)C(=O)OC,CHEMBL1005
1607,12006,oxymorphone,9.4437,Ki,AGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@H](C4)[C@]1(O)CCC2=O,CHEMBL963
1608,12006,oxycodone,7.7959,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3OC,CHEMBL656
1609,12006,naloxone,8.81,Ki,ANTAGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O,CHEMBL80
1610,12006,nalbuphine,8.8,Ki,AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CCC6)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O,CHEMBL895
1611,12006,morphine,7.86,EC50,AGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,CHEMBL70
1612,12006,naltrexone,9.38,Ki,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=O,CHEMBL19019
1613,12006,methadone,8.78,Ki,AGONIST,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL651
1614,12006,loperamide,8.8239,Ki,AGONIST,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL841
1615,12006,levomethadyl acetate,,,AGONIST,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1514
1616,12006,fentanyl,9.0014,EC50,AGONIST,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,CHEMBL596
1617,12006,diphenoxylate,7.1674,IC50,AGONIST,CCOC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,CHEMBL1200665
1618,12006,dextropropoxyphene,,,AGONIST,[H][C@@](C)(CN(C)C)[C@](CC1=CC=CC=C1)(OC(=O)CC)C1=CC=CC=C1,CHEMBL1213351
1619,12006,buprenorphine,8.29,Ki,PARTIAL AGONIST,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O,CHEMBL511142
1620,1917,ibrutinib,9.14266777,Ki,INHIBITOR,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,CHEMBL1873475
1621,12006,anileridine,,,AGONIST,CCOC(=O)C1(CCN(CCC2=CC=C(N)C=C2)CC1)C1=CC=CC=C1,CHEMBL1200543
1622,12006,alvimopan,9.3979,Ki,ANTAGONIST,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1,CHEMBL270190
1623,12006,alfentanil,8.5,EC50,AGONIST,CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)C2=CC=CC=C2)C1=O,CHEMBL634
1624,13316,tolmetin,6.27,IC50,INHIBITOR,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,CHEMBL1020
1625,13316,suprofen,5.96,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1,CHEMBL956
1626,13316,piroxicam,5.18,IC50,INHIBITOR,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O,CHEMBL527
1627,13316,naproxen,5.16,IC50,INHIBITOR,COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O,CHEMBL154
1628,13316,mesalazine,,,INHIBITOR,NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL704
1629,13316,mefenamic acid,4.78,IC50,INHIBITOR,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,CHEMBL686
1630,13316,meclofenamic acid,6.66,IC50,INHIBITOR,CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl,CHEMBL509
1631,13316,ketorolac,9.72,IC50,INHIBITOR,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,CHEMBL469
1632,13316,ketoprofen,7.33,IC50,INHIBITOR,CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL571
1633,13316,indomethacin,7.21,IC50,INHIBITOR,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,CHEMBL6
1634,13316,ibuprofen,5.12,IC50,INHIBITOR,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,CHEMBL521
1635,13316,flurbiprofen,8.74,IC50,INHIBITOR,CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,CHEMBL563
1636,13316,fenoprofen,5.36,IC50,INHIBITOR,CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1,CHEMBL1297
1637,13316,diflunisal,4.4,IC50,INHIBITOR,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,CHEMBL898
1638,13316,diclofenac,7.52,IC50,INHIBITOR,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,CHEMBL139
1639,13316,bromfenac,8.29,IC50,INHIBITOR,NC1=C(C=CC=C1CC(O)=O)C(=O)C1=CC=C(Br)C=C1,CHEMBL751
1640,13316,balsalazide,,,INHIBITOR,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,CHEMBL1200760
1641,13316,nepafenac,6.6,IC50,INHIBITOR,NC(=O)CC1=C(N)C(=CC=C1)C(=O)C1=CC=CC=C1,CHEMBL25146
1642,13316,acetylsalicylic acid,5.77,IC50,INHIBITOR,CC(=O)OC1=CC=CC=C1C(O)=O,CHEMBL25
1643,15103,topiramate,,,BLOCKER,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
1644,15103,ropivacaine,4.56,IC50,BLOCKER,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,CHEMBL1077896
1645,15103,riluzole,,,BLOCKER,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,CHEMBL744
1646,15103,phenytoin,,,BLOCKER,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL16
1647,15103,oxcarbazepine,,,BLOCKER,NC(=O)N1C2=CC=CC=C2C(=O)CC2=C1C=CC=C2,CHEMBL1068
1648,15103,orphenadrine,4.8861,IC50,BLOCKER,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,CHEMBL900
1649,15103,moracizine,,,BLOCKER,CCOC(=O)NC1=CC=C2SC3=CC=CC=C3N(C(=O)CCN3CCOCC3)C2=C1,CHEMBL1075
1650,15103,mexiletine,4.53,IC50,BLOCKER,CC(N)COC1=C(C)C=CC=C1C,CHEMBL558
1651,15103,mepivacaine,,,BLOCKER,[H]C1(CCCCN1C)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1087
1652,15103,etidocaine,,,BLOCKER,CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C,CHEMBL492
1653,15103,disopyramide,,,BLOCKER,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C,CHEMBL517
1654,15103,carbamazepine,,,BLOCKER,NC(=O)N1C2=CC=CC=C2C=CC2=C1C=CC=C2,CHEMBL108
1655,3552,paracetamol,,,AGONIST,CC(=O)NC1=CC=C(O)C=C1,CHEMBL112
1656,18599,paracetamol,,,OPENER,CC(=O)NC1=CC=C(O)C=C1,CHEMBL112
1657,12865,valdecoxib,8.3,IC50,INHIBITOR,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,CHEMBL865
1658,12865,tolmetin,6.84,IC50,INHIBITOR,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,CHEMBL1020
1659,12865,suprofen,5.06,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(C=C1)C(=O)C1=CC=CS1,CHEMBL956
1660,12865,sulindac,4.25,IC50,INHIBITOR,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O,CHEMBL15770
1661,12865,rofecoxib,6.51,IC50,INHIBITOR,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1,CHEMBL122
1662,12865,piroxicam,4.7,IC50,INHIBITOR,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O,CHEMBL527
1663,12865,oxaprozin,4.44,IC50,INHIBITOR,OC(=O)CCC1=NC(=C(O1)C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1071
1664,12865,mefenamic acid,6.83,IC50,INHIBITOR,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,CHEMBL686
1665,12865,meclofenamic acid,6.7,IC50,INHIBITOR,CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl,CHEMBL509
1666,12865,ketorolac,6.9,IC50,INHIBITOR,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,CHEMBL469
1667,12865,ketoprofen,6.62,IC50,INHIBITOR,CC(C(O)=O)C1=CC=CC(=C1)C(=O)C1=CC=CC=C1,CHEMBL571
1668,12865,indomethacin,6.33,IC50,INHIBITOR,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,CHEMBL6
1669,12865,ibuprofen,5.14,IC50,INHIBITOR,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,CHEMBL521
1670,12865,flurbiprofen,8.39,IC50,INHIBITOR,CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1,CHEMBL563
1671,12865,fenoprofen,5.23,IC50,INHIBITOR,CC(C(O)=O)C1=CC=CC(OC2=CC=CC=C2)=C1,CHEMBL1297
1672,12865,etoricoxib,6.1,IC50,INHIBITOR,CC1=NC=C(C=C1)C1=C(C=C(Cl)C=N1)C1=CC=C(C=C1)S(C)(=O)=O,CHEMBL416146
1673,12865,diflunisal,5.09,IC50,INHIBITOR,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,CHEMBL898
1674,12865,diclofenac,7.7,IC50,INHIBITOR,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,CHEMBL139
1675,12865,celecoxib,7.24,IC50,INHIBITOR,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,CHEMBL118
1676,12865,bromfenac,8.4,IC50,INHIBITOR,NC1=C(C=CC=C1CC(O)=O)C(=O)C1=CC=C(Br)C=C1,CHEMBL751
1677,12865,balsalazide,,,INHIBITOR,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,CHEMBL1200760
1678,12865,nepafenac,6.82,IC50,INHIBITOR,NC(=O)CC1=C(N)C(=CC=C1)C(=O)C1=CC=CC=C1,CHEMBL25146
1679,12865,acetylsalicylic acid,5.12,IC50,INHIBITOR,CC(=O)OC1=CC=CC=C1C(O)=O,CHEMBL25
1680,12865,paracetamol,4.31,IC50,INHIBITOR,CC(=O)NC1=CC=C(O)C=C1,CHEMBL112
1681,79,vilanterol,9.4,EC50,AGONIST,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl,CHEMBL1084172
1682,79,timolol,9.7,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1,CHEMBL499
1683,79,terbutaline,5.6,Ki,AGONIST,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,CHEMBL1760
1684,79,sotalol,6.9,Ki,ANTAGONIST,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,CHEMBL471
1685,79,ritodrine,7.62,EC50,AGONIST,C[C@@H](NCCC1=CC=C(O)C=C1)[C@@H](O)C1=CC=C(O)C=C1,CHEMBL785
1686,79,propranolol,8.25,Ki,ANTAGONIST,[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1,CHEMBL27
1687,79,pirbuterol,,,AGONIST,CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1,CHEMBL1094966
1688,79,pindolol,9.0,Ki,PARTIAL AGONIST,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,CHEMBL500
1689,79,penbutolol,9.0,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1,CHEMBL1290
1690,79,oxprenolol,8.0,Ki,ANTAGONIST,CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1,CHEMBL546
1691,79,nebivolol,7.5,Ki,ANTAGONIST,[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1,CHEMBL434394
1692,79,isoprenaline,9.8,EC50,AGONIST,CC(C)NCC(O)C1=CC=C(O)C(O)=C1,CHEMBL434
1693,79,dobutamine,6.2,EC50,AGONIST,CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,CHEMBL926
1694,79,carteolol,9.2,Ki,ANTAGONIST,CC(C)(C)NCC(O)COC1=C2CCC(=O)NC2=CC=C1,CHEMBL839
1695,79,salbutamol,5.95,Ki,AGONIST,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,CHEMBL714
1696,547,timolol,9.0,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1,CHEMBL499
1697,547,sotalol,6.1,Ki,ANTAGONIST,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,CHEMBL471
1698,547,propranolol,8.71,Ki,ANTAGONIST,[H]C(O)(CNC(C)C)COC1=C2C=CC=CC2=CC=C1,CHEMBL27
1699,547,pindolol,9.4,Ki,PARTIAL AGONIST,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,CHEMBL500
1700,547,penbutolol,8.8,Ki,ANTAGONIST,CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1,CHEMBL1290
1701,547,oxprenolol,8.11,Ki,ANTAGONIST,CC(C)NCC(O)COC1=C(OCC=C)C=CC=C1,CHEMBL546
1702,547,nebivolol,8.5,Ki,ANTAGONIST,[H]C1(CCC2=CC(F)=CC=C2O1)C(O)CNCC(O)C1([H])CCC2=CC(F)=CC=C2O1,CHEMBL434394
1703,547,metoprolol,7.6,Ki,ANTAGONIST,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,CHEMBL13
1704,547,isoprenaline,9.0,EC50,AGONIST,CC(C)NCC(O)C1=CC=C(O)C(O)=C1,CHEMBL434
1705,547,dopamine,5.0,Ki,AGONIST,NCCC1=CC(O)=C(O)C=C1,CHEMBL59
1706,547,dobutamine,5.5,EC50,AGONIST,CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,CHEMBL926
1707,547,carteolol,9.3,Ki,ANTAGONIST,CC(C)(C)NCC(O)COC1=C2CCC(=O)NC2=CC=C1,CHEMBL839
1708,547,bisoprolol,7.65,Ki,ANTAGONIST,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,CHEMBL645
1709,547,betaxolol,8.8,Kd,ANTAGONIST,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,CHEMBL423
1710,547,atenolol,7.3,Ki,ANTAGONIST,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,CHEMBL24
1711,547,acebutolol,7.3,Ki,ANTAGONIST,CCCC(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)C)C=C1,CHEMBL642
1712,6778,diazepam,6.6655,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1713,6559,diazepam,6.6655,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1714,6560,diazepam,6.6655,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1715,6829,diazepam,6.7055,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1716,6559,diazepam,6.7055,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1717,6560,diazepam,6.7055,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1718,15387,clomipramine,7.4202,Kd,INHIBITOR,CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2,CHEMBL415
1719,6829,zopiclone,7.1759,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1720,6480,zopiclone,7.1759,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1721,6559,zopiclone,7.1759,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1722,6480,zopiclone,6.5817,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1723,6778,zopiclone,6.5817,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1724,6559,zopiclone,6.5817,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1725,6829,zolpidem,6.7033,EC50,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1726,6480,zolpidem,6.7033,EC50,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1727,6559,zolpidem,6.7033,EC50,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1728,6829,zolpidem,7.5735,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1729,6480,zolpidem,7.5735,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1730,6479,zolpidem,7.5735,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1731,6480,zolpidem,6.8069,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1732,6479,zolpidem,6.8069,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1733,6777,zolpidem,6.8069,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1734,6480,zolpidem,6.1643,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1735,6778,zolpidem,6.1643,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1736,6559,zolpidem,6.1643,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1737,6480,zolpidem,6.4168,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1738,6479,zolpidem,6.4168,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1739,6778,zolpidem,6.4168,Ki,POSITIVE ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
1740,6829,zaleplon,6.5302,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1741,6480,zaleplon,6.5302,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1742,6559,zaleplon,6.5302,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1743,6480,zaleplon,5.7889,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1744,6479,zaleplon,5.7889,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1745,6777,zaleplon,5.7889,EC50,POSITIVE ALLOSTERIC MODULATOR,CCN(C(C)=O)C1=CC(=CC=C1)C1=CC=NC2=C(C=NN12)C#N,CHEMBL1521
1746,6480,triazolam,9.02,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1747,6479,triazolam,9.02,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1748,6477,triazolam,9.02,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1749,6829,triazolam,9.1549,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1750,6480,triazolam,9.1549,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1751,6559,triazolam,9.1549,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1752,6829,triazolam,9.0969,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1753,6480,triazolam,9.0969,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1754,6479,triazolam,9.0969,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1755,6480,triazolam,9.2291,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1756,6479,triazolam,9.2291,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1757,6777,triazolam,9.2291,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1758,6480,triazolam,8.8761,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1759,6778,triazolam,8.8761,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1760,6559,triazolam,8.8761,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1761,6480,triazolam,8.8447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1762,6479,triazolam,8.8447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1763,6778,triazolam,8.8447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1764,6829,topiramate,,,POSITIVE MODULATOR,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
1765,6480,topiramate,,,POSITIVE MODULATOR,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
1766,6559,topiramate,,,POSITIVE MODULATOR,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
1767,6829,thiopental,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL441
1768,6480,thiopental,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL441
1769,6559,thiopental,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,CHEMBL441
1770,6829,temazepam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=CC=CC=C1,CHEMBL967
1771,6480,temazepam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=CC=CC=C1,CHEMBL967
1772,6559,temazepam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NC(O)C1=O)C1=CC=CC=C1,CHEMBL967
1773,6829,secobarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL447
1774,6480,secobarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL447
1775,6559,secobarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL447
1776,6478,quazepam,6.6271,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1777,6480,quazepam,6.6271,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1778,6778,quazepam,6.6271,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1779,6478,quazepam,6.6882,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1780,6480,quazepam,6.6882,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1781,6777,quazepam,6.6882,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1782,6829,primidone,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,CHEMBL856
1783,6480,primidone,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,CHEMBL856
1784,6559,primidone,,,POSITIVE ALLOSTERIC MODULATOR,CCC1(C(=O)NCNC1=O)C1=CC=CC=C1,CHEMBL856
1785,6829,prazepam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N(CC3CC3)C(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL969
1786,6480,prazepam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N(CC3CC3)C(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL969
1787,6559,prazepam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N(CC3CC3)C(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL969
1788,6829,pentobarbital,4.301,EC50,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL448
1789,6480,pentobarbital,4.301,EC50,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL448
1790,6559,pentobarbital,4.301,EC50,POSITIVE ALLOSTERIC MODULATOR,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL448
1791,6829,oxazepam,7.745,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL568
1792,6480,oxazepam,7.745,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL568
1793,6479,oxazepam,7.745,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL568
1794,6829,nitrazepam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL13209
1795,6480,nitrazepam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL13209
1796,6559,nitrazepam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,CHEMBL13209
1797,6829,midazolam,8.7447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1798,6480,midazolam,8.7447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1799,6559,midazolam,8.7447,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1800,6480,midazolam,8.4437,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1801,6778,midazolam,8.4437,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1802,6559,midazolam,8.4437,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1803,6829,methyprylon,,,POSITIVE ALLOSTERIC MODULATOR,[H]C1(C)CNC(=O)C(CC)(CC)C1=O,CHEMBL1200790
1804,6480,methyprylon,,,POSITIVE ALLOSTERIC MODULATOR,[H]C1(C)CNC(=O)C(CC)(CC)C1=O,CHEMBL1200790
1805,6479,methyprylon,,,POSITIVE ALLOSTERIC MODULATOR,[H]C1(C)CNC(=O)C(CC)(CC)C1=O,CHEMBL1200790
1806,6829,methohexital,,,POSITIVE ALLOSTERIC MODULATOR,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL7413
1807,6480,methohexital,,,POSITIVE ALLOSTERIC MODULATOR,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL7413
1808,6479,methohexital,,,POSITIVE ALLOSTERIC MODULATOR,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,CHEMBL7413
1809,6829,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1810,6480,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1811,6479,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1812,6480,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1813,6479,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1814,6777,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1815,6480,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1816,6479,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1817,6778,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1818,6480,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1819,6479,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1820,6477,meprobamate,,,AGONIST,CCCC(C)(COC(N)=O)COC(N)=O,CHEMBL979
1821,6829,lorazepam,8.456,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC(Cl)=CC=C2NC1=O)C1=C(Cl)C=CC=C1,CHEMBL580
1822,6480,lorazepam,8.456,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC(Cl)=CC=C2NC1=O)C1=C(Cl)C=CC=C1,CHEMBL580
1823,6479,lorazepam,8.456,IC50,POSITIVE ALLOSTERIC MODULATOR,OC1N=C(C2=CC(Cl)=CC=C2NC1=O)C1=C(Cl)C=CC=C1,CHEMBL580
1824,6829,glutethimide,,,POSITIVE MODULATOR,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,CHEMBL1102
1825,6480,glutethimide,,,POSITIVE MODULATOR,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,CHEMBL1102
1826,6479,glutethimide,,,POSITIVE MODULATOR,CCC1(CCC(=O)NC1=O)C1=CC=CC=C1,CHEMBL1102
1827,6829,flurazepam,8.1,IC50,POSITIVE ALLOSTERIC MODULATOR,CCN(CC)CCN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=C(F)C=CC=C1,CHEMBL968
1828,6480,flurazepam,8.1,IC50,POSITIVE ALLOSTERIC MODULATOR,CCN(CC)CCN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=C(F)C=CC=C1,CHEMBL968
1829,6559,flurazepam,8.1,IC50,POSITIVE ALLOSTERIC MODULATOR,CCN(CC)CCN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=C(F)C=CC=C1,CHEMBL968
1830,6829,flumazenil,9.0969,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1831,6480,flumazenil,9.0969,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1832,6479,flumazenil,9.0969,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1833,6480,flumazenil,9.0458,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1834,6479,flumazenil,9.0458,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1835,6777,flumazenil,9.0458,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1836,6480,flumazenil,8.9788,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1837,6479,flumazenil,8.9788,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1838,6778,flumazenil,8.9788,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1839,6480,flumazenil,9.2218,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1840,6479,flumazenil,9.2218,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1841,6477,flumazenil,9.2218,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1842,6480,flumazenil,6.8297,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1843,6479,flumazenil,6.8297,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1844,6780,flumazenil,6.8297,Ki,ALLOSTERIC ANTAGONIST,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,CHEMBL407
1845,6829,etomidate,5.4559,EC50,POSITIVE MODULATOR,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,CHEMBL23731
1846,6480,etomidate,5.4559,EC50,POSITIVE MODULATOR,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,CHEMBL23731
1847,6559,etomidate,5.4559,EC50,POSITIVE MODULATOR,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,CHEMBL23731
1848,6829,ethchlorvynol,,,POSITIVE MODULATOR,CCC(O)(C=CCl)C#C,CHEMBL591
1849,6480,ethchlorvynol,,,POSITIVE MODULATOR,CCC(O)(C=CCl)C#C,CHEMBL591
1850,6479,ethchlorvynol,,,POSITIVE MODULATOR,CCC(O)(C=CCl)C#C,CHEMBL591
1851,6829,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1852,6480,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1853,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1854,6480,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1855,6778,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1856,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1857,6480,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1858,6479,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1859,6477,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1860,6480,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1861,6479,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1862,6778,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1863,6829,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1864,6480,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1865,6559,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1866,6480,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1867,6479,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1868,6777,estazolam,,,POSITIVE ALLOSTERIC MODULATOR,ClC1=CC=C2N3C=NN=C3CN=C(C3=CC=CC=C3)C2=C1,CHEMBL285674
1869,6480,diazepam,7.65,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1870,6479,diazepam,7.65,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1871,6778,diazepam,7.65,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1872,6829,diazepam,7.1427,EC50,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1873,6480,diazepam,7.1427,EC50,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1874,6559,diazepam,7.1427,EC50,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1875,6829,diazepam,7.8539,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1876,6480,diazepam,7.8539,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1877,6479,diazepam,7.8539,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1878,6480,diazepam,7.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1879,6479,diazepam,7.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1880,6777,diazepam,7.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1881,6480,diazepam,7.9393,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1882,6778,diazepam,7.9393,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1883,6559,diazepam,7.9393,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1884,6480,diazepam,7.9586,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1885,6479,diazepam,7.9586,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1886,6477,diazepam,7.9586,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
1887,6829,clorazepate,7.47,EC50,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1888,6480,clorazepate,7.47,EC50,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1889,6559,clorazepate,7.47,EC50,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1890,6480,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1891,6479,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1892,6777,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1893,6480,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1894,6479,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1895,6778,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1896,6480,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1897,6479,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1898,6477,clorazepate,,,POSITIVE ALLOSTERIC MODULATOR,OC(=O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O,CHEMBL1213252
1899,6829,clonazepam,8.0706,Ki,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C2=C1)C1=C(Cl)C=CC=C1,CHEMBL452
1900,6480,clonazepam,8.0706,Ki,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C2=C1)C1=C(Cl)C=CC=C1,CHEMBL452
1901,6559,clonazepam,8.0706,Ki,POSITIVE ALLOSTERIC MODULATOR,[O-][N+](=O)C1=CC=C2NC(=O)CN=C(C2=C1)C1=C(Cl)C=CC=C1,CHEMBL452
1902,6829,clobazam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2N(C2=CC=CC=C2)C(=O)CC1=O,CHEMBL70418
1903,6480,clobazam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2N(C2=CC=CC=C2)C(=O)CC1=O,CHEMBL70418
1904,6559,clobazam,,,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2N(C2=CC=CC=C2)C(=O)CC1=O,CHEMBL70418
1905,6829,chlordiazepoxide,6.2518,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1906,6480,chlordiazepoxide,6.2518,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1907,6559,chlordiazepoxide,6.2518,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1908,6480,chlordiazepoxide,6.3372,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1909,6479,chlordiazepoxide,6.3372,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1910,6777,chlordiazepoxide,6.3372,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1911,6480,chlordiazepoxide,6.5607,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1912,6479,chlordiazepoxide,6.5607,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1913,6778,chlordiazepoxide,6.5607,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1914,6480,chlordiazepoxide,6.4949,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1915,6479,chlordiazepoxide,6.4949,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1916,6477,chlordiazepoxide,6.4949,Ki,POSITIVE ALLOSTERIC MODULATOR,CNC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=[N+]([O-])C1,CHEMBL451
1917,6829,butalbital,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL454
1918,6480,butalbital,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL454
1919,6479,butalbital,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,CHEMBL454
1920,6829,secbutabarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL449
1921,6480,secbutabarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL449
1922,6559,secbutabarbital,,,POSITIVE ALLOSTERIC MODULATOR,CCC(C)C1(CC)C(=O)NC(=O)NC1=O,CHEMBL449
1923,6829,alprazolam,7.4318,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1924,6480,alprazolam,7.4318,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1925,6559,alprazolam,7.4318,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1926,6480,alprazolam,7.9208,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1927,6479,alprazolam,7.9208,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1928,6777,alprazolam,7.9208,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1929,6480,alprazolam,7.1612,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1930,6479,alprazolam,7.1612,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1931,6778,alprazolam,7.1612,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1932,6480,alprazolam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1933,6479,alprazolam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1934,6477,alprazolam,8.0,EC50,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL661
1935,6829,acamprosate,,,POSITIVE MODULATOR,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1936,6480,acamprosate,,,POSITIVE MODULATOR,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1937,6479,acamprosate,,,POSITIVE MODULATOR,CC(=O)NCCCS(O)(=O)=O,CHEMBL1201293
1938,6829,quazepam,7.7077,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1939,6478,quazepam,7.7077,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1940,6480,quazepam,7.7077,Ki,POSITIVE ALLOSTERIC MODULATOR,FC1=C(C=CC=C1)C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,CHEMBL1200472
1941,425,doxacurium,,,ANTAGONIST,[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1,CHEMBL1237099
1942,427,doxacurium,,,ANTAGONIST,[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1,CHEMBL1237099
1943,217,doxacurium,,,ANTAGONIST,[H]C1(CC2=CC(OC)=C(OC)C(OC)=C2)C2=C(OC)C(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CCC(=O)OCCC[N+]1(C)CCC2=CC(OC)=C(OC)C(OC)=C2C1([H])CC1=CC(OC)=C(OC)C(OC)=C1,CHEMBL1237099
1944,425,vecuronium,7.8239,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,CHEMBL1200629
1945,427,vecuronium,7.8239,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,CHEMBL1200629
1946,217,vecuronium,7.8239,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,CHEMBL1200629
1947,425,tubocurarine,7.6198,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,CHEMBL339427
1948,427,tubocurarine,7.6198,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,CHEMBL339427
1949,217,tubocurarine,7.6198,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,CHEMBL339427
1950,425,rocuronium,7.7696,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,CHEMBL1200648
1951,427,rocuronium,7.7696,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,CHEMBL1200648
1952,217,rocuronium,7.7696,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)[C@H](C[C@]12C)N1CCOCC1)[N+]1(CC=C)CCCC1,CHEMBL1200648
1953,425,pipecuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,CHEMBL1200722
1954,427,pipecuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,CHEMBL1200722
1955,217,pipecuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,CHEMBL1200722
1956,425,pancuronium,8.2007,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,CHEMBL185073
1957,427,pancuronium,8.2007,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,CHEMBL185073
1958,217,pancuronium,8.2007,IC50,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,CHEMBL185073
1959,425,mivacurium,,,ANTAGONIST,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,CHEMBL984
1960,427,mivacurium,,,ANTAGONIST,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,CHEMBL984
1961,217,mivacurium,,,ANTAGONIST,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,CHEMBL984
1962,425,dimethyltubocurarinium,7.7447,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(OC)C(OC6=CC1=C(CC[N+]2(C)C)C=C6OC)=C5)=CC(OC)=C4OC)C=C3,CHEMBL1259
1963,427,dimethyltubocurarinium,7.7447,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(OC)C(OC6=CC1=C(CC[N+]2(C)C)C=C6OC)=C5)=CC(OC)=C4OC)C=C3,CHEMBL1259
1964,217,dimethyltubocurarinium,7.7447,IC50,ANTAGONIST,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(OC)C(OC6=CC1=C(CC[N+]2(C)C)C=C6OC)=C5)=CC(OC)=C4OC)C=C3,CHEMBL1259
1965,425,cisatracurium,8.0,IC50,ANTAGONIST,COC1=C(OC)C=C(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1200641
1966,427,cisatracurium,8.0,IC50,ANTAGONIST,COC1=C(OC)C=C(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1200641
1967,217,cisatracurium,8.0,IC50,ANTAGONIST,COC1=C(OC)C=C(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1200641
1968,425,atracurium,7.7696,IC50,ANTAGONIST,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1360
1969,427,atracurium,7.7696,IC50,ANTAGONIST,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1360
1970,217,atracurium,7.7696,IC50,ANTAGONIST,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3C2CC2=CC(OC)=C(OC)C=C2)C=C1,CHEMBL1360
1971,6778,zopiclone,6.4881,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1972,6559,zopiclone,6.4881,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1973,6560,zopiclone,6.4881,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1974,6778,triazolam,8.1079,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1975,6559,triazolam,8.1079,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1976,6560,triazolam,8.1079,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1977,6778,midazolam,7.6126,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1978,6559,midazolam,7.6126,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1979,6560,midazolam,7.6126,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1980,6778,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1981,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1982,6560,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1983,6829,zopiclone,7.1549,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1984,6559,zopiclone,7.1549,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1985,6560,zopiclone,7.1549,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
1986,6829,triazolam,8.6383,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1987,6559,triazolam,8.6383,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1988,6560,triazolam,8.6383,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
1989,6829,midazolam,7.7496,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1990,6559,midazolam,7.7496,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1991,6560,midazolam,7.7496,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
1992,6829,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1993,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1994,6560,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
1995,10723,melatonin,9.7,EC50,AGONIST,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,CHEMBL45
1996,10909,melatonin,9.4,EC50,AGONIST,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,CHEMBL45
1997,16966,tyramine,7.16,EC50,AGONIST,NCCC1=CC=C(O)C=C1,CHEMBL11608
1998,12712,carbimazole,,,INHIBITOR,CCOC(=O)N1C=CN(C)C1=S,CHEMBL508102
1999,13203,beraprost,8.37,IC50,AGONIST,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C1=C(O2)C(CCCC(O)=O)=CC=C1,CHEMBL435883
2000,14571,hydroxycarbamide,,,INHIBITOR,NC(=O)NO,CHEMBL467
2001,14571,gemcitabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,CHEMBL888
2002,14571,clofarabine,8.3,IC50,INHIBITOR,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1,CHEMBL1750
2003,14296,hydroxycarbamide,,,INHIBITOR,NC(=O)NO,CHEMBL467
2004,14296,gemcitabine,,,INHIBITOR,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,CHEMBL888
2005,14296,clofarabine,8.3,IC50,INHIBITOR,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3F)C2=NC(Cl)=N1,CHEMBL1750
2006,5171,edatrexate,8.36,IC50,INHIBITOR,CCC(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,CHEMBL296373
2007,14053,etretinate,,,AGONIST,CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(C)=C(OC)C=C1C,CHEMBL464
2008,14053,acitretin,,,AGONIST,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,CHEMBL1131
2009,1980,aprindine,4.7447,ID50,INHIBITOR,CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1,CHEMBL1213033
2010,1694,aprindine,4.7447,ID50,INHIBITOR,CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1,CHEMBL1213033
2011,1695,aprindine,4.7447,ID50,INHIBITOR,CCN(CC)CCCN(C1CC2=C(C1)C=CC=C2)C1=CC=CC=C1,CHEMBL1213033
2012,15619,finasteride,7.58,IC50,INHIBITOR,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,CHEMBL710
2013,875,cyproterone acetate,7.432,IC50,ANTAGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]12C,CHEMBL142130
2014,5154,raloxifene,9.4,IC50,ANTAGONIST,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,CHEMBL81
2015,7076,enflurane,,,POSITIVE MODULATOR,FC(F)OC(F)(F)C(F)Cl,CHEMBL1257
2016,539,urapidil,7.1,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1,CHEMBL279229
2017,63,urapidil,7.9,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1,CHEMBL279229
2018,15088,nomifensine,7.31,Ki,INHIBITOR,CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1,CHEMBL273575
2019,15028,piretanide,8.3,Kd,INHIBITOR,NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O,CHEMBL349803
2020,42,pirenzepine,7.68,Ki,ANTAGONIST,CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1,CHEMBL9967
2021,7510,roxatidine acetate,7.6,Kd,ANTAGONIST,CC(=O)OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1,CHEMBL46102
2022,7509,terfenadine,8.699,Ki,ANTAGONIST,[H]C(O)(CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=C(C=C1)C(C)(C)C,CHEMBL17157
2023,7509,oxatomide,7.699,Ki,ANTAGONIST,O=C1NC2=C(C=CC=C2)N1CCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL13828
2024,7509,mizolastine,8.84,Ki,ANTAGONIST,CN(C1CCN(CC1)C1=NC2=C(C=CC=C2)N1CC1=CC=C(F)C=C1)C1=NC=CC(=O)N1,CHEMBL94454
2025,7509,mebhydrolin,7.1192,Ki,ANTAGONIST,CN1CCC2=C(C1)C1=C(C=CC=C1)N2CC1=CC=CC=C1,CHEMBL1625607
2026,7509,ebastine,8.0,Ki,ANTAGONIST,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL305660
2027,7509,astemizole,8.58,A2,ANTAGONIST,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1,CHEMBL296419
2028,4817,prochlorperazine,8.611,Ki,ANTAGONIST,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,CHEMBL728
2029,4817,amisulpride,8.4946,Ki,ANTAGONIST,CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC,CHEMBL243712
2030,973,urapidil,8.85,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CCCNC2=CC(=O)N(C)C(=O)N2C)CC1,CHEMBL279229
2031,27,mianserin,8.5204,Ki,ANTAGONIST,[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1,CHEMBL6437
2032,26,mianserin,8.12,Ki,ANTAGONIST,[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1,CHEMBL6437
2033,104,mianserin,8.17,Ki,ANTAGONIST,[H]C12CN(C)CCN1C1=C(CC3=C2C=CC=C3)C=CC=C1,CHEMBL6437
2034,15387,nomifensine,7.67,Ki,INHIBITOR,CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1,CHEMBL273575
2035,15387,lofepramine,8.2676,Ki,INHIBITOR,CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1,CHEMBL87708
2036,15387,dosulepin,7.3372,Kd,INHIBITOR,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,CHEMBL108947
2037,15089,lofepramine,7.1549,Ki,INHIBITOR,CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1,CHEMBL87708
2038,15089,dosulepin,8.0655,Kd,INHIBITOR,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,CHEMBL108947
2039,4816,zuclopenthixol,,,ANTAGONIST,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1,CHEMBL53904
2040,4816,levodopa,,,AGONIST,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL1009
2041,4816,bromperidol,8.43,Ki,ANTAGONIST,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1,CHEMBL28218
2042,4816,amisulpride,8.5528,Ki,ANTAGONIST,CCN1CCCC1CNC(=O)C1=C(OC)C=C(N)C(=C1)S(=O)(=O)CC,CHEMBL243712
2043,4815,zuclopenthixol,,,ANTAGONIST,OCCN1CCN(CC\C=C2\C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1,CHEMBL53904
2044,4815,levodopa,,,AGONIST,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O,CHEMBL1009
2045,12006,tilidine,5.1,EC50,AGONIST,[H]C1(C=CCCC1(C(=O)OCC)C1=CC=CC=C1)N(C)C,CHEMBL2218854
2046,12006,propiram,,,AGONIST,CCC(=O)N(C(C)CN1CCCCC1)C1=CC=CC=N1,CHEMBL2106935
2047,12006,meptazinol,8.06,EC50,PARTIAL AGONIST,CCC1(CCCCN(C)C1)C1=CC(O)=CC=C1,CHEMBL314437
2048,13316,tiaprofenic acid,5.9,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1,CHEMBL365795
2049,13316,flufenamic acid,5.52,IC50,INHIBITOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,CHEMBL23588
2050,13316,fenbufen,,,INHIBITOR,OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,CHEMBL277522
2051,12865,tiaprofenic acid,7.1,IC50,INHIBITOR,CC(C(O)=O)C1=CC=C(S1)C(=O)C1=CC=CC=C1,CHEMBL365795
2052,12865,flufenamic acid,6.93,IC50,INHIBITOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,CHEMBL23588
2053,12865,fenbufen,,,INHIBITOR,OC(=O)CCC(=O)C1=CC=C(C=C1)C1=CC=CC=C1,CHEMBL277522
2054,79,fenoterol,6.9,EC50,AGONIST,CC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1,CHEMBL32800
2055,79,bopindolol,9.65,Ki,ANTAGONIST,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,CHEMBL357995
2056,547,celiprolol,8.1,Ki,ANTAGONIST,CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OCC(O)CNC(C)(C)C)C=C1,CHEMBL27810
2057,547,bopindolol,9.51,Ki,ANTAGONIST,CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C1=CC=CC=C1,CHEMBL357995
2058,547,bevantolol,,,ANTAGONIST,COC1=C(OC)C=C(CCNCC(O)COC2=CC(C)=CC=C2)C=C1,CHEMBL314010
2059,4215,ketoconazole,7.28,IC50,INHIBITOR,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,CHEMBL157101
2060,6480,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2061,6477,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2062,6559,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2063,6477,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2064,6559,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2065,6560,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2066,6480,triazolam,9.2218,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2067,6477,triazolam,9.2218,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2068,6559,triazolam,9.2218,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2069,6477,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2070,6559,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2071,6560,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2072,6480,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2073,6477,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2074,6559,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2075,6477,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2076,6559,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2077,6560,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2078,6480,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2079,6477,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2080,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2081,6477,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2082,6559,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2083,6560,eszopiclone,,,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2084,6480,diazepam,8.0044,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2085,6477,diazepam,8.0044,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2086,6559,diazepam,8.0044,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2087,6477,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2088,6559,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2089,6560,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2090,1226,enoxaparin sodium,,,ACTIVATOR,,CHEMBL1201476
2091,19094,alfacalcidol,,,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)C,CHEMBL1601669
2092,15538,quinidine,5.49,IC50,BLOCKER,[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12,CHEMBL21578
2093,15101,quinidine,5.49,IC50,BLOCKER,[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12,CHEMBL21578
2094,15251,quinidine,5.49,IC50,BLOCKER,[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12,CHEMBL21578
2095,15103,quinidine,5.16,IC50,BLOCKER,[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12,CHEMBL21578
2096,2741,dorzolamide,9.7,Ki,INHIBITOR,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,CHEMBL218490
2097,3446,vorozole,8.86,IC50,INHIBITOR,CN1N=NC2=C1C=C(C=C2)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1,CHEMBL224060
2098,150,tolterodine,8.57,Ki,ANTAGONIST,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,CHEMBL1382
2099,430,tolterodine,8.49,Ki,ANTAGONIST,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,CHEMBL1382
2100,12188,butorphanol,9.92,Ki,PARTIAL AGONIST,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,CHEMBL33986
2101,12006,butorphanol,9.92,Ki,PARTIAL AGONIST,[H][C@@]12CC3=C(C=C(O)C=C3)[C@]3(CCCC[C@@]13O)CCN2CC1CCC1,CHEMBL33986
2102,4816,loxapine,7.68,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,CHEMBL831
2103,104,loxapine,8.62,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,CHEMBL831
2104,875,stanozolol,,,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=C(C[C@]12C)C=NN3,CHEMBL2079587
2105,15089,paroxetine,10.4,Ki,INHIBITOR,[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1,CHEMBL490
2106,79,protokylol,,,AGONIST,CC(CC1=CC=C2OCOC2=C1)NCC(O)C1=CC=C(O)C(O)=C1,CHEMBL1200893
2107,444,naratriptan,8.48,Ki,AGONIST,CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1,CHEMBL1278
2108,875,fluoxymesterone,8.24,Ki,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1445
2109,15187,chlortalidone,,,INHIBITOR,NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12,CHEMBL1055
2110,2741,topiramate,8.3,Ki,INHIBITOR,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2111,2138,topiramate,5.31,Ki,INHIBITOR,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2112,6744,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2113,6745,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2114,6746,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2115,6747,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2116,6873,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2117,6874,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2118,7095,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2119,6875,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2120,7096,topiramate,,,ANTAGONIST,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,CHEMBL220492
2121,12188,nalmefene,9.92,Ki,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,CHEMBL982
2122,12187,nalmefene,9.04,Kd,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,CHEMBL982
2123,12006,nalmefene,9.53,Kd,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CCC2=C,CHEMBL982
2124,430,mepenzolate,8.59,Ki,ANTAGONIST,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL524004
2125,42,mepenzolate,,,ANTAGONIST,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL524004
2126,4816,sulpiride,8.12,Ki,ANTAGONIST,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,CHEMBL26
2127,7412,belinostat,7.56863642,IC50,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2128,15103,propafenone,5.48,IC50,BLOCKER,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,CHEMBL631
2129,79,formoterol,8.6,Kd,AGONIST,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1,CHEMBL1256786
2130,430,oxyphencyclimine,,,ANTAGONIST,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1495
2131,42,oxyphencyclimine,,,ANTAGONIST,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1495
2132,6487,medrysone,,,AGONIST,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,CHEMBL1201173
2133,1535,omeprazole,5.7,IC50,INHIBITOR,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,CHEMBL1503
2134,1158,omeprazole,5.7,IC50,INHIBITOR,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,CHEMBL1503
2135,1535,esomeprazole,,,INHIBITOR,COC1=CC=C2N=C(NC2=C1)[S@@](=O)CC1=C(C)C(OC)=C(C)C=N1,CHEMBL1200470
2136,1158,esomeprazole,,,INHIBITOR,COC1=CC=C2N=C(NC2=C1)[S@@](=O)CC1=C(C)C(OC)=C(C)C=N1,CHEMBL1200470
2137,1677,nifedipine,9.4,Kd,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,CHEMBL193
2138,17638,nafamostat,7.77,IC50,INHIBITOR,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,CHEMBL273264
2139,1927,nafamostat,6.0,IC50,INHIBITOR,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,CHEMBL273264
2140,15182,bexarotene,7.85,Kd,AGONIST,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O,CHEMBL1023
2141,15716,bexarotene,8.23,Ki,AGONIST,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O,CHEMBL1023
2142,15016,bexarotene,8.08,Ki,AGONIST,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O,CHEMBL1023
2143,430,oxyphenonium,,,ANTAGONIST,CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1200906
2144,13069,idelalisib,8.60206032,IC50,INHIBITOR,CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1,CHEMBL2216870
2145,12865,meloxicam,6.8,IC50,INHIBITOR,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=CC=CC=C2S1(=O)=O,CHEMBL599
2146,14092,tazarotene,9.1,EC50,AGONIST,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1,CHEMBL1657
2147,14053,tazarotene,7.2,EC50,AGONIST,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1,CHEMBL1657
2148,14054,tazarotene,7.4,EC50,AGONIST,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1,CHEMBL1657
2149,42,clidinium,,,ANTAGONIST,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL620
2150,12757,dinoprostone,9.77,Ki,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL548
2151,12781,dinoprostone,8.04,Ki,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL548
2152,12782,dinoprostone,8.77,Ki,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL548
2153,12756,dinoprostone,9.48,Ki,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL548
2154,6786,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2155,6782,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2156,6829,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2157,6478,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2158,6480,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2159,6479,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2160,6477,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2161,6778,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2162,6777,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2163,6559,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2164,6779,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2165,6783,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2166,6780,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2167,6784,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2168,6560,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2169,6789,halazepam,,,POSITIVE ALLOSTERIC MODULATOR,FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL970
2170,430,isopropamide,,,ANTAGONIST,CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C,CHEMBL1200347
2171,42,isopropamide,,,ANTAGONIST,CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C,CHEMBL1200347
2172,67,yohimbine,9.38,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2,CHEMBL15245
2173,316,yohimbine,8.7,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2,CHEMBL15245
2174,540,yohimbine,9.3,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2,CHEMBL15245
2175,12942,dinoprost,8.4,Kd,AGONIST,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL815
2176,5154,estradiol valerate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL1511
2177,8938,balsalazide,,,INHIBITOR,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,CHEMBL1200760
2178,13436,balsalazide,,,AGONIST,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,CHEMBL1200760
2179,1795,cinacalcet,7.7,EC50,POSITIVE ALLOSTERIC MODULATOR,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2,CHEMBL1200776
2180,42,oxybutynin,9.0,Ki,ANTAGONIST,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1133
2181,430,oxybutynin,9.11,Ki,ANTAGONIST,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,CHEMBL1133
2182,1535,rabeprazole,,,INHIBITOR,COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C,CHEMBL1219
2183,1158,rabeprazole,,,INHIBITOR,COCCCOC1=CC=NC(CS(=O)C2=NC3=C(N2)C=CC=C3)=C1C,CHEMBL1219
2184,15187,methylclothiazide,,,INHIBITOR,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,CHEMBL1577
2185,13566,fenofibrate,6.0,IC50,AGONIST,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,CHEMBL672
2186,17846,protirelin,7.7,Ki,AGONIST,NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,CHEMBL1472
2187,150,solifenacin,6.24,IC50,ANTAGONIST,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,CHEMBL1734
2188,430,solifenacin,6.88,IC50,ANTAGONIST,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,CHEMBL1734
2189,15187,metolazone,,,INHIBITOR,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=C(C)C=CC=C1)S(N)(=O)=O,CHEMBL878
2190,447,prucalopride,8.6,Ki,AGONIST,COCCCN1CCC(CC1)NC(=O)C1=CC(Cl)=C(N)C2=C1OCC2,CHEMBL117287
2191,483,perindopril,8.82,IC50,INHIBITOR,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,CHEMBL1581
2192,12942,carboprost,,,AGONIST,CCCCC[C@](C)(O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,CHEMBL1237105
2193,1535,lansoprazole,,,INHIBITOR,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,CHEMBL480
2194,1158,lansoprazole,,,INHIBITOR,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,CHEMBL480
2195,6487,rimexolone,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](C)(C(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200617
2196,4816,remoxipride,6.06,IC50,ANTAGONIST,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC,CHEMBL22242
2197,5154,tamoxifen,7.51,Ki,MODULATOR,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,CHEMBL83
2198,6487,meprednisone,,,AGONIST,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1201148
2199,9891,desoxycorticosterone acetate,,,AGONIST,[H][C@@]12CC[C@H](C(=O)COC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200542
2200,3552,nabilone,8.4,Ki,AGONIST,[H]C12CC(=O)CCC1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,CHEMBL947
2201,15522,tiagabine,7.77,Ki,INHIBITOR,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,CHEMBL1027
2202,6487,fluprednisolone,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1200774
2203,8323,doxapram,,,BLOCKER,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1754
2204,8326,doxapram,,,BLOCKER,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1754
2205,5666,chlorotrianisene,,,MODULATOR,COC1=CC=C(C=C1)C(Cl)=C(C1=CC=C(OC)C=C1)C1=CC=C(OC)C=C1,CHEMBL1200761
2206,444,eletriptan,8.52,Kd,AGONIST,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,CHEMBL1510
2207,103,eletriptan,9.05,Kd,AGONIST,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,CHEMBL1510
2208,1535,pantoprazole,,,INHIBITOR,COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC,CHEMBL1502
2209,1158,pantoprazole,,,INHIBITOR,COC1=CC=NC(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=C1OC,CHEMBL1502
2210,2741,brinzolamide,9.9,Ki,INHIBITOR,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,CHEMBL220491
2211,13817,bortezomib,7.28,IC50,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,CHEMBL325041
2212,13819,bortezomib,9.26,Ki,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,CHEMBL325041
2213,13799,bortezomib,6.23,IC50,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,CHEMBL325041
2214,13860,bortezomib,8.09,IC50,INHIBITOR,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,CHEMBL325041
2215,6779,eszopiclone,6.99,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2216,6777,eszopiclone,6.94,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,CHEMBL1522
2217,12630,tadalafil,8.0,Ki,INHIBITOR,[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1,CHEMBL779
2218,63,alfuzosin,8.44,Ki,ANTAGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1,CHEMBL709
2219,973,alfuzosin,8.09,Ki,ANTAGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1,CHEMBL709
2220,539,alfuzosin,8.55,Ki,ANTAGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)C1CCCO1,CHEMBL709
2221,15187,cyclothiazide,,,INHIBITOR,NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C2CC3CC2C=C3)C=C1Cl,CHEMBL61593
2222,7509,meclozine,,,ANTAGONIST,CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1,CHEMBL1623
2223,12769,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2224,12770,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2225,12628,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2226,12629,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2227,12846,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2228,12772,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2229,12773,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2230,12847,flavoxate,,,INHIBITOR,CC1=C(OC2=C(C=CC=C2C1=O)C(=O)OCCN1CCCCC1)C1=CC=CC=C1,CHEMBL1493
2231,150,trospium,,,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,CHEMBL1888176
2232,11552,ursodiol,,,AGONIST,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,CHEMBL1551
2233,4816,spiperone,10.22,Ki,ANTAGONIST,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,CHEMBL267930
2234,104,spiperone,8.65,Ki,ANTAGONIST,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,CHEMBL267930
2235,5154,estradiol cypionate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL1200973
2236,13316,sulfasalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,CHEMBL421
2237,12865,sulfasalazine,,,INHIBITOR,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC=N1,CHEMBL421
2238,17638,camostat,7.3,IC50,INHIBITOR,CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(NC(N)=N)C=C2)C=C1,CHEMBL590799
2239,6240,sunitinib,9.66,Kd,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2240,18451,sunitinib,9.7,Kd,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2241,12659,sunitinib,10.12,Kd,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2242,8988,sunitinib,9.68,Kd,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2243,4068,sunitinib,8.7,Kd,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2244,19096,sunitinib,7.77,Ki,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2245,19094,calcifediol,,,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C)[C@H](C)CCCC(C)(C)O,CHEMBL1040
2246,6487,prednisolone acetate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1152
2247,12769,roflumilast,9.1,IC50,INHIBITOR,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,CHEMBL193240
2248,12770,roflumilast,9.1,IC50,INHIBITOR,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,CHEMBL193240
2249,12628,roflumilast,9.1,IC50,INHIBITOR,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,CHEMBL193240
2250,12629,roflumilast,9.1,IC50,INHIBITOR,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,CHEMBL193240
2251,15335,sulfinpyrazone,4.0,IC50,INHIBITOR,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(N1C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL832
2252,1678,flunarizine,5.44,Kd,BLOCKER,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,CHEMBL30008
2253,2127,flunarizine,6.08,Kd,BLOCKER,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,CHEMBL30008
2254,2126,flunarizine,6.28,Kd,BLOCKER,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,CHEMBL30008
2255,483,imidapril,5.0,IC50,INHIBITOR,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(=O)OCC)C(=O)N1[C@@H](CN(C)C1=O)C(O)=O,CHEMBL317094
2256,4638,icosapent ethyl,,,INHIBITOR,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,CHEMBL2095209
2257,887,nesiritide,,,AGONIST,[H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O,CHEMBL1201668
2258,17559,lepirudin,13.0,Ki,INHIBITOR,[H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C,CHEMBL1201666
2259,17559,desirudin,12.7,Ki,INHIBITOR,[H]N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC1=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC2=O)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC1=O)C(C)C,CHEMBL1201662
2260,6782,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2261,6829,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2262,6478,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2263,6480,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2264,6479,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2265,6477,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2266,6778,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2267,6777,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2268,6559,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2269,6779,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2270,6780,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2271,6784,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2272,6560,fospropofol,,,POSITIVE ALLOSTERIC MODULATOR,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O,CHEMBL1201766
2273,5154,conjugated estrogens,,,AGONIST,,CHEMBL1201649
2274,5666,conjugated estrogens,,,AGONIST,,CHEMBL1201649
2275,6487,prednisolone sodium phosphate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1201014
2276,4816,paliperidone palmitate,,,ANTAGONIST,CCCCCCCCCCCCCCCC(=O)OC1CCCN2C(=O)C(CCN3CCC(CC3)C3=NOC4=C3C=CC(F)=C4)=C(C)N=C12,CHEMBL2107360
2277,104,paliperidone palmitate,,,ANTAGONIST,CCCCCCCCCCCCCCCC(=O)OC1CCCN2C(=O)C(CCN3CCC(CC3)C3=NOC4=C3C=CC(F)=C4)=C(C)N=C12,CHEMBL2107360
2278,5793,palifermin,,,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O,CHEMBL1201821
2279,9159,metreleptin,,,AGONIST,[H]N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC1=O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(O)=O,CHEMBL2107857
2280,9501,ecallantide,10.60206032,Ki,INHIBITOR,[H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC4=CNC=N4)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC3=O)[C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](C)NC1=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O,CHEMBL1201837
2281,6834,somatropin,,,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL1201621
2282,5154,estrone sulphate,,,AGONIST,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,CHEMBL1200980
2283,5666,estrone sulphate,,,AGONIST,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,CHEMBL1200980
2284,12006,naloxegol,,,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CC[C@@H]2OCCOCCOCCOCCOCCOCCOCCOC,CHEMBL2219416
2285,3216,flopropione,,,INHIBITOR,CCC(=O)C1=C(O)C=C(O)C=C1O,CHEMBL1605835
2286,6000,edoxaban,9.25181198,Ki,INHIBITOR,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=CC=C(Cl)C=N2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,CHEMBL1269025
2287,4816,benzquinamide,5.4,Ki,AGONIST,CCN(CC)C(=O)C1CN2CCC3=C(C=C(OC)C(OC)=C3)C2CC1OC(C)=O,CHEMBL1200707
2288,42,biperiden,9.32,Kd,ANTAGONIST,[H]C1(CC2CC1C=C2)C(O)(CCN1CCCCC1)C1=CC=CC=C1,CHEMBL1101
2289,11575,netupitant,9.02227592,Ki,ANTAGONIST,CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C1=CN=C(C=C1C1=C(C)C=CC=C1)N1CCN(C)CC1,CHEMBL206253
2290,12154,diquafosol,7.46852112,EC50,AGONIST,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O)N1C=CC(=O)NC1=O,CHEMBL221326
2291,8163,vernakalant,4.87451887,IC50,BLOCKER,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1,CHEMBL2107383
2292,430,imidafenacin,9.49894047,Kb,ANTAGONIST,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL53366
2293,18451,nintedanib,8.30103016,IC50,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2294,5845,nintedanib,7.42021656,IC50,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2295,12948,nintedanib,7.74472761,IC50,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2296,19095,nintedanib,6.98296642,IC50,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2297,19096,nintedanib,8.30103016,IC50,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2298,17609,adalimumab,,,ANTIBODY BINDING,,CHEMBL1201580
2299,18405,levosimendan,3.15490198,Kd,OPENER,C[C@@H]1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,CHEMBL2051955
2300,862,fimasartan,9.37675095,IC50,ANTAGONIST,CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,CHEMBL1951143
2301,15102,pilsicainide,4.37675095,IC50,BLOCKER,CC1=CC=CC(C)=C1NC(=O)CC12CCCN1CCC2,CHEMBL163238
2302,11810,olaparib,8.30103016,IC50,INHIBITOR,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,CHEMBL521686
2303,11683,olaparib,9.0,IC50,INHIBITOR,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,CHEMBL521686
2304,10973,afamelanotide,10.0,IC50,AGONIST,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,CHEMBL2108301
2305,18877,pegaptanib,,,ANTAGONIST,,CHEMBL1201421
2306,18606,tafamidis,,,OTHER,OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1,CHEMBL2103837
2307,2123,efonidipine,,,BLOCKER,CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,CHEMBL2074922
2308,1677,efonidipine,,,BLOCKER,CC1=C(C(C2=CC(=CC=C2)[N+]([O-])=O)C(=C(C)N1)P1(=O)OCC(C)(C)CO1)C(=O)OCCN(CC1=CC=CC=C1)C1=CC=CC=C1,CHEMBL2074922
2309,2123,aranidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)=O,CHEMBL2104030
2310,1677,aranidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)=O,CHEMBL2104030
2311,2123,(S)-nicardipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,
2312,1677,(S)-nicardipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,
2313,2123,barnidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1,CHEMBL2103761
2314,1677,barnidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@H]1CCN(CC2=CC=CC=C2)C1,CHEMBL2103761
2315,2123,azelnidipine,,,BLOCKER,CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1275868
2316,1677,azelnidipine,,,BLOCKER,CC(C)OC(=O)C1=C(C)NC(N)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1275868
2317,14456,remikiren,9.1549015,IC50,INHIBITOR,[H][C@@](CC1CCCCC1)(NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CC1=CC=CC=C1)CS(=O)(=O)C(C)(C)C)[C@@H](O)[C@@H](O)C1CC1,CHEMBL31601
2318,2119,pregabalin,7.25963736,IC50,MODULATOR,CC(C)C[C@H](CN)CC(O)=O,CHEMBL1059
2319,2119,gabapentin,6.92811823,IC50,MODULATOR,NCC1(CC(O)=O)CCCCC1,CHEMBL940
2320,6814,tesamorelin,,,AGONIST,[H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O,CHEMBL1237026
2321,7425,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2322,7412,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2323,7335,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2324,7428,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2325,7336,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2326,7136,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2327,7334,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2328,7228,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2329,7427,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2330,7229,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2331,7426,romidepsin,5.96,Ki,INHIBITOR,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,CHEMBL343448
2332,3307,tacrine,7.30103016,IC50,INHIBITOR,NC1=C2CCCCC2=NC2=CC=CC=C12,CHEMBL95
2333,144,acotiamide,5.52287865,IC50,INHIBITOR,COC1=CC(O)=C(C=C1OC)C(=O)NC1=NC(=CS1)C(=O)NCCN(C(C)C)C(C)C,CHEMBL2107308
2334,483,temocapril,,,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CS[C@@H](CN(CC(O)=O)C1=O)C1=CC=CS1,CHEMBL300841
2335,483,delapril,9.97000027,Ki,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2,CHEMBL589583
2336,483,alacepril,,,INHIBITOR,C[C@H](CSC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL2103775
2337,8077,insulin glargine,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)NCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1201497
2338,862,tasosartan,7.49,IC50,ANTAGONIST,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=C(C=CC=C3)C3=NN=NN3)C2=N1,CHEMBL432162
2339,7742,fluvastatin,7.55,IC50,INHIBITOR,CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=C1C=CC=C2)C1=CC=C(F)C=C1,CHEMBL1078
2340,14054,adapalene,6.89,Ki,AGONIST,COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O,CHEMBL1265
2341,14092,adapalene,7.47,Ki,AGONIST,COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O,CHEMBL1265
2342,19094,calcipotriene,9.51,Kd,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@@H](O)C1CC1,CHEMBL1200666
2343,15103,flecainide,5.19,IC50,BLOCKER,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,CHEMBL652
2344,15387,dexamfetamine,7.0,Ki,INHIBITOR,C[C@H](N)CC1=CC=CC=C1,CHEMBL612
2345,12847,dipyridamole,4.3,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2346,4562,eflornithine,4.89,Kd,INHIBITOR,NCCCC(N)(C(F)F)C(O)=O,CHEMBL830
2347,11421,ezetimibe,6.66,Kd,ANTAGONIST,O[C@@H](CC[C@@H]1[C@H](N(C1=O)C1=CC=C(F)C=C1)C1=CC=C(O)C=C1)C1=CC=C(F)C=C1,CHEMBL1138
2348,13566,gemfibrozil,4.23,EC50,AGONIST,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,CHEMBL457
2349,79,salmeterol,9.41,Ki,AGONIST,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,CHEMBL1263
2350,7509,rupatadine,8.41,IC50,ANTAGONIST,CC1=CC(CN2CCC(CC2)=C2C3=CC=C(Cl)C=C3CCC3=C2N=CC=C3)=CN=C1,CHEMBL91397
2351,18107,hydroxychloroquine,5.56,IC50,ANTAGONIST,CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,CHEMBL1535
2352,18343,hydroxychloroquine,7.1,IC50,ANTAGONIST,CCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,CHEMBL1535
2353,16563,lanreotide,9.3,Ki,AGONIST,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O,CHEMBL1201184
2354,16803,lanreotide,9.6,Ki,AGONIST,[H][C@](N)(CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O,CHEMBL1201184
2355,17274,ramatroban,9.24,Ki,INVERSE AGONIST,OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12,CHEMBL361812
2356,6487,desonide,,,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,CHEMBL1201109
2357,1977,methocarbamol,7.6,Ki,INHIBITOR,COC1=C(OCC(O)COC(N)=O)C=CC=C1,CHEMBL1201117
2358,547,norepinephrine,6.0,Ki,AGONIST,NC[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL1437
2359,862,olmesartan medoxomil,8.1,IC50,ANTAGONIST,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=O)OCC1=C(C)OC(=O)O1)C(C)(C)O,CHEMBL1516
2360,18515,conivaptan,9.44,Ki,ANTAGONIST,CC1=NC2=C(N1)C1=C(C=CC=C1)N(CC2)C(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C2=CC=CC=C2)C=C1,CHEMBL1755
2361,19016,conivaptan,9.37,Ki,ANTAGONIST,CC1=NC2=C(N1)C1=C(C=CC=C1)N(CC2)C(=O)C1=CC=C(NC(=O)C2=C(C=CC=C2)C2=CC=CC=C2)C=C1,CHEMBL1755
2362,862,losartan,9.48,IC50,ANTAGONIST,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,CHEMBL995
2363,15335,benzbromarone,7.59,IC50,INHIBITOR,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2,CHEMBL388590
2364,862,eprosartan,8.7,IC50,ANTAGONIST,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,CHEMBL813
2365,7742,pravastatin,7.52,IC50,INHIBITOR,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,CHEMBL690
2366,15333,probenecid,4.9,IC50,INHIBITOR,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,CHEMBL897
2367,12006,difenoxin,,,AGONIST,OC(=O)C1(CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1)C1=CC=CC=C1,CHEMBL1200599
2368,104,carfenazine,,,ANTAGONIST,CCC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(CCO)CC3)C2=C1,CHEMBL1201328
2369,430,darifenacin,9.52,Kd,ANTAGONIST,NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL1346
2370,15668,secretin human,9.7,EC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O,CHEMBL1201488
2371,13203,treprostinil,8.72,EC50,AGONIST,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=CC=CC(OCC(O)=O)=C1C2,CHEMBL1237119
2372,15542,triamterene,5.30000019,IC50,BLOCKER,NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1,CHEMBL585
2373,15107,triamterene,5.30000019,IC50,BLOCKER,NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1,CHEMBL585
2374,15544,triamterene,5.30000019,IC50,BLOCKER,NC1=NC2=NC(N)=C(N=C2C(N)=N1)C1=CC=CC=C1,CHEMBL585
2375,6782,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2376,6829,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2377,6478,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2378,6480,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2379,6479,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2380,6477,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2381,6778,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2382,6777,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2383,6559,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2384,6779,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2385,6780,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2386,6784,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2387,6560,triazolam,9.10000038,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2388,875,methyltestosterone,9.66,EC50,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1395
2389,6479,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2390,6477,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2391,6560,diazepam,7.2034,Ki,POSITIVE ALLOSTERIC MODULATOR,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,CHEMBL12
2392,5171,pralatrexate,7.35,Ki,INHIBITOR,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1,CHEMBL1201746
2393,13783,ulipristal,9.7,IC50,ANTAGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],CHEMBL260538
2394,8328,retigabine,5.6,EC50,ACTIVATOR,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,CHEMBL41355
2395,8417,retigabine,5.2,EC50,ACTIVATOR,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,CHEMBL41355
2396,8418,retigabine,5.0,EC50,ACTIVATOR,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,CHEMBL41355
2397,8329,retigabine,6.2,EC50,ACTIVATOR,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1,CHEMBL41355
2398,15089,vilazodone,9.3,IC50,INHIBITOR,NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,CHEMBL439849
2399,443,vilazodone,9.7,Ki,AGONIST,NC(=O)C1=CC2=C(O1)C=CC(=C2)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,CHEMBL439849
2400,862,azilsartan medoxomil,,,ANTAGONIST,CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NOC(=O)N1,CHEMBL57242
2401,16804,pasireotide,8.8,IC50,AGONIST,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,CHEMBL3039583
2402,16562,pasireotide,8.0,IC50,AGONIST,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,CHEMBL3039583
2403,16563,pasireotide,9.8,IC50,AGONIST,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,CHEMBL3039583
2404,16803,pasireotide,9.0,IC50,AGONIST,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)C(NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,CHEMBL3039583
2405,2123,nitrendipine,8.4,IC50,GATING INHIBITOR,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,CHEMBL475534
2406,1148,digitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL254219
2407,6711,degarelix,8.77,Ki,ANTAGONIST,[H][C@]1(CC(=O)NC(=O)N1)C(=O)NC1=CC=C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](CC2=CN=CC=C2)NC(=O)[C@@H](CC2=CC=C(Cl)C=C2)NC(=O)[C@@H](CC2=CC3=C(C=CC=C3)C=C2)NC(C)=O)C(=O)N[C@H](CC2=CC=C(NC(N)=O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(N)=O)C=C1,CHEMBL415606
2408,7509,dexchlorpheniramine,,,ANTAGONIST,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,CHEMBL1200927
2409,11575,fosaprepitant,8.92,IC50,ANTAGONIST,C[C@@H](O[C@H]1OCCN(CC2=NN(C(=O)N2)P(O)(O)=O)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,CHEMBL1199324
2410,13834,teriparatide,7.4,IC50,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL525610
2411,18451,regorafenib,7.9,IC50,INHIBITOR,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1946170
2412,12630,udenafil,8.08354568,IC50,INHIBITOR,CCCOC1=CC=C(C=C1C1=NC(=O)C2=C(N1)C(CCC)=NN2C)S(=O)(=O)NCCC1CCCN1C,CHEMBL2103849
2413,3128,alemtuzumab,,,ANTIBODY BINDING,,CHEMBL1201587
2414,63,naftopidil,8.92081833,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1,CHEMBL142635
2415,973,naftopidil,8.43179798,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1,CHEMBL142635
2416,539,naftopidil,7.69896984,Ki,ANTAGONIST,COC1=C(C=CC=C1)N1CCN(CC(O)COC2=CC=CC3=CC=CC=C23)CC1,CHEMBL142635
2417,12006,ciramadol,,,MODULATOR,[H][C@@]1(CCCC[C@H]1O)[C@@H](N(C)C)C1=CC(O)=CC=C1,CHEMBL2104041
2418,12006,acetylmethadol,,,AGONIST,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL170179
2419,19016,felypressin,,,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O,CHEMBL1908309
2420,19101,acenocoumarol,6.11350918,IC50,INHIBITOR,[H]C(CC(O)=O)(C1=CC=C(C=C1)[N+]([O-])=O)C1=C(O)C2=C(OC1=O)C=CC=C2,CHEMBL397420
2421,19101,phenprocoumon,5.74472761,IC50,INHIBITOR,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,CHEMBL16694
2422,19101,dicoumarol,5.50863838,IC50,INHIBITOR,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12,CHEMBL1466
2423,7509,aceprometazine,,,ANTAGONIST,CC(CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C(C)=O)N(C)C,CHEMBL2104054
2424,6782,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2425,6829,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2426,6478,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2427,6480,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2428,6479,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2429,6477,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2430,6778,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2431,6777,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2432,6559,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2433,6779,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2434,6780,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2435,6784,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2436,6560,adinazolam,,,POSITIVE ALLOSTERIC MODULATOR,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,CHEMBL328250
2437,13783,dienogest,,,AGONIST,[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC1=C3CCC(=O)C=C3CC[C@@]21[H],CHEMBL1201864
2438,4816,blonanserin,9.8538723,Ki,ANTAGONIST,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,CHEMBL178803
2439,104,blonanserin,9.09151459,Ki,ANTAGONIST,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,CHEMBL178803
2440,9230,ingenol mebutate,8.32790184,EC50,ACTIVATOR,[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C,CHEMBL1863513
2441,7135,dronedarone,,,BLOCKER,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,CHEMBL184412
2442,7303,dronedarone,,,BLOCKER,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,CHEMBL184412
2443,7304,dronedarone,,,BLOCKER,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,CHEMBL184412
2444,7409,dronedarone,,,BLOCKER,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,CHEMBL184412
2445,6479,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2446,6477,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2447,6560,midazolam,8.2596,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2448,6479,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2449,6477,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2450,6560,triazolam,8.699,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NN=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(Cl)C=CC=C1,CHEMBL646
2451,6479,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2452,6477,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2453,6560,zopiclone,6.7496,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2454,6480,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2455,6479,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2456,6477,midazolam,9.1249,Ki,POSITIVE ALLOSTERIC MODULATOR,CC1=NC=C2CN=C(C3=CC(Cl)=CC=C3N12)C1=C(F)C=CC=C1,CHEMBL655
2457,6480,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2458,6479,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2459,6477,zopiclone,7.2782,Ki,POSITIVE MODULATOR,CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1N=CC=N2)C1=CC=C(Cl)C=N1,CHEMBL135400
2460,3616,quinidine,7.92081881,Ki,INHIBITOR,[H][C@@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@@H](O)C1=CC=NC2=CC=C(OC)C=C12,CHEMBL21578
2461,547,alprenolol,9.67778111,Kd,ANTAGONIST,CC(C)NCC(O)COC1=C(CC=C)C=CC=C1,CHEMBL266195
2462,79,alprenolol,9.65757751,Kd,ANTAGONIST,CC(C)NCC(O)COC1=C(CC=C)C=CC=C1,CHEMBL266195
2463,6584,phenibut,,,AGONIST,NCC(CC(O)=O)C1=CC=CC=C1,CHEMBL315818
2464,6543,phenibut,,,AGONIST,NCC(CC(O)=O)C1=CC=CC=C1,CHEMBL315818
2465,18451,ramucirumab,10.3,Kd,ANTIBODY BINDING,,CHEMBL1743062
2466,14050,pramlintide,9.44999981,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2467,1978,pramlintide,9.44999981,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2468,14051,pramlintide,9.05000019,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2469,1978,pramlintide,9.05000019,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2470,14345,pramlintide,8.64000034,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2471,1978,pramlintide,8.64000034,EC50,AGONIST,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O,CHEMBL2103758
2472,18948,aflibercept,11.71669865,Kd,INHIBITOR,,CHEMBL1742982
2473,13225,aflibercept,10.40893555,Kd,INHIBITOR,,CHEMBL1742982
2474,18877,aflibercept,12.30103016,Kd,INHIBITOR,,CHEMBL1742982
2475,12841,pembrolizumab,10.0,Kd,ANTIBODY BINDING,,CHEMBL3137343
2476,15186,piretanide,5.62,IC50,INHIBITOR,NS(=O)(=O)C1=CC(=CC(N2CCCC2)=C1OC1=CC=CC=C1)C(O)=O,CHEMBL349803
2477,13391,aprotinin,6.8,IC50,INHIBITOR,[H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC3=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O,CHEMBL1201619
2478,6829,zolpidem,7.68,Ki,ALLOSTERIC MODULATOR,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,CHEMBL911
2479,6778,flunitrazepam,7.8,Ki,ALLOSTERIC MODULATOR,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,CHEMBL13280
2480,6477,flunitrazepam,8.26,Ki,ALLOSTERIC MODULATOR,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,CHEMBL13280
2481,6829,flunitrazepam,8.28,Ki,ALLOSTERIC MODULATOR,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,CHEMBL13280
2482,6777,flunitrazepam,8.28,Ki,ALLOSTERIC MODULATOR,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,CHEMBL13280
2483,79,procaterol,8.43,EC50,AGONIST,CC[C@@H](NC(C)C)[C@@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1,CHEMBL160519
2484,4816,perospirone,9.22,Ki,ANTAGONIST,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,CHEMBL1472975
2485,18274,nafamostat,10.0,IC50,INHIBITOR,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,CHEMBL273264
2486,5364,peginesatide,10.43,IC50,AGONIST,[H]C(CCCCNC(=O)OCCOC)(NC(=O)OCCOC)C(=O)NCCC(=O)N(CC(=O)NCCCC[C@H](NC(=O)CN(C)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(C)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@]([H])(CC2=CC=CC3=C2C=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)N1)C(N)=O)CC(=O)NCCCC[C@H](NC(=O)CN(C)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(C)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@]([H])(CC2=CC=CC3=C2C=CC=C3)C(=O)N[C@@H](C(C)C)C(=O)N1)C(N)=O,CHEMBL1963684
2487,9891,desoxycortone,11.0,IC50,AGONIST,[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1498
2488,187,gliclazide,6.22184896,Kd,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,CHEMBL427216
2489,8396,gliclazide,6.22184896,Kd,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1,CHEMBL427216
2490,187,glibenclamide,9.52287865,Kd,BLOCKER,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL472
2491,8396,glibenclamide,9.52287865,Kd,BLOCKER,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL472
2492,187,glipizide,9.09691048,Kd,BLOCKER,CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL1073
2493,8396,glipizide,9.09691048,Kd,BLOCKER,CC1=CN=C(C=N1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL1073
2494,187,gliquidone,9.0,Kd,BLOCKER,COC1=CC=C2C(=C1)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C,CHEMBL383634
2495,8396,gliquidone,9.0,Kd,BLOCKER,COC1=CC=C2C(=C1)C(=O)N(CCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1)C(=O)C2(C)C,CHEMBL383634
2496,187,glisoxepide,7.9586072,Kd,BLOCKER,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,CHEMBL2106618
2497,8396,glisoxepide,7.9586072,Kd,BLOCKER,CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1,CHEMBL2106618
2498,187,glibornuride,7.04575729,Kd,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]1[C@H](O)[C@]2(C)CC[C@H]1C2(C)C,CHEMBL529888
2499,8396,glibornuride,7.04575729,Kd,BLOCKER,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@@H]1[C@H](O)[C@]2(C)CC[C@H]1C2(C)C,CHEMBL529888
2500,187,chlorpropamide,5.04575729,Kd,BLOCKER,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,CHEMBL498
2501,8396,chlorpropamide,5.04575729,Kd,BLOCKER,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,CHEMBL498
2502,187,tolbutamide,5.04575729,Kd,BLOCKER,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,CHEMBL782
2503,8396,tolbutamide,5.04575729,Kd,BLOCKER,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,CHEMBL782
2504,187,carbutamide,4.60205984,Kd,BLOCKER,CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,CHEMBL448570
2505,8396,carbutamide,4.60205984,Kd,BLOCKER,CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1,CHEMBL448570
2506,187,glimepiride,9.23999977,Ki,BLOCKER,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,CHEMBL1481
2507,8396,glimepiride,9.23999977,Ki,BLOCKER,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,CHEMBL1481
2508,187,nateglinide,6.46000004,Ki,BLOCKER,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,CHEMBL783
2509,8396,nateglinide,6.46000004,Ki,BLOCKER,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,CHEMBL783
2510,187,repaglinide,9.14000034,Ki,BLOCKER,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O,CHEMBL1272
2511,8396,repaglinide,9.14000034,Ki,BLOCKER,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O,CHEMBL1272
2512,103,vortioxetine,7.26760626,Ki,ANTAGONIST,CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,CHEMBL2104993
2513,26,methysergide,9.34000015,Ki,AGONIST,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,CHEMBL1065
2514,27,methysergide,8.34000015,Ki,AGONIST,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,CHEMBL1065
2515,187,mitiglinide,7.0,IC50,BLOCKER,[H][C@@]12CN(C[C@]1([H])CCCC2)C(=O)C[C@H](CC1=CC=CC=C1)C(O)=O,CHEMBL471498
2516,8396,mitiglinide,7.0,IC50,BLOCKER,[H][C@@]12CN(C[C@]1([H])CCCC2)C(=O)C[C@H](CC1=CC=CC=C1)C(O)=O,CHEMBL471498
2517,187,acetohexamide,4.63940668,Ki,BLOCKER,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL1589
2518,8396,acetohexamide,4.63940668,Ki,BLOCKER,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,CHEMBL1589
2519,12659,becaplermin,,,AGONIST,,CHEMBL1201556
2520,12948,becaplermin,,,AGONIST,,CHEMBL1201556
2521,6977,pralmorelin,,,AGONIST,C[C@@H](N)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O,CHEMBL106593
2522,6814,sermorelin,,,AGONIST,[H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,CHEMBL1201490
2523,7044,albiglutide,9.69896984,EC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O,CHEMBL2107841
2524,6443,follitropin,,,AGONIST,,CHEMBL1201520
2525,9138,lutropin alfa,10.9,IC50,AGONIST,,CHEMBL1201419
2526,18807,thyrotropin alfa,,,AGONIST,,CHEMBL1201532
2527,6711,buserelin,10.52,EC50,AGONIST,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,CHEMBL2110824
2528,204,corticotropin,,,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL1201609
2529,105,tropisetron,8.8,Ki,ANTAGONIST,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2,CHEMBL56564
2530,7927,tocilizumab,,,ANTIBODY BINDING,,CHEMBL1237022
2531,8056,tocilizumab,,,ANTIBODY BINDING,,CHEMBL1237022
2532,19095,sunitinib,7.22914791,IC50,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2533,12948,sunitinib,6.9586072,IC50,INHIBITOR,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,CHEMBL535
2534,253,alectinib,8.72124672,IC50,INHIBITOR,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,CHEMBL1738797
2535,1816,ketoconazole,6.89619637,IC50,INHIBITOR,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,CHEMBL157101
2536,7800,basiliximab,10.0,Kd,ANTIBODY BINDING,,CHEMBL1201439
2537,14788,ripasudil,7.72124624,IC50,INHIBITOR,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=CC=CC2=C1C(F)=CN=C2,
2538,14787,ripasudil,7.29242992,IC50,INHIBITOR,[H][C@]1(C)CNCCCN1S(=O)(=O)C1=CC=CC2=C1C(F)=CN=C2,
2539,13834,parathyroid hormone,,,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O,CHEMBL2108078
2540,7964,secukinumab,,,ANTIBODY BINDING,,CHEMBL1743068
2541,79,arformoterol,8.53760242,Kd,AGONIST,[H]C(=O)NC1=C(O)C=CC(=C1)[C@@H](O)CN[C@H](C)CC1=CC=C(OC)C=C1,CHEMBL1363
2542,13689,pemetrexed,6.42,Ki,INHIBITOR,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,CHEMBL225072
2543,15103,ranolazine,,,BLOCKER,COC1=C(OCC(O)CN2CCN(CC(=O)NC3=C(C)C=CC=C3C)CC2)C=CC=C1,CHEMBL1404
2544,18515,mozavaptan,8.03,Ki,ANTAGONIST,CN(C)C1CCCN(C(=O)C2=CC=C(NC(=O)C3=C(C)C=CC=C3)C=C2)C2=CC=CC=C12,CHEMBL420762
2545,5154,fosfestrol,,,AGONIST,CC\C(=C(\CC)C1=CC=C(OP(O)(O)=O)C=C1)C1=CC=C(OP(O)(O)=O)C=C1,CHEMBL1200598
2546,5666,fosfestrol,,,AGONIST,CC\C(=C(\CC)C1=CC=C(OP(O)(O)=O)C=C1)C1=CC=C(OP(O)(O)=O)C=C1,CHEMBL1200598
2547,862,irbesartan,9.1,Ki,ANTAGONIST,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,CHEMBL1513
2548,875,nandrolone decanoate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL1200946
2549,483,zofenopril,9.4,IC50,INHIBITOR,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1,CHEMBL16332
2550,875,bicalutamide,7.72,Ki,ANTAGONIST,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,CHEMBL409
2551,6487,hydrocortisone butyrate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1683
2552,7509,buclizine,,,ANTAGONIST,CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)C=C1,CHEMBL1200403
2553,5277,sivelestat,6.7,Ki,,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O,CHEMBL76688
2554,6487,dexamethasone acetate,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1651
2555,6487,betamethasone acetate,,,AGONIST,[H][C@@]12C[C@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200538
2556,862,valsartan,5.33,Ki,ANTAGONIST,CCCCC(=O)N(CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)[C@@H](C(C)C)C(O)=O,CHEMBL1069
2557,19095,pazopanib,7.85,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2558,18451,pazopanib,7.85,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2559,5794,pazopanib,6.21,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2560,12948,pazopanib,8.31,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2561,12659,pazopanib,8.7,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2562,5845,pazopanib,6.0,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2563,8988,pazopanib,8.74,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2564,4068,pazopanib,8.1,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2565,19096,pazopanib,7.57,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2566,9058,pazopanib,5.92,Kd,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2567,8095,pazopanib,,,INHIBITOR,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,CHEMBL477772
2568,483,quinapril,8.08,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,CHEMBL1592
2569,4816,sertindole,9.35,Ki,ANTAGONIST,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,CHEMBL12713
2570,27,sertindole,9.7,Ki,INVERSE AGONIST,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,CHEMBL12713
2571,104,sertindole,9.22,Ki,ANTAGONIST,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,CHEMBL12713
2572,8165,dofetilide,8.19,Ki,BLOCKER,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,CHEMBL473
2573,4969,gefitinib,9.4,Ki,INHIBITOR,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,CHEMBL939
2574,5092,sitaxentan,9.37,Ki,ANTAGONIST,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl,CHEMBL282724
2575,875,testosterone undecanoate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL2107067
2576,6487,prednisolone tebutate,9.28,IC50,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200909
2577,79,bitolterol,,,AGONIST,CC1=CC=C(C=C1)C(=O)OC1=C(OC(=O)C2=CC=C(C)C=C2)C=C(C=C1)C(O)CNC(C)(C)C,CHEMBL1200405
2578,6240,sorafenib,8.35,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2579,19095,sorafenib,7.51,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2580,18451,sorafenib,10.68,Ki,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2581,14082,sorafenib,8.22,Ki,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2582,1625,sorafenib,7.66,Ki,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2583,12659,sorafenib,7.43,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2584,8988,sorafenib,7.8,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2585,19096,sorafenib,7.8,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2586,14497,sorafenib,8.13,Kd,INHIBITOR,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1336
2587,447,cisapride,7.54,Ki,AGONIST,[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,CHEMBL1729
2588,6487,dexamethasone phosphate,9.3,IC50,AGONIST,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200637
2589,6487,methylprednisolone succinate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,CHEMBL1201081
2590,6487,hydrocortamate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CN(CC)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200635
2591,6487,betamethasone valerate,,,AGONIST,[H][C@]1(C)C[C@@]2([H])[C@]3([H])CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)CCCC)C(=O)CO,CHEMBL1497
2592,6487,triamcinolone diacetate,,,AGONIST,[H][C@@]12C[C@@H](OC(C)=O)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200449
2593,7742,rosuvastatin,9.05,Ki,INHIBITOR,CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(=NC(=N1)N(C)S(C)(=O)=O)C1=CC=C(F)C=C1,CHEMBL1496
2594,6487,ulobetasol propionate,,,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1200908
2595,6487,hydrocortisone cypionate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC3CCCC3)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1549
2596,16099,dasatinib,9.68,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2597,5647,dasatinib,9.07,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2598,19310,dasatinib,9.52,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2599,12659,dasatinib,9.2,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2600,8988,dasatinib,9.24,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2601,6205,dasatinib,9.1,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2602,9058,dasatinib,9.7,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,CHEMBL1421
2603,6487,prednicarbate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200386
2604,469,imatinib,8.96,Kd,INHIBITOR,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,CHEMBL941
2605,12659,imatinib,7.85,Kd,INHIBITOR,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,CHEMBL941
2606,8988,imatinib,7.89,Kd,INHIBITOR,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,CHEMBL941
2607,8889,orlistat,,,INHIBITOR,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,CHEMBL175247
2608,6487,betamethasone benzoate,,,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)C3=CC=CC=C3)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200376
2609,483,moexipril,8.59,IC50,INHIBITOR,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,CHEMBL1165
2610,6487,amcinonide,,,AGONIST,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC1(CCCC1)O2)C(=O)COC(C)=O,CHEMBL1200732
2611,144,hexafluronium,,,INHIBITOR,C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C2=C1C=CC=C2)C1C2=CC=CC=C2C2=C1C=CC=C2,CHEMBL1200933
2612,6487,betamethasone dipropionate,,,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL1200384
2613,12630,dipyridamole,6.28,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2614,15734,dipyridamole,8.5,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2615,12631,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2616,12844,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2617,3385,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2618,12845,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2619,12771,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2620,3789,dipyridamole,6.9,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2621,12772,dipyridamole,6.0,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2622,12846,dipyridamole,6.22,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2623,12772,dipyridamole,6.22,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2624,12626,dipyridamole,4.35,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2625,12767,dipyridamole,4.35,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2626,12627,dipyridamole,4.35,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2627,12842,dipyridamole,5.49,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2628,12768,dipyridamole,4.37,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2629,12843,dipyridamole,4.37,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2630,12913,dipyridamole,6.0,Ki,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2631,12773,dipyridamole,5.1,IC50,INHIBITOR,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,CHEMBL932
2632,6487,difluprednate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1201749
2633,3104,maraviroc,7.6,Kd,ANTAGONIST,[H][C@]12CC[C@]([H])(C[C@@H](C1)N1C(C)=NN=C1C(C)C)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1,CHEMBL1201187
2634,862,telmisartan,9.31,IC50,ANTAGONIST,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O,CHEMBL1017
2635,185,probucol,,,INHIBITOR,CC(C)(SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)SC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C,CHEMBL608
2636,5666,estramustine phosphate,,,MODULATOR,[H][C@@]12CC[C@H](OP(O)(O)=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)N(CCCl)CCCl)C=C3,CHEMBL1756
2637,469,nilotinib,8.44,Kd,INHIBITOR,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,CHEMBL255863
2638,11575,aprepitant,10.7,Ki,ANTAGONIST,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,CHEMBL1471
2639,144,ambenonium,,,INHIBITOR,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=C(Cl)C=CC=C1)CC1=C(Cl)C=CC=C1,CHEMBL1652
2640,17618,doxorubicin,6.0,IC50,INHIBITOR,[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]1C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)CO,CHEMBL53463
2641,5092,bosentan,8.19,Ki,ANTAGONIST,COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1,CHEMBL957
2642,5005,bosentan,7.1,Ki,ANTAGONIST,COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1,CHEMBL957
2643,483,fosinopril,9.0,IC50,INHIBITOR,CCC(=O)O[C@@H](O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,CHEMBL581
2644,4592,carbenoxolone,7.08,IC50,INHIBITOR,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CCC(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,CHEMBL499915
2645,3354,zafirlukast,9.5,Ki,ANTAGONIST,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1,CHEMBL603
2646,18527,deserpidine,,,INHIBITOR,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2,CHEMBL1200515
2647,4969,lapatinib,9.04,Kd,INHIBITOR,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1,CHEMBL554
2648,5479,lapatinib,8.15,Kd,INHIBITOR,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1,CHEMBL554
2649,103,ergotamine,9.1,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,CHEMBL442
2650,3354,montelukast,9.3,Ki,ANTAGONIST,CC(C)(O)C1=C(CC[C@@H](SCC2(CC(O)=O)CC2)C2=CC(\C=C\C3=NC4=CC(Cl)=CC=C4C=C3)=CC=C2)C=CC=C1,CHEMBL787
2651,4816,fluphenazine decanoate,,,ANTAGONIST,CCCCCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,CHEMBL1200854
2652,425,rapacuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,CHEMBL1200549
2653,219,rapacuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,CHEMBL1200549
2654,427,rapacuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,CHEMBL1200549
2655,218,rapacuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,CHEMBL1200549
2656,217,rapacuronium,,,ANTAGONIST,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1,CHEMBL1200549
2657,17559,dabigatran etexilate,8.35,Ki,INHIBITOR,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1,CHEMBL48361
2658,18527,rescinnamine,,,INHIBITOR,[H][C@]12C[C@@H](OC(=O)\C=C\C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,CHEMBL1668
2659,7742,bezafibrate,,,INHIBITOR,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O,CHEMBL264374
2660,13436,mesalazine,,,AGONIST,NC1=CC(C(O)=O)=C(O)C=C1,CHEMBL704
2661,875,nandrolone,,,AGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],CHEMBL757
2662,15515,dapagliflozin,9.3,IC50,INHIBITOR,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1,CHEMBL429910
2663,17603,belimumab,,,ANTIBODY BINDING,,CHEMBL1789843
2664,8563,abciximab,,,ANTIBODY BINDING,,CHEMBL1201584
2665,8254,abciximab,,,ANTIBODY BINDING,,CHEMBL1201584
2666,3119,ofatumumab,9.92,Kd,ANTIBODY BINDING,,CHEMBL1201836
2667,8659,canakinumab,,,ANTIBODY BINDING,,CHEMBL1201834
2668,7800,daclizumab,8.0,Kd,ANTIBODY BINDING,,CHEMBL1201605
2669,7801,daclizumab,8.0,Kd,ANTIBODY BINDING,,CHEMBL1201605
2670,8664,daclizumab,8.0,Kd,ANTIBODY BINDING,,CHEMBL1201605
2671,4969,cetuximab,9.41,Kd,ANTIBODY BINDING,,CHEMBL1201577
2672,4969,panitumumab,10.3,Kd,AGONIST,,CHEMBL1201827
2673,18877,bevacizumab,,,ANTIBODY BINDING,,CHEMBL1201583
2674,5479,pertuzumab,,,ANTIBODY BINDING,,CHEMBL2007641
2675,3934,ipilimumab,,,ANTIBODY BINDING,,CHEMBL1789844
2676,8559,efalizumab,11.4,Kd,ANTIBODY BINDING,,CHEMBL1201575
2677,8077,insulin degludec,,,AGONIST,[H]NCC(=O)NC([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)NC(CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NC1CSSC[C@@H]2NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)C(NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)C(CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)C(N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)NC(CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSCC(NC(=O)[C@@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=C(O)C=C2)C(=O)N[C@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC(O)=O)C(O)=O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL2107869
2678,11684,olaparib,7.34,IC50,INHIBITOR,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,CHEMBL521686
2679,17978,brentuximab vedotin,,,ANTIBODY BINDING,,CHEMBL1742994
2680,17831,denosumab,,,ANTIBODY BINDING,,CHEMBL1237023
2681,7923,ustekinumab,,,ANTIBODY BINDING,,CHEMBL1201835
2682,7963,ustekinumab,,,ANTIBODY BINDING,,CHEMBL1201835
2683,7963,ustekinumab,,,ANTIBODY BINDING,,CHEMBL1201835
2684,8048,ustekinumab,,,ANTIBODY BINDING,,CHEMBL1201835
2685,17609,golimumab,,,ANTIBODY BINDING,,CHEMBL1201833
2686,17609,certolizumab pegol,10.04575729,Kd,ANTIBODY BINDING,,CHEMBL1201831
2687,3561,eculizumab,,,ANTIBODY BINDING,,CHEMBL1201828
2688,8261,natalizumab,,,ANTIBODY BINDING,,CHEMBL1201607
2689,8086,natalizumab,,,ANTIBODY BINDING,,CHEMBL1201607
2690,8086,natalizumab,,,ANTIBODY BINDING,,CHEMBL1201607
2691,8262,natalizumab,,,ANTIBODY BINDING,,CHEMBL1201607
2692,18877,ranibizumab,,,ANTIBODY BINDING,,CHEMBL1201825
2693,7953,omalizumab,8.16,Kd,ANTIBODY BINDING,,CHEMBL1201589
2694,3119,rituximab,8.51,Kd,ANTIBODY BINDING,,CHEMBL1201576
2695,868,acarbose,,,INHIBITOR,[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,CHEMBL404271
2696,17382,liothyronine,10.24,Kd,AGONIST,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,CHEMBL1544
2697,17465,liothyronine,10.1,Ki,AGONIST,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,CHEMBL1544
2698,17618,etoposide phosphate,,,INHIBITOR,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OP(O)(O)=O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@H]2O[C@]1([H])O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,CHEMBL1200645
2699,17382,dextrothyroxine,,,AGONIST,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,CHEMBL559
2700,17465,dextrothyroxine,,,AGONIST,N[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,CHEMBL559
2701,1148,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2702,1151,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2703,1149,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2704,1255,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2705,962,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2706,1525,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2707,1279,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2708,1150,digoxin,6.4,IC50,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1751
2709,5154,polyestradiol phosphate,,,AGONIST,,CHEMBL1201477
2710,1148,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2711,1151,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2712,1149,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2713,1255,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2714,962,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2715,1525,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2716,1279,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2717,1150,acetyldigitoxin,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL3545057
2718,862,saralasin,9.77,Ki,ANTAGONIST,CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O,CHEMBL938
2719,1148,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2720,1151,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2721,1149,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2722,1255,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2723,962,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2724,1525,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2725,1279,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2726,1150,deslanoside,,,INHIBITOR,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])C[C@@H](O)[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,CHEMBL1614
2727,12645,sucralfate,,,INHIBITOR,,CHEMBL2367706
2728,12148,atosiban,7.96,Ki,ANTAGONIST,[H][C@]1(NC(=O)[C@@]([H])(NC(=O)[C@@H](CC2=CC=C(OCC)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)[C@@H](C)CC)[C@@H](C)O,CHEMBL382301
2729,12148,oxytocin,9.1,Ki,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)[C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,CHEMBL395429
2730,16562,octreotide,6.65,Ki,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O,CHEMBL1680
2731,16435,octreotide,6.4,Ki,AGONIST,[H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC1=O)[C@@H](C)O)C(=O)N[C@]([H])(CO)[C@@]([H])(C)O,CHEMBL1680
2732,18515,desmopressin,8.3,Ki,AGONIST,NC(=O)CCC1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,CHEMBL376685
2733,18515,vasopressin,8.92,Ki,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,CHEMBL373742
2734,19016,vasopressin,9.59,Ki,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,CHEMBL373742
2735,19017,vasopressin,9.31,Ki,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O,CHEMBL373742
2736,18515,lypressin,,,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O,CHEMBL1200690
2737,19016,lypressin,,,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O,CHEMBL1200690
2738,19017,lypressin,,,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O,CHEMBL1200690
2739,6711,gonadorelin,8.0,IC50,AGONIST,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,CHEMBL1007
2740,6711,goserelin,,,AGONIST,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,CHEMBL1200501
2741,6711,histrelin,,,AGONIST,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1=CN(CC2=CC=CC=C2)C=N1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,CHEMBL1200509
2742,6711,cetrorelix,8.8,Ki,ANTAGONIST,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,CHEMBL1200490
2743,1226,fondaparinux,7.49,Kd,ACTIVATOR,[H][C@@]1(O[C@@H]2[C@@H](COS(O)(=O)=O)O[C@H](O[C@@]3([H])[C@H](O)[C@@H](OS(O)(=O)=O)[C@H](O[C@@]4([H])[C@H](O)[C@@H](NS(O)(=O)=O)[C@@H](OC)O[C@@H]4COS(O)(=O)=O)O[C@H]3C(O)=O)[C@H](NS(O)(=O)=O)[C@H]2OS(O)(=O)=O)O[C@@H]([C@@H](O[C@@]2([H])O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]2NS(O)(=O)=O)[C@H](O)[C@H]1O)C(O)=O,CHEMBL1200644
2744,6711,ganirelix,,,ANTAGONIST,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,CHEMBL1251
2745,16803,somatostatin,10.46,Ki,AGONIST,[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O,CHEMBL1823872
2746,16562,somatostatin,9.54,Ki,AGONIST,[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O,CHEMBL1823872
2747,16563,somatostatin,9.85,Ki,AGONIST,[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O,CHEMBL1823872
2748,16804,somatostatin,10.0,Ki,AGONIST,[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O,CHEMBL1823872
2749,16435,somatostatin,9.23,Ki,AGONIST,[H]N[C@@H](C)C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O)[C@@H](C)O)[C@@H](C)O)C(O)=O,CHEMBL1823872
2750,7044,exenatide,9.18,IC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O,CHEMBL414357
2751,7427,vorinostat,9.0,Ki,INHIBITOR,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,CHEMBL98
2752,7335,vorinostat,8.89,Ki,INHIBITOR,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,CHEMBL98
2753,7425,vorinostat,8.3,Ki,INHIBITOR,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,CHEMBL98
2754,7336,vorinostat,8.8,Ki,INHIBITOR,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,CHEMBL98
2755,15387,lisdexamfetamine,,,RELEASING AGENT,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,CHEMBL1201178
2756,18527,lisdexamfetamine,,,INHIBITOR,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,CHEMBL1201178
2757,875,testosterone propionate,9.6,Ki,AGONIST,[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1170
2758,973,silodosin,10.44,Ki,ANTAGONIST,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,CHEMBL24778
2759,3552,rimonabant,9.72,Ki,ANTAGONIST,CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1,CHEMBL111
2760,5857,temsirolimus,,,INHIBITOR,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(OC(=O)C(C)(CO)CO)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,CHEMBL1201182
2761,1535,dexlansoprazole,,,INHIBITOR,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=C(N1)C=CC=C2,CHEMBL1201863
2762,1158,dexlansoprazole,,,INHIBITOR,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=C(N1)C=CC=C2,CHEMBL1201863
2763,8329,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2764,8328,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2765,8318,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2766,8775,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2767,8777,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2768,8162,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2769,8776,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2770,8163,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2771,8781,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2772,9447,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2773,8417,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2774,8314,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2775,8600,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2776,8165,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2777,8783,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2778,8779,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2779,8766,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2780,8332,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2781,8402,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2782,8317,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2783,8400,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2784,8333,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2785,8780,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2786,8330,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2787,8167,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2788,8782,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2789,8778,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2790,9450,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2791,8320,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2792,9446,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2793,8418,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2794,8166,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2795,8784,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2796,8785,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2797,8399,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2798,8316,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2799,8786,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2800,8401,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2801,9449,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2802,8319,fampridine,,,BLOCKER,NC1=CC=NC=C1,CHEMBL284348
2803,7509,alcaftadine,,,ANTAGONIST,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=C1C=CC=C2,CHEMBL1201747
2804,15198,fingolimod,8.52,EC50,AGONIST,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,CHEMBL314854
2805,15199,fingolimod,9.52,EC50,AGONIST,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,CHEMBL314854
2806,15719,fingolimod,9.52,EC50,AGONIST,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,CHEMBL314854
2807,15197,fingolimod,9.52,EC50,AGONIST,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1,CHEMBL314854
2808,4923,linagliptin,10.0,IC50,INHIBITOR,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,CHEMBL237500
2809,4215,abiraterone acetate,8.54,IC50,INHIBITOR,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@]([H])(CC[C@]12C)OC(C)=O,CHEMBL254328
2810,4969,vandetanib,8.32,Kd,INHIBITOR,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,CHEMBL24828
2811,18451,vandetanib,6.33,Kd,INHIBITOR,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,CHEMBL24828
2812,14497,vandetanib,7.85,Kd,INHIBITOR,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,CHEMBL24828
2813,6000,rivaroxaban,9.4,Ki,INHIBITOR,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,CHEMBL198362
2814,79,indacaterol,7.8,Ki,AGONIST,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2,CHEMBL1095777
2815,12157,ticagrelor,7.85,Ki,NEGATIVE ALLOSTERIC MODULATOR,CCCSC1=NC(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=C2N=NN([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)C2=N1,CHEMBL398435
2816,1625,vemurafenib,7.68,IC50,INHIBITOR,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F,CHEMBL1229517
2817,1738,icatibant,10.22,Ki,ANTAGONIST,[H]N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@]([H])(O)C[C@@]1([H])C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@@H](C[C@]3([H])CCCC[C@]13[H])C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2,CHEMBL2028850
2818,9664,crizotinib,9.26,Kd,INHIBITOR,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,CHEMBL601719
2819,253,crizotinib,9.13,Ki,INHIBITOR,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,CHEMBL601719
2820,8242,ruxolitinib,10.44,Kd,INHIBITOR,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,CHEMBL1789941
2821,8267,ruxolitinib,10.05,Ki,INHIBITOR,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,CHEMBL1789941
2822,8475,lithium carbonate,,,INHIBITOR,,CHEMBL1200826
2823,7019,lithium carbonate,,,INHIBITOR,,CHEMBL1200826
2824,7020,lithium carbonate,,,INHIBITOR,,CHEMBL1200826
2825,63,prazosin,9.7,Ki,INVERSE AGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,CHEMBL2
2826,973,prazosin,10.4,Ki,INVERSE AGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,CHEMBL2
2827,539,prazosin,9.68,Ki,INVERSE AGONIST,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,CHEMBL2
2828,6487,hydrocortisone acetate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1091
2829,67,methyldopate,,,AGONIST,CCOC(=O)[C@@](C)(N)CC1=CC(O)=C(O)C=C1,CHEMBL1200432
2830,316,methyldopate,,,AGONIST,CCOC(=O)[C@@](C)(N)CC1=CC(O)=C(O)C=C1,CHEMBL1200432
2831,540,methyldopate,,,AGONIST,CCOC(=O)[C@@](C)(N)CC1=CC(O)=C(O)C=C1,CHEMBL1200432
2832,18300,mequinol,,,INHIBITOR,COC1=CC=C(O)C=C1,CHEMBL544
2833,19095,axitinib,8.24,Kd,INHIBITOR,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,CHEMBL1289926
2834,18451,axitinib,8.23,Kd,INHIBITOR,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,CHEMBL1289926
2835,19096,axitinib,6.77,Kd,INHIBITOR,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,CHEMBL1289926
2836,15779,vismodegib,7.79,Ki,INHIBITOR,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,CHEMBL473417
2837,3299,ivacaftor,8.52,EC50,POSITIVE MODULATOR,CC(C)(C)C1=CC(=C(NC(=O)C2=CNC3=CC=CC=C3C2=O)C=C1O)C(C)(C)C,CHEMBL2010601
2838,12942,tafluprost,,,AGONIST,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,CHEMBL1963683
2839,18300,avobenzone,,,INHIBITOR,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,CHEMBL1200522
2840,13316,bismuth subsalicylate,,,INHIBITOR,O[Bi]1OC(=O)C2=CC=CC=C2O1,CHEMBL1120
2841,12865,bismuth subsalicylate,,,INHIBITOR,O[Bi]1OC(=O)C2=CC=CC=C2O1,CHEMBL1120
2842,6000,apixaban,10.1,Ki,INHIBITOR,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,CHEMBL231779
2843,15538,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2844,15102,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2845,15539,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2846,15103,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2847,15541,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2848,15101,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2849,15251,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2850,15105,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2851,15540,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2852,15104,eslicarbazepine acetate,,,BLOCKER,CC(=O)O[C@H]1CC2=C(C=CC=C2)N(C(N)=O)C2=CC=CC=C12,CHEMBL315985
2853,5154,lasofoxifene,8.89,IC50,AGONIST,[H]C1(CCC2=CC(O)=CC=C2C1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,CHEMBL328190
2854,5666,lasofoxifene,8.74,IC50,AGONIST,[H]C1(CCC2=CC(O)=CC=C2C1([H])C1=CC=C(OCCN2CCCC2)C=C1)C1=CC=CC=C1,CHEMBL328190
2855,15541,lacosamide,6.74,IC50,BLOCKER,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,CHEMBL58323
2856,4969,afatinib,10.0,Kd,INHIBITOR,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,CHEMBL1173655
2857,5479,afatinib,8.3,Kd,INHIBITOR,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,CHEMBL1173655
2858,5480,afatinib,8.2,Kd,INHIBITOR,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,CHEMBL1173655
2859,12623,laropiprant,10.52,Kd,ANTAGONIST,CS(=O)(=O)C1=C2N(CC3=CC=C(Cl)C=C3)C3=C(CC[C@@H]3CC(O)=O)C2=CC(F)=C1,CHEMBL426559
2860,5154,bazedoxifene,9.22,IC50,MODULATOR,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,CHEMBL46740
2861,5666,bazedoxifene,8.42,IC50,MODULATOR,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,CHEMBL46740
2862,4923,alogliptin,9.0,IC50,INHIBITOR,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,CHEMBL227529
2863,469,bosutinib,10.54,Kd,INHIBITOR,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,CHEMBL288441
2864,16099,bosutinib,9.0,Kd,INHIBITOR,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,CHEMBL288441
2865,7302,bosutinib,8.47,Kd,INHIBITOR,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,CHEMBL288441
2866,9591,bosutinib,8.38,Kd,INHIBITOR,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,CHEMBL288441
2867,11552,chenodiol,5.47,EC50,AGONIST,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,CHEMBL240597
2868,12769,choline theophyllinate,4.25,Ki,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2869,12770,choline theophyllinate,4.25,Ki,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2870,12628,choline theophyllinate,4.25,Ki,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2871,12629,choline theophyllinate,4.25,Ki,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2872,37,choline theophyllinate,9.22,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2873,385,choline theophyllinate,9.22,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2874,38,choline theophyllinate,5.57,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2875,385,choline theophyllinate,4.85,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2876,38,choline theophyllinate,4.85,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2877,12768,choline theophyllinate,,,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2878,12843,choline theophyllinate,,,INHIBITOR,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,CHEMBL1200434
2879,11575,casopitant,9.9,Ki,ANTAGONIST,C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C1=C(C)C=C(F)C=C1)N1CCN(CC1)C(C)=O)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,CHEMBL1672054
2880,4120,plerixafor,6.05,Ki,PARTIAL AGONIST,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,CHEMBL18442
2881,12769,bufylline,4.25,Ki,INHIBITOR,,CHEMBL2104089
2882,12770,bufylline,4.25,Ki,INHIBITOR,,CHEMBL2104089
2883,12628,bufylline,4.25,Ki,INHIBITOR,,CHEMBL2104089
2884,12629,bufylline,4.25,Ki,INHIBITOR,,CHEMBL2104089
2885,37,bufylline,9.22,Ki,ANTAGONIST,,CHEMBL2104089
2886,385,bufylline,9.22,Ki,ANTAGONIST,,CHEMBL2104089
2887,38,bufylline,5.57,Ki,ANTAGONIST,,CHEMBL2104089
2888,385,bufylline,4.85,Ki,ANTAGONIST,,CHEMBL2104089
2889,38,bufylline,4.85,Ki,ANTAGONIST,,CHEMBL2104089
2890,12768,bufylline,,,INHIBITOR,,CHEMBL2104089
2891,12843,bufylline,,,INHIBITOR,,CHEMBL2104089
2892,875,testosterone cypionate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1201101
2893,6487,hydrocortisone succinate,,,AGONIST,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL977
2894,67,corbadrine,,,AGONIST,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL677
2895,316,corbadrine,,,AGONIST,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL677
2896,540,corbadrine,,,AGONIST,C[C@H](N)[C@H](O)C1=CC(O)=C(O)C=C1,CHEMBL677
2897,430,aclidinium bromide,10.15,Ki,ANTAGONIST,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,CHEMBL551466
2898,6487,alclometasone dipropionate,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,CHEMBL1200989
2899,5154,estradiol acetate,,,AGONIST,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(C)=O)C=C3,CHEMBL1200430
2900,6487,hydrocortisone valerate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200562
2901,13566,choline fenofibrate,4.46,Ki,AGONIST,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,CHEMBL981
2902,8475,lithium citrate,,,INHIBITOR,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,CHEMBL1201170
2903,7019,lithium citrate,,,INHIBITOR,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,CHEMBL1201170
2904,7020,lithium citrate,,,INHIBITOR,[Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,CHEMBL1201170
2905,6487,fluticasone furoate,10.12,IC50,AGONIST,[H][C@@]1(C)C[C@@]2([H])[C@]3([H])C[C@]([H])(F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@]([H])(O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF,CHEMBL1473
2906,6584,sodium oxybate,,,AGONIST,[Na+].OCCCC([O-])=O,CHEMBL1342
2907,6543,sodium oxybate,,,AGONIST,[Na+].OCCCC([O-])=O,CHEMBL1342
2908,6487,hydrocortisone probutate,,,AGONIST,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200953
2909,6487,clocortolone pivalate,,,AGONIST,[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,CHEMBL1200975
2910,875,testosterone enantate,,,AGONIST,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,CHEMBL1200335
2911,875,enzalutamide,7.31,EC50,ANTAGONIST,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC(=C(C=C1)C#N)C(F)(F)F,CHEMBL1082407
2912,6490,nitroprusside,,,ACTIVATOR,,CHEMBL136478
2913,6792,nitroprusside,,,ACTIVATOR,,CHEMBL136478
2914,7026,nitroprusside,,,ACTIVATOR,,CHEMBL136478
2915,6793,nitroprusside,,,ACTIVATOR,,CHEMBL136478
2916,14018,teriflunomide,7.52,Ki,INHIBITOR,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,CHEMBL973
2917,16966,levmetamfetamine,5.48,EC50,AGONIST,CN[C@H](C)CC1=CC=CC=C1,CHEMBL1927030
2918,1625,regorafenib,7.55,IC50,INHIBITOR,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1,CHEMBL1946170
2919,12188,nalfurafine,9.64,Ki,AGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC[C@H]2N(C)C(=O)\C=C\C1=COC=C1,CHEMBL267495
2920,7136,panobinostat,7.51,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2921,7334,panobinostat,8.46,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2922,7228,panobinostat,7.66,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2923,7229,panobinostat,8.92,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2924,7427,panobinostat,9.15,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2925,7335,panobinostat,9.0,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2926,7412,panobinostat,9.22,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2927,7425,panobinostat,8.96,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2928,7336,panobinostat,9.19,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2929,7426,panobinostat,9.15,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2930,7428,panobinostat,8.64,Ki,INHIBITOR,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,CHEMBL483254
2931,6744,perampanel,6.61,IC50,ANTAGONIST,O=C1N(C=C(C=C1C1=C(C=CC=C1)C#N)C1=CC=CC=N1)C1=CC=CC=C1,CHEMBL1214124
2932,6745,perampanel,6.61,IC50,ANTAGONIST,O=C1N(C=C(C=C1C1=C(C=CC=C1)C#N)C1=CC=CC=N1)C1=CC=CC=C1,CHEMBL1214124
2933,6746,perampanel,6.61,IC50,ANTAGONIST,O=C1N(C=C(C=C1C1=C(C=CC=C1)C#N)C1=CC=CC=N1)C1=CC=CC=C1,CHEMBL1214124
2934,6747,perampanel,6.61,IC50,ANTAGONIST,O=C1N(C=C(C=C1C1=C(C=CC=C1)C#N)C1=CC=CC=N1)C1=CC=CC=C1,CHEMBL1214124
2935,8242,tofacitinib,6.64,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2936,18616,tofacitinib,6.64,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2937,8267,tofacitinib,7.46,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2938,18616,tofacitinib,7.46,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2939,1896,ponatinib,,,INHIBITOR,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,CHEMBL1171837
2940,6825,teduglutide,10.05,EC50,AGONIST,[H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O,CHEMBL2104987
2941,547,levobetaxolol,9.1,Ki,ANTAGONIST,CC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1,CHEMBL1200837
2942,9459,dimethyl fumarate,,,INHIBITOR,COC(=O)\C=C\C(=O)OC,CHEMBL589586
2943,9501,aprotinin,,,INHIBITOR,[H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCSC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@@H](NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC3=O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N2)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O,CHEMBL1201619
2944,7136,belinostat,7.23,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2945,7334,belinostat,7.57,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2946,7228,belinostat,7.66,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2947,7229,belinostat,7.62,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2948,7427,belinostat,8.8,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2949,7335,belinostat,9.07,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2950,7425,belinostat,8.82,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2951,7336,belinostat,9.07,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2952,7426,belinostat,7.6,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2953,7428,belinostat,7.29,Ki,INHIBITOR,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,CHEMBL408513
2954,385,istradefylline,8.66,Ki,ANTAGONIST,CCN1C2=C(N(C)C(\C=C\C3=CC(OC)=C(OC)C=C3)=N2)C(=O)N(CC)C1=O,CHEMBL431770
2955,5794,nintedanib,7.03,Kd,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2956,5795,nintedanib,5.74,Kd,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2957,12659,nintedanib,7.82,Kd,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2958,5793,nintedanib,6.46,Kd,INHIBITOR,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,CHEMBL502835
2959,8242,tofacitinib,6.39147377,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2960,8267,tofacitinib,6.39147377,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2961,8267,tofacitinib,7.25181198,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2962,8243,tofacitinib,7.25181198,IC50,INHIBITOR,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,CHEMBL221959
2963,7928,siltuximab,,,ANTIBODY BINDING,,CHEMBL1743070
2964,17609,etanercept,,,INHIBITOR,,CHEMBL1201572
2965,5479,trastuzumab,,,ANTIBODY BINDING,,CHEMBL1201585
2966,2123,nicardipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,CHEMBL1484
2967,1677,nicardipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,CHEMBL1484
2968,2435,gemtuzumab ozogamicin,,,ANTIBODY BINDING,,CHEMBL1201506
2969,8077,insulin aspart,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL1201496
2970,3119,obinutuzumab,,,ANTIBODY BINDING,,CHEMBL1743048
2971,3119,ibritumomab tiuxetan,7.85387182,Kd,ANTIBODY BINDING,,CHEMBL1201606
2972,8077,insulin detemir,,,AGONIST,[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC3=CNC=N3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC3=CC=CC=C3)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CNC=N3)C(=O)N[C@@H](CC(C)C)C(=O)NC(C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC(C)C)C(=O)NC(C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC,CHEMBL2104391
2973,12559,evolocumab,9.72,Kd,INHIBITOR,,CHEMBL2364655
2974,6378,proglumide,,,ANTAGONIST,CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1,CHEMBL316561
2975,17942,metamizole,4.0409584,IC50,BLOCKER,CN(CS(O)(=O)=O)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,CHEMBL461522
2976,17942,propyphenazone,4.48148584,IC50,BLOCKER,CC(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1,CHEMBL28318
2977,17942,phenazone,3.08092189,IC50,BLOCKER,CN1N(C(=O)C=C1C)C1=CC=CC=C1,CHEMBL277474
2978,1535,revaprazan,,,INHIBITOR,CC1N(CCC2=CC=CC=C12)C1=C(C)C(C)=NC(NC2=CC=C(F)C=C2)=N1,CHEMBL1257753
2979,1158,revaprazan,,,INHIBITOR,CC1N(CCC2=CC=CC=C12)C1=C(C)C(C)=NC(NC2=CC=C(F)C=C2)=N1,CHEMBL1257753
2980,7756,betahistine,9.52287865,EC50,INVERSE AGONIST,CNCCC1=CC=CC=N1,CHEMBL24441
2981,3278,corticorelin,8.48148632,Kd,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(N)=O,CHEMBL2107324
2982,11035,ridaforolimus,9.69896984,IC50,INHIBITOR,[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](OP(C)(C)=O)[C@@H](C1)OC,CHEMBL2103839
2983,8329,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2984,8328,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2985,8318,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2986,8775,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2987,8777,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2988,8162,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2989,8776,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2990,8163,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2991,8781,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2992,9447,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2993,8417,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2994,8314,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2995,8600,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2996,8165,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2997,8783,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2998,8779,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
2999,8766,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3000,8332,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3001,8402,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3002,8317,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3003,8400,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3004,8333,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3005,8780,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3006,8330,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3007,8167,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3008,8782,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3009,8778,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3010,9450,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3011,8320,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3012,9446,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3013,8418,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3014,8166,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3015,8784,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3016,8785,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3017,8399,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3018,8316,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3019,8786,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3020,8401,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3021,9449,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3022,8319,amifampridine,,,BLOCKER,NC1=CC=NC=C1N,CHEMBL354077
3023,17391,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3024,16765,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3025,16764,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3026,16763,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3027,17077,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3028,16987,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3029,17297,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3030,16762,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3031,17076,cabazitaxel,,,INHIBITOR,[H][C@](O)(C(=O)O[C@@]1([H])C[C@@]2(O)[C@@]([H])(OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@]4([H])C[C@]([H])(OC)[C@@]3(C)C(=O)[C@]([H])(OC)C(=C1C)C2(C)C)OC(C)=O)[C@@]([H])(NC(=O)OC(C)(C)C)C1=CC=CC=C1,CHEMBL1201748
3032,12157,cangrelor,8.62708759,IC50,ANTAGONIST,CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O,CHEMBL334966
3033,12157,prasugrel,,,ANTAGONIST,[H]C(N1CCC2=C(C1)C=C(OC(C)=O)S2)(C(=O)C1CC1)C1=C(F)C=CC=C1,CHEMBL1201772
3034,5364,epoetin theta,,,AGONIST,,CHEMBL2108290
3035,7509,phenyltoloxamine,,,ANTAGONIST,CN(C)CCOC1=C(CC2=CC=CC=C2)C=CC=C1,CHEMBL186720
3036,8563,eptifibatide,6.24412537,IC50,INHIBITOR,NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O,CHEMBL1174
3037,8254,eptifibatide,6.24412537,IC50,INHIBITOR,NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O,CHEMBL1174
3038,8563,tirofiban,7.9586072,IC50,INHIBITOR,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,CHEMBL916
3039,8254,tirofiban,7.9586072,IC50,INHIBITOR,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O,CHEMBL916
3040,15779,sonidegib,8.22184849,Ki,ANTAGONIST,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=NC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=C1,CHEMBL2105737
3041,15088,cocaine,,,INHIBITOR,[H][C@@]12CC[C@@]([H])(N1C)[C@@]([H])(C(=O)OC)[C@]([H])(C2)OC(=O)C1=CC=CC=C1,CHEMBL120901
3042,7911,mecasermin,8.30980396,IC50,AGONIST,[H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC4=CC=CC=C4)NC2=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC1=O)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N3)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O,CHEMBL1201716
3043,3299,lumacaftor,6.45593214,EC50,PHARMACOLOGICAL CHAPERONE,CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC=CC(=C1)C(O)=O,CHEMBL2103870
3044,7800,aldesleukin,,,AGONIST,,CHEMBL1201438
3045,7801,aldesleukin,,,AGONIST,,CHEMBL1201438
3046,8664,aldesleukin,,,AGONIST,,CHEMBL1201438
3047,12630,mirodenafil,9.46852112,IC50,INHIBITOR,CCCOC1=CC=C(C=C1C1=NC2C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1,
3048,4816,cariprazine,9.31000042,Ki,PARTIAL AGONIST,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,CHEMBL2024517
3049,443,cariprazine,8.59000015,Ki,PARTIAL AGONIST,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,CHEMBL2024517
3050,104,cariprazine,7.73000002,Ki,ANTAGONIST,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,CHEMBL2024517
3051,6834,somatrem,,,AGONIST,,CHEMBL1201620
3052,13391,reteplase,,,ACTIVATOR,,CHEMBL2107885
3053,17750,lusutrombopag,,,AGONIST,CCCCCCO[C@@H](C)C1=CC=CC(C2=CSC(NC(=O)C3=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C3)=N2)=C1OC,CHEMBL2107831
3054,8669,mepolizumab,10.0,Kd,ANTIBODY BINDING,,CHEMBL2108429
3055,105,indisetron,8.73992825,Ki,ANTAGONIST,CN1C[C@@H]2C[C@@H](C[C@H](C1)N2C)NC(=O)C1=NNC2=C1C=CC=C2,CHEMBL2104994
3056,105,azasetron,9.26760578,Ki,ANTAGONIST,[H]C1(CN2CCC1CC2)NC(=O)C1=C2OCC(=O)N(C)C2=CC(Cl)=C1,CHEMBL1598608
3057,105,dolasetron,7.69831896,Ki,ANTAGONIST,[H][C@]12C[C@@H](C[C@]3([H])CC(C1)C(=O)CN23)OC(=O)C1=CNC2=C1C=CC=C2,CHEMBL2368924
3058,4969,osimertinib,7.82390881,IC50,INHIBITOR,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,CHEMBL3353410
3059,15538,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3060,15102,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3061,15539,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3062,15103,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3063,15541,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3064,15101,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3065,15251,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3066,15105,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3067,15540,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3068,15104,procainamide,,,BLOCKER,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,CHEMBL605
3069,15538,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3070,15102,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3071,15539,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3072,15103,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3073,15541,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3074,15101,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3075,15251,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3076,15105,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3077,15540,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3078,15104,tocainide,,,BLOCKER,CC(N)C(=O)NC1=C(C)C=CC=C1C,CHEMBL1762
3079,12768,pimobendan,6.38999987,IC50,INHIBITOR,COC1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NNC(=O)CC1C,CHEMBL24646
3080,12843,pimobendan,6.38999987,IC50,INHIBITOR,COC1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NNC(=O)CC1C,CHEMBL24646
3081,11400,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3082,11088,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3083,11089,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3084,11228,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3085,11519,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3086,11520,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3087,11518,ketamine,6.38000011,Ki,BLOCKER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3088,11400,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3089,11088,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3090,11089,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3091,11228,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3092,11519,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3093,11520,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3094,11518,amantadine,4.98000002,Ki,BLOCKER,NC12CC3CC(CC(C3)C1)C2,CHEMBL660
3095,187,diazoxide,4.63000011,EC50,OPENER,CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1,CHEMBL181
3096,8396,diazoxide,4.63000011,EC50,OPENER,CC1=NC2=CC=C(Cl)C=C2S(=O)(=O)N1,CHEMBL181
3097,15538,prilocaine,4.26999998,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(C)C=CC=C1,CHEMBL1194
3098,15101,prilocaine,4.26999998,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(C)C=CC=C1,CHEMBL1194
3099,15251,prilocaine,4.26999998,IC50,BLOCKER,CCCNC(C)C(=O)NC1=C(C)C=CC=C1,CHEMBL1194
3100,15335,lesinurad,5.13667727,IC50,INHIBITOR,OC(=O)CSC1=NN=C(Br)N1C1=C2C=CC=CC2=C(C=C1)C1CC1,CHEMBL2105720
3101,2123,lacidipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC,CHEMBL460291
3102,1677,lacidipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC,CHEMBL460291
3103,1677,(S)-nitrendipine,,,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,CHEMBL251230
3104,2123,benidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,CHEMBL2105555
3105,1677,benidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(CC2=CC=CC=C2)C1,CHEMBL2105555
3106,13436,lobeglitazone,7.74472761,EC50,AGONIST,[H]C1(CC2=CC=C(OCCN(C)C3=NC=NC(OC4=CC=C(OC)C=C4)=C3)C=C2)SC(=O)NC1=O,
3107,875,danazol,,,AGONIST,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,CHEMBL1479
3108,12782,rioprostil,,,AGONIST,[H][C@@]1(O)CC(=O)[C@]([H])(CCCCCCCO)[C@@]1([H])\C=C\CC(C)(O)CCCC,CHEMBL3301679
3109,13316,acemetacin,,,INHIBITOR,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O,CHEMBL189171
3110,12865,acemetacin,,,INHIBITOR,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(O)=O,CHEMBL189171
3111,9891,canrenone,6.52287865,IC50,ANTAGONIST,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@]12C,CHEMBL1463345
3112,14054,acitretin,,,AGONIST,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,CHEMBL1131
3113,12148,carbetocin,8.14874172,Ki,AGONIST,[H][C@]1(CSCCCC(=O)N[C@@H](CC2=CC=C(OC)C=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,CHEMBL3301668
3114,2123,lercanidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL250270
3115,1677,lercanidipine,,,BLOCKER,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,CHEMBL250270
3116,12865,felbinac,,,INHIBITOR,OC(=O)CC1=CC=C(C=C1)C1=CC=CC=C1,CHEMBL413965
3117,875,mestanolone,,,AGONIST,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,CHEMBL261514
3118,12865,floctafenine,5.9586072,IC50,INHIBITOR,OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1,CHEMBL2105075
3119,13316,floctafenine,6.26760626,IC50,INHIBITOR,OCC(O)COC(=O)C1=C(NC2=CC=NC3=C(C=CC=C23)C(F)(F)F)C=CC=C1,CHEMBL2105075
3120,7800,denileukin diftitox,,,ANTIBODY BINDING,,CHEMBL1201550
3121,7801,denileukin diftitox,,,ANTIBODY BINDING,,CHEMBL1201550
3122,8664,denileukin diftitox,,,ANTIBODY BINDING,,CHEMBL1201550
3123,2295,alefacept,,,INHIBITOR,,CHEMBL1201571
3124,2995,abatacept,7.92,Kd,INHIBITOR,,CHEMBL1201823
3125,2997,abatacept,7.92,Kd,INHIBITOR,,CHEMBL1201823
3126,2995,belatacept,,,INHIBITOR,,CHEMBL1742990
3127,2997,belatacept,,,INHIBITOR,,CHEMBL1742990
3128,17609,infliximab,,,ANTIBODY BINDING,,CHEMBL1201581
3129,8086,vedolizumab,8.30000019,IC50,ANTIBODY BINDING,,CHEMBL1743087
3130,8262,vedolizumab,8.30000019,IC50,ANTIBODY BINDING,,CHEMBL1743087
3131,6487,cortivazol,,,AGONIST,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C=C(C)C2=CC3=C(C[C@]12C)C=NN3C1=CC=CC=C1,CHEMBL2105842
3132,7964,ixekizumab,,,ANTIBODY BINDING,,CHEMBL1743034
3133,8669,reslizumab,10.09151459,Kd,ANTIBODY BINDING,,CHEMBL2107884
3134,8659,rilonacept,12.30103016,Kd,INHIBITOR,,CHEMBL1201830
3135,13391,urokinase,,,ACTIVATOR,,CHEMBL1201420
3136,7510,ebrotidine,,,ANTAGONIST,NC(=N)NC1=NC(CSCCN\C=N\S(=O)(=O)C2=CC=C(Br)C=C2)=CS1,CHEMBL1742471
3137,8938,benoxaprofen,,,INHIBITOR,CC(C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(Cl)C=C2)C=C1,CHEMBL340978
3138,7509,bisulepine,,,ANTAGONIST,CN(C)CC\C=C1/C2=C(SC=C2)SCC2=C1C=CC=C2,
3139,7509,bamipine,,,ANTAGONIST,CN1CCC(CC1)N(CC1=CC=CC=C1)C1=CC=CC=C1,CHEMBL520400
3140,5154,estriol,8.67,Ki,AGONIST,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,CHEMBL193482
3141,5364,darbepoetin alfa,,,AGONIST,,CHEMBL1201566
3142,8481,peginterferon alfa-2a,,,AGONIST,,CHEMBL1201560
3143,8217,peginterferon alfa-2a,,,AGONIST,,CHEMBL1201560
3144,5364,epoetin beta,,,AGONIST,,CHEMBL2109092
3145,8481,peginterferon alfa-2b,,,AGONIST,,CHEMBL1201561
3146,8217,peginterferon alfa-2b,,,AGONIST,,CHEMBL1201561
3147,5364,methoxy polyethylene glycol-epoetin beta,,,AGONIST,,CHEMBL3707314
3148,3649,lenograstim,,,ACTIVATOR,,CHEMBL2109128
3149,19094,eldecalcitol,,,AGONIST,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)[C@@]([H])(OCCCO)[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O,
3150,5364,epoetin zeta,,,AGONIST,,CHEMBL2108593
3151,15089,dapoxetine,8.95,IC50,INHIBITOR,CN(C)[C@@H](CCOC1=CC=CC2=C1C=CC=C2)C1=CC=CC=C1,CHEMBL2106574
3152,17617,belotecan,6.5614419,IC50,INHIBITOR,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CCNC(C)C)C4=CC=CC=C4N=C13)C2=O,CHEMBL2107315
3153,547,esmolol,6.9,Ki,ANTAGONIST,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,CHEMBL768
3154,6487,halopredone acetate,,,AGONIST,[H][C@@]12CC[C@](OC(C)=O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@@H](F)C2=CC(=O)C(Br)=C[C@]12C,CHEMBL2106520
3155,11552,obeticholic acid,7.00436497,EC50,AGONIST,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,CHEMBL566315
3156,1795,etelcalcetide,4.6,EC50,AGONIST,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,CHEMBL3545183
3157,17895,telotristat ethyl,7.79587984,IC50,INHIBITOR,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=C(C=C(Cl)C=C2)N2C=CC(C)=N2)C(F)(F)F)=C1,CHEMBL2103855
3158,6487,clobetasone butyrate,,,AGONIST,[H][C@@]12C[C@H](C)[C@](OC(=O)CCC)(C(=O)CCl)[C@@]1(C)CC(=O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,CHEMBL2308885
3159,12781,limaprost,,,AGONIST,CCCC[C@H](C)C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(O)=O,CHEMBL2107456
3160,6744,ketamine,,,OPENER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3161,6745,ketamine,,,OPENER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3162,6746,ketamine,,,OPENER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3163,6747,ketamine,,,OPENER,CNC1(CCCCC1=O)C1=C(Cl)C=CC=C1,CHEMBL742
3164,3144,ribociclib,8.0,IC50,INHIBITOR,CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1,CHEMBL3545110
3165,3145,ribociclib,7.40893555,IC50,INHIBITOR,CN(C)C(=O)C1=CC2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N1C1CCCC1,CHEMBL3545110
3166,12621,avelumab,,,ANTIBODY BINDING,,CHEMBL3833373
3167,11810,niraparib,8.42,IC50,INHIBITOR,[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1,CHEMBL1094636
3168,11683,niraparib,8.68,IC50,INHIBITOR,[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1,CHEMBL1094636
3169,12006,naldemedine,,,ANTAGONIST,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC3CC3)[C@]([H])(C4)[C@]1(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O,CHEMBL2105755
3170,3119,ocrelizumab,9.08,Kd,ANTIBODY BINDING,,CHEMBL2108041
3171,7967,dupilumab,11.06,IC50,ANTIBODY BINDING,,CHEMBL2108675
3172,18527,deutetrabenazine,,,INHIBITOR,[H]C12CC(=O)C(CC(C)C)CN1CCC1=C2C=C(OC([2H])([2H])[2H])C(OC([2H])([2H])[2H])=C1,
3173,18527,valbenazine,8.52287865,Ki,INHIBITOR,[H][C@]12C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CCC1=C2C=C(OC)C(OC)=C1,CHEMBL2364639
3174,13410,forodesine,10.14266777,Ki,INHIBITOR,OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1NC=NC2=O,CHEMBL218291
3175,6240,midostaurin,7.96,Kd,INHIBITOR,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,CHEMBL608533
3176,13834,abaloparatide,9.69999981,IC50,AGONIST,[H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(N)=O,CHEMBL3301581
3177,253,brigatinib,9.22184849,IC50,INHIBITOR,COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1,CHEMBL3545311
3178,12621,durvalumab,,,ANTIBODY BINDING,,CHEMBL3301587
3179,7927,sarilumab,11.10000038,Kd,ANTIBODY BINDING,,CHEMBL2108730
3180,8056,sarilumab,11.10000038,Kd,ANTIBODY BINDING,,CHEMBL2108730
3181,4816,ropinirole,8.14,Ki,AGONIST,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2,CHEMBL589
3182,12865,polmacoxib,8.08085155,IC50,INHIBITOR,CC1(C)OC(=C(C1=O)C1=CC=CC(F)=C1)C1=CC=C(C=C1)S(N)(=O)=O,CHEMBL166863
3183,4923,evogliptin,9.04575729,IC50,INHIBITOR,[H][C@]1(COC(C)(C)C)N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F,
3184,6000,betrixaban,8.82390881,IC50,INHIBITOR,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,CHEMBL512351
3185,6443,corifollitropin alfa,,,AGONIST,,CHEMBL2108185
3186,7963,guselkumab,,,ANTIBODY BINDING,,CHEMBL2364648
3187,8048,guselkumab,,,ANTIBODY BINDING,,CHEMBL2364648
3188,3121,inotuzumab ozogamicin,9.7,Kd,ANTIBODY BINDING,,CHEMBL2108611
3189,13566,pemafibrate,9.0,EC50,AGONIST,CC[C@@H](OC1=CC=CC(CN(CCCOC2=CC=C(OC)C=C2)C2=NC3=C(O2)C=CC=C3)=C1)C(O)=O,CHEMBL3545412
3190,12865,imrecoxib,7.82390881,IC50,INHIBITOR,CCCN1CC(=C(C1=O)C1=CC=C(C)C=C1)C1=CC=C(C=C1)S(C)(=O)=O,CHEMBL504535
3191,7783,enasidenib,7.0,IC50,INHIBITOR,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=CC=CC(=N1)C(F)(F)F,CHEMBL3989908
3192,4969,neratinib,7.03621197,IC50,INHIBITOR,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,CHEMBL180022
3193,5479,neratinib,7.22914791,IC50,INHIBITOR,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,CHEMBL180022
3194,5480,neratinib,8.61978912,Kd,INHIBITOR,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,CHEMBL180022
3195,11447,cenegermin,,,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC1=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC3=C1C=CC=C3)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)[C@@H](C)CC,
3196,18160,cenegermin,,,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC4=CNC5=C4C=CC=C5)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC1=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N3)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC3=C1C=CC=C3)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)[C@@H](C)CC,
3197,1917,acalabrutinib,8.29243,IC50,INHIBITOR,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,CHEMBL3707348
3198,19095,tivozanib,9.677781,IC50,INHIBITOR,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,CHEMBL1289494
3199,18451,tivozanib,9.79588,IC50,INHIBITOR,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,CHEMBL1289494
3200,19096,tivozanib,9.619789,IC50,INHIBITOR,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,CHEMBL1289494
3201,1978,calcitonin (salmon synthetic),11.08566,EC50,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O)[C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(N)=O,CHEMBL1201661
3202,1978,calcitonin human,7.809668,IC50,AGONIST,[H]N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC1=O)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O,CHEMBL1201614
3203,15515,ertugliflozin,9.057,IC50,INHIBITOR,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,CHEMBL1770248
3204,862,angiotensin II,9.3,IC50,AGONIST,[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,CHEMBL408403
3205,875,apalutamide,7.79588,IC50,INHIBITOR,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,CHEMBL3183409
3206,13068,copanlisib,8.43179798,IC50,INHIBITOR,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,
3207,13361,copanlisib,8.19382,IC50,INHIBITOR,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,
3208,4818,brexpiprazole,8.20065945,Ki,AGONIST,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,
3209,448,brexpiprazole,7.23657201,Ki,,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,
3210,11648,adenosine triphosphate,7.25,EC50,AGONIST,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,
3211,11649,adenosine triphosphate,6.3,EC50,AGONIST,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,
3212,12888,rucaparib,6.07999992,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,
3213,17724,rucaparib,6.84000015,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,
3214,18404,rucaparib,6.05000019,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,
3215,12734,rucaparib,6.25,IC50,INHIBITOR,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=CC(F)=CC(N1)=C23,
3216,6914,lodoxamide,8.79317379,EC50,AGONIST,OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N,
3217,7447,nafamostat,9.27999973,Ki,,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3218,7557,nafamostat,7.5999999,Ki,,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3219,402,orlistat,7.32000017,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3220,6420,pemetrexed,7.38000011,IC50,,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,
3221,6420,raltitrexed,7.82000017,IC50,,CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3222,13854,sivelestat,6.46999979,IC50,,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O,
3223,2142,venetoclax,7.31875896,Ki,INHIBITOR,CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1,
3224,1561,venetoclax,6.61083412,Ki,INHIBITOR,CC1(C)CCC(CN2CCN(CC2)C2=CC(OC3=CC4=C(NC=C4)N=C3)=C(C=C2)C(=O)NS(=O)(=O)C2=CC(=C(NCC3CCOCC3)C=C2)[N+]([O-])=O)=C(C1)C1=CC=C(Cl)C=C1,
3225,4818,aripiprazole lauroxil,7.35654736,Ki,,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,
3226,4818,flibanserin,8.39793968,Ki,ANTAGONIST,FC(F)(F)C1=CC=CC(=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1,
3227,4781,teneligliptin,6.58502674,IC50,,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1,
3228,4782,teneligliptin,6.26760626,IC50,,[H][C@]1(CN[C@@]([H])(C1)C(=O)N1CCSC1)N1CCN(CC1)C1=CC(C)=NN1C1=CC=CC=C1,
3229,4781,anagliptin,7.16749096,IC50,,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,
3230,4782,anagliptin,7.22184896,IC50,,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,
3231,18012,ceritinib,7.63827229,IC50,,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,
3232,7698,histamine,8.1,Ki,,NCCC1=CN=CN1,
3233,1232,phenelzine,7.7,IC50,,NNCCC1=CC=CC=C1,
3234,424,acetylcholine,5.1,Ki,,CC(=O)OCC[N+](C)(C)C,
3235,2630,niflumic acid,5.0,EC50,ACTIVATOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1,
3236,4788,apomorphine,7.8,Ki,AGONIST,[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23,
3237,110,methysergide,7.0,Ki,ANTAGONIST,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,
3238,7260,dexfosfoserine,7.2,IC50,AGONIST,N[C@@H](COP(O)(O)=O)C(O)=O,
3239,448,zotepine,8.3,Ki,ANTAGONIST,CN(C)CCOC1=CC2=C(SC3=CC=C(Cl)C=C13)C=CC=C2,
3240,448,thioridazine,7.2,Ki,ANTAGONIST,[H]C1(CCN2C3=CC=CC=C3SC3=CC=C(SC)C=C23)CCCCN1C,
3241,446,naratriptan,8.2,Ki,AGONIST,CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1,
3242,446,methysergide,8.2,Ki,ANTAGONIST,[H][C@@]12CC3=CN(C)C4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,
3243,4788,flupentixol,8.1,Ki,ANTAGONIST,OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,
3244,4788,cabergoline,7.7,Ki,AGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,
3245,445,naratriptan,7.7,Ki,AGONIST,CNS(=O)(=O)CCC1=CC=C2NC=C(C3CCN(C)CC3)C2=C1,
3246,6882,glutamic acid,7.4,Ki,AGONIST,N[C@@H](CCC(O)=O)C(O)=O,
3247,4818,cabergoline,7.3,Ki,AGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,
3248,448,amoxapine,7.3,Ki,ANTAGONIST,ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1,
3249,11235,meclozine,7.16,IC50,ANTAGONIST,CC1=CC=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=C1,
3250,8416,nitrendipine,7.6,IC50,BLOCKER,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,
3251,2125,nifedipine,6.0,IC50,GATING INHIBITOR,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,
3252,8416,riluzole,5.7,IC50,ACTIVATOR,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2,
3253,17943,adenosine triphosphate,5.8,IC50,BLOCKER,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,
3254,448,ergotamine,8.6,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,
3255,445,methylergometrine,7.2,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,
3256,448,metergoline,7.4,Ki,ANTAGONIST,[H][C@]1(CNC(=O)OCC2=CC=CC=C2)CN(C)[C@]2([H])CC3=CN(C)C4=C3C(=CC=C4)[C@@]2([H])C1,
3257,446,dihydroergotamine,7.1,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,
3258,4818,terguride,8.1,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=C3C(=CC=C4)[C@@]1([H])C[C@@H](CN2C)NC(=O)N(CC)CC,
3259,446,eletriptan,8.0,Ki,AGONIST,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,
3260,446,methylergometrine,7.5,Ki,ANTAGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N[C@@H](CC)CO,
3261,448,bromocriptine,7.5,Ki,AGONIST,[H][C@@]12CCCN1C(=O)[C@]([H])(CC(C)C)N1C(=O)[C@](NC(=O)[C@@]3([H])CN(C)[C@]4([H])CC5=C(Br)NC6=C5C(=CC=C6)C4=C3)(O[C@@]21O)C(C)C,
3262,445,eletriptan,7.2,Ki,AGONIST,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,
3263,446,yohimbine,7.0,Ki,ANTAGONIST,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2,
3264,8016,menadione,6.0,IC50,,CC1=CC(=O)C2=CC=CC=C2C1=O,
3265,4443,hymecromone,6.0,IC50,,CC1=CC(=O)OC2=C1C=CC(O)=C2,
3266,39,theophylline,7.85,Ki,ANTAGONIST,CN1C2=C(N=CN2)C(=O)N(C)C1=O,
3267,9727,nitroxoline,7.26,IC50,,OC1=C2N=CC=CC2=C(C=C1)[N+]([O-])=O,
3268,16644,miglitol,6.3,IC50,,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,
3269,424,varenicline,6.9,Ki,,[H][C@]12C[C@]([H])(CNC1)C1=C2C=C2N=CC=NC2=C1,
3270,4818,pramipexole,9.31,Ki,AGONIST,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,
3271,39,kainic acid,7.11,IC50,,CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O,
3272,39,baclofen,7.3,IC50,,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,
3273,9106,captopril,7.15,IC50,,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,
3274,6466,miglustat,6.64,IC50,,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,
3275,16644,miglustat,6.3,IC50,,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,
3276,1759,fadrozole,9.1,IC50,INHIBITOR,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,
3277,1759,metyrapone,7.38,IC50,,CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1,
3278,17464,ozagrel,7.96,IC50,,OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1,
3279,1241,amiloride,5.0,IC50,,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,
3280,1243,amiloride,5.36,IC50,,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,
3281,1168,naproxen,6.32,IC50,,COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O,
3282,11613,melatonin,7.56,Ki,,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,
3283,7831,zileuton,6.23,IC50,,CC(N(O)C(N)=O)C1=CC2=C(S1)C=CC=C2,
3284,10292,thiram,6.01,IC50,,CN(C)C(=S)SSC(=S)N(C)C,
3285,1168,mefenamic acid,6.52,Ki,,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,
3286,1167,mefenamic acid,6.66,Ki,,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,
3287,1166,mefenamic acid,6.09,Ki,,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,
3288,12705,phencyclidine,7.04,IC50,,C1CCN(CC1)C1(CCCCC1)C1=CC=CC=C1,
3289,1759,etomidate,10.0,IC50,,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,
3290,11648,pyridoxal phosphate,5.0,IC50,,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,
3291,8671,tolmetin,7.05,IC50,,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,
3292,1168,tolfenamic acid,8.1,Ki,,CC1=C(NC2=C(C=CC=C2)C(O)=O)C=CC=C1Cl,
3293,39,protriptyline,8.96,IC50,,CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2,
3294,39,atenolol,8.75,IC50,,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,
3295,4818,apomorphine,8.05,Ki,AGONIST,[H][C@]12CC3=CC=C(O)C(O)=C3C3=CC=CC(CCN1C)=C23,
3296,15442,estrone,8.18,Kd,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3297,4648,estrone,8.52,Ki,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3298,16980,tolonium,7.16,Ki,,CN(C)C1=CC2=[S+]C3=CC(N)=C(C)C=C3N=C2C=C1,
3299,15442,estradiol,8.83,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3300,5233,estradiol,8.49,IC50,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3301,5232,estradiol,8.44,IC50,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3302,15442,nandrolone,6.3,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3303,39,imipramine,8.36,IC50,,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,
3304,6012,linoleic acid,9.7,Kd,,CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,
3305,5750,linoleic acid,6.0,IC50,,CCCCC\C=C/C\C=C/CCCCCCCC(O)=O,
3306,17943,flufenamic acid,5.55,IC50,,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,
3307,5557,oleic acid,6.61,Ki,,CCCCCCCC\C=C/CCCCCCCC(O)=O,
3308,6013,oleic acid,6.7,Kd,,CCCCCCCC\C=C/CCCCCCCC(O)=O,
3309,5750,oleic acid,6.73,Ki,,CCCCCCCC\C=C/CCCCCCCC(O)=O,
3310,424,tropisetron,8.16,Ki,,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2,
3311,106,tropisetron,8.8,Ki,,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2,
3312,39,diazepam,7.92,IC50,,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,
3313,39,mepyramine,8.89,IC50,,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1,
3314,15442,androstenedione,7.46,Kd,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3315,4443,androstenedione,6.31,IC50,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3316,14461,retinol,6.74,Kd,,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,
3317,15442,estriol,6.63,Kd,,[H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3318,15442,testosterone,9.2,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3319,15442,prasterone,7.84,Kd,,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,
3320,12705,caramiphen,7.59,Ki,,CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1,
3321,2759,triclosan,7.22,Ki,,OC1=C(OC2=CC=C(Cl)C=C2Cl)C=CC(Cl)=C1,
3322,15442,androstanolone,9.74,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,
3323,15442,androstenediol,9.17,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,
3324,6595,lindane,7.04,IC50,,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl,
3325,5143,terbinafine,7.52,Ki,,CN(C\C=C\C#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1,
3326,15370,ondansetron,6.8,IC50,,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,
3327,15369,ondansetron,7.52,IC50,,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,
3328,106,ondansetron,8.3,Ki,,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,
3329,446,sumatriptan,7.59,Ki,,CNS(=O)(=O)CC1=CC2=C(NC=C2CCN(C)C)C=C1,
3330,1168,meclofenamic acid,6.27,IC50,,CC1=CC=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C1Cl,
3331,8671,diclofenac,8.1,IC50,,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,
3332,3874,diclofenac,7.92,IC50,,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,
3333,15442,ethinylestradiol,6.81,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,
3334,106,palonosetron,9.74,Kd,,[H][C@@]12CCCC3=CC=CC(C(=O)N(C1)[C@]1([H])CN4CCC1CC4)=C23,
3335,15442,norethisterone,7.97,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3336,11106,quercetin,6.17,IC50,,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,
3337,4218,quercetin,7.11,IC50,,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,
3338,9547,quercetin,6.36,IC50,,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,
3339,13209,quercetin,7.6,Kd,,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,
3340,4218,hesperetin,6.29,IC50,,[H][C@]1(CC(=O)C2=C(O)C=C(O)C=C2O1)C1=CC(O)=C(OC)C=C1,
3341,9547,masoprocol,6.96,IC50,,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,
3342,10058,masoprocol,6.96,IC50,,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,
3343,9825,masoprocol,7.07,IC50,,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,
3344,15442,methyltestosterone,8.43,Kd,,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3345,4781,vildagliptin,6.09,Ki,,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,
3346,4782,vildagliptin,7.17,Ki,,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,
3347,15442,mesterolone,9.6,Kd,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)C[C@H](C)[C@]12C,
3348,15442,mestanolone,8.81,Kd,,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C,
3349,7023,glutathione,7.7,IC50,,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,
3350,4998,buflomedil,7.22,Ki,,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1,
3351,865,ubenimex,9.22,Ki,,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O,
3352,9106,ubenimex,6.3,IC50,,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1)C(O)=O,
3353,15442,gestrinone,8.11,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H],
3354,6623,picrotin,5.22,IC50,,[H][C@@]12C[C@@]3(O)[C@@H]4[C@@H]([C@@H](OC4=O)[C@H]4OC(=O)[C@]1(O2)[C@@]34C)C(C)(C)O,
3355,3421,bifonazole,6.47,IC50,,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1,
3356,15442,desogestrel,6.6,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H],
3357,106,granisetron,8.8,Ki,,[H][C@]1(C[C@]2([H])CCC[C@]([H])(C1)N2C)NC(=O)C1=NN(C)C2=C1C=CC=C2,
3358,15442,levonorgestrel,8.91,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3359,15442,ethisterone,8.78,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3360,4818,amoxapine,7.47,Ki,ANTAGONIST,ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1,
3361,3718,dronabinol,8.48,Ki,,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21,
3362,3718,dronabinol,7.39,Ki,,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=CC(CCCCC)=CC(O)=C21,
3363,15442,progesterone,6.94,Kd,,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3364,4781,saxagliptin,6.89,Ki,,[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2,
3365,4782,saxagliptin,7.15,Ki,,[H][C@@](N)(C(=O)N1[C@@]2([H])C[C@@]2([H])C[C@@]1([H])C#N)C12CC3CC(CC(O)(C3)C1)C2,
3366,4818,rotigotine,7.26,Ki,AGONIST,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,
3367,7831,triclocarban,7.89,IC50,,ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1,
3368,448,chlorprothixene,8.52,Ki,,CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,
3369,4788,chlorprothixene,8.05,Ki,,CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,
3370,15442,pregnenolone succinate,7.15,Kd,,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OC(=O)CCC(O)=O,
3371,9948,chlorpromazine,6.22,Ki,,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,
3372,1054,epalrestat,6.48,IC50,,C\C(\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/C1=CC=CC=C1,
3373,15201,gabexate,6.05,IC50,,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,
3374,15369,gabexate,6.3,IC50,,CCOC(=O)C1=CC=C(OC(=O)CCCCCNC(N)=N)C=C1,
3375,110,lysergide,8.05,Ki,,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,
3376,4818,lysergide,7.25,Ki,,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,
3377,445,lysergide,7.03,Ki,,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@H](CN2C)C(=O)N(CC)CC,
3378,18886,reserpine,7.45,Ki,INHIBITOR,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,
3379,15442,etonogestrel,8.23,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3380,16901,niclosamide,6.6,IC50,,OC1=C(C=C(Cl)C=C1)C(=O)NC1=C(Cl)C=C(C=C1)[N+]([O-])=O,
3381,39,naloxone,8.8,IC50,,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O,
3382,448,loxapine,7.82,Ki,,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,
3383,4818,loxapine,8.31,Ki,ANTAGONIST,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,
3384,11649,paroxetine,5.33,IC50,,[H][C@@]1(COC2=CC3=C(OCO3)C=C2)CNCC[C@@]1([H])C1=CC=C(F)C=C1,
3385,15442,desoxycortone,7.38,Kd,,[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3386,17736,ciprofloxacin,7.52,EC50,,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,
3387,4818,zotepine,7.41,Ki,,CN(C)CCOC1=CC2=C(SC3=CC=C(Cl)C=C13)C=CC=C2,
3388,12705,pentoxyverine,7.49,IC50,,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1,
3389,6914,dicoumarol,7.41,Ki,,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12,
3390,15369,famotidine,6.12,IC50,,NC(=N)NC1=NC(CSCCC(=N)NS(N)(=O)=O)=CS1,
3391,15442,danazol,8.2,Kd,,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,
3392,754,pentamidine,6.54,Ki,,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,
3393,15558,pentamidine,6.0,Kd,,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,
3394,15369,pentamidine,6.39,IC50,,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,
3395,1168,medroxyprogesterone,6.52,IC50,,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,
3396,15442,medroxyprogesterone,6.2,Kd,,[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)CC[C@]12C,
3397,8416,clotrimazole,7.15,IC50,,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,
3398,3421,clotrimazole,6.89,IC50,,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,
3399,5701,adenosine phosphate,6.85,IC50,,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,
3400,1928,nafamostat,6.85,IC50,,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3401,8821,nafamostat,6.19,IC50,,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3402,39,pirenzepine,7.66,IC50,,CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1,
3403,39,yohimbine,7.02,IC50,,[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=C3C=CC=C1)C2,
3404,16886,hexamidine,6.03,Ki,,NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,
3405,7480,amodiaquine,7.72,Ki,,CCN(CC)CC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,
3406,1053,tolrestat,6.14,IC50,,COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O,
3407,1054,tolrestat,7.3,Ki,,COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O,
3408,1168,indomethacin,7.0,IC50,,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,
3409,8671,indomethacin,7.3,IC50,,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,
3410,6851,prednisolone,7.49,EC50,,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
3411,15442,cortisone acetate,6.43,Kd,,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3412,6457,haloprogin,6.3,IC50,,ClC1=CC(Cl)=C(OCC#CI)C=C1Cl,
3413,15442,hydrocortisone,6.2,Kd,,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3414,4998,opipramol,7.89,Ki,,OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=C2C=CC=C3)CC1,
3415,16980,lansoprazole,8.6,Ki,,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,
3416,5177,tamoxifen,8.55,Ki,,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,
3417,3718,nabilone,8.2,Ki,,[H]C12CC(=O)CCC1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,
3418,4818,clebopride,8.49,Ki,,COC1=C(C=C(Cl)C(N)=C1)C(=O)NC1CCN(CC2=CC=CC=C2)CC1,
3419,3421,econazole,7.3,IC50,,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,
3420,4818,tandospirone,8.14,Ki,,[H][C@]12CC[C@]([H])(C1)[C@]1([H])C(=O)N(CCCCN3CCN(CC3)C3=NC=CC=N3)C(=O)[C@]21[H],
3421,1708,bortezomib,6.2,Ki,,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,
3422,3526,bortezomib,6.49,Ki,,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,
3423,11347,bortezomib,8.01,IC50,,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,
3424,11183,bortezomib,8.01,IC50,,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,
3425,17529,bortezomib,8.01,IC50,,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,
3426,4818,nemonapride,9.68,Kd,,CNC1=CC(OC)=C(C=C1Cl)C(=O)N[C@@H]1CCN(CC2=CC=CC=C2)[C@@H]1C,
3427,12624,tadalafil,7.48,IC50,,[H][C@]12CC3=C(NC4=C3C=CC=C4)[C@]([H])(N1C(=O)CN(C)C2=O)C1=CC=C2OCOC2=C1,
3428,6223,erlotinib,8.51,Kd,,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,
3429,16909,erlotinib,7.72,Kd,,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,
3430,9835,erlotinib,7.6,Kd,,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,
3431,16037,erlotinib,7.59,Kd,,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,
3432,17736,amsacrine,6.14,EC50,,COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1,
3433,39,ketanserin,8.57,IC50,,FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1,
3434,4818,ketanserin,8.46,Ki,,FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1,
3435,4818,spiperone,9.7,Ki,,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,
3436,8764,sunitinib,7.89,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3437,11788,sunitinib,7.8,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3438,6223,sunitinib,7.7,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3439,8152,sunitinib,7.82,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3440,7362,sunitinib,7.51,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3441,13790,sunitinib,6.41,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3442,9698,sunitinib,7.8,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3443,2528,sunitinib,7.7,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3444,10626,sunitinib,7.82,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3445,3775,sunitinib,7.66,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3446,16909,sunitinib,7.72,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3447,180,sunitinib,7.96,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3448,9336,sunitinib,7.77,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3449,12803,sunitinib,8.23,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3450,10627,sunitinib,7.64,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3451,10377,sunitinib,7.54,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3452,2183,sunitinib,8.26,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3453,16621,sunitinib,9.0,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3454,17867,sunitinib,7.6,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3455,2529,sunitinib,7.54,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3456,8529,sunitinib,7.85,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3457,16697,sunitinib,7.72,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3458,392,sunitinib,7.72,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3459,9140,sunitinib,7.77,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3460,18422,sunitinib,7.89,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3461,12802,sunitinib,8.26,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3462,4373,sunitinib,7.66,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3463,9835,sunitinib,7.77,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3464,18652,sunitinib,8.05,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3465,4673,sunitinib,7.0,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3466,10765,sunitinib,7.64,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3467,19084,sunitinib,7.64,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3468,16695,sunitinib,7.77,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3469,2702,sunitinib,8.15,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3470,10456,sunitinib,7.59,Kd,,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,
3471,13544,mepacrine,6.52,EC50,,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=CC(Cl)=CC=C12,
3472,5749,amperozide,6.34,IC50,,CCNC(=O)N1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,
3473,15369,nifekalant,6.19,IC50,,CN1C(=O)C=C(NCCN(CCO)CCCC2=CC=C(C=C2)[N+]([O-])=O)N(C)C1=O,
3474,4998,clomifene,9.0,Ki,,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,
3475,5177,trifluoperazine,8.41,Ki,,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,
3476,4998,trifluoperazine,8.1,Ki,,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,
3477,4998,trifluperidol,6.78,Ki,,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F,
3478,16984,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3479,16761,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3480,17073,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3481,16760,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3482,16983,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3483,16985,podophyllotoxin,6.0,IC50,,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OC)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@@H]2O,
3484,3421,miconazole,6.7,IC50,,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,
3485,12839,ramatroban,8.37,Ki,,OC(=O)CCN1C2=C(C[C@@H](CC2)NS(=O)(=O)C2=CC=C(F)C=C2)C2=CC=CC=C12,
3486,18900,calcitriol,7.62,Kd,,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)CCCC(C)(C)O,
3487,7564,topotecan,7.22,IC50,,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(CN(C)C)C(O)=CC=C4N=C13)C2=O,
3488,996,losartan,8.43,Kd,,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,
3489,10510,benzbromarone,6.72,Ki,,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2,
3490,1166,benzbromarone,7.32,IC50,,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C2=C(O1)C=CC=C2,
3491,16644,acarbose,6.60906506,Ki,,[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,
3492,9303,ingenol mebutate,8.95860767,EC50,,[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C,
3493,9505,ingenol mebutate,7.52287865,EC50,,[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C,
3494,4818,haloperidol,9.42021656,Kd,INVERSE AGONIST,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,
3495,2727,niflumic acid,5.0,EC50,ACTIVATOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1,
3496,424,ivermectin,5.1,EC50,ALLOSTERIC MODULATOR,,
3497,11839,ciclosporin,6.0,IC50,INHIBITOR,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3498,17634,progesterone,5.3,IC50,BLOCKER,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3499,6622,picrotoxin,5.6,IC50,BLOCKER,,
3500,1243,nafamostat,5.6,IC50,BLOCKER,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3501,8414,tubocurarine,5.7,IC50,BLOCKER,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,
3502,13573,boceprevir,6.0,IC50,INHIBITOR,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3503,15984,sildenafil,6.1,IC50,INHIBITOR,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1,
3504,15984,ciclosporin,6.1,IC50,INHIBITOR,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3505,8405,tenidap,6.4,EC50,ACTIVATOR,NC(=O)N1C(=O)\C(=C(/O)C2=CC=CS2)C2=C1C=CC(Cl)=C2,
3506,8413,dequalinium,6.4,IC50,BLOCKER,CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1,
3507,14836,tretinoin,9.82,IC50,ANTAGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,
3508,1340,icatibant,7.0,Ki,ANTAGONIST,[H]N[C@H](CCCNC(N)=N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@]([H])(O)C[C@@]1([H])C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@@H](C[C@]3([H])CCCC[C@]13[H])C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2,
3509,13573,telaprevir,7.0,IC50,INHIBITOR,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3510,15369,pyrimethamine,7.1,Ki,INHIBITOR,CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1,
3511,7185,adenosine triphosphate,7.43,EC50,AGONIST,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,
3512,13835,teriparatide,7.8,IC50,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,
3513,13493,tretinoin,7.8,Kd,AGONIST,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,
3514,445,asenapine,8.0,Ki,AGONIST,[H]C12CN(C)CC1([H])C1=C(OC3=C2C=CC=C3)C=CC(Cl)=C1,
3515,3852,progesterone,8.11,EC50,ACTIVATOR,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3516,3853,progesterone,8.11,EC50,ACTIVATOR,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3517,3996,progesterone,8.11,EC50,ACTIVATOR,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3518,3997,progesterone,8.11,EC50,ACTIVATOR,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3519,4818,lisuride,8.3,Ki,AGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,
3520,4788,lisuride,8.5,Ki,AGONIST,[H][C@@]12CC3=CNC4=CC=CC(=C34)C1=C[C@@H](CN2C)NC(=O)N(CC)CC,
3521,9934,afamelanotide,8.8,Ki,AGONIST,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,
3522,9933,afamelanotide,8.9,Ki,AGONIST,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,
3523,10050,afamelanotide,9.0,IC50,AGONIST,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,
3524,9304,ingenol mebutate,9.79,Ki,ACTIVATOR,[H][C@@]12C[C@@]([H])(C)[C@]34C=C(C)[C@]([H])(OC(=O)C(\C)=C/C)[C@@]3(O)[C@]([H])(O)C(CO)=C[C@]([H])(C4=O)[C@]1([H])C2(C)C,
3525,4818,perospirone,10.05,Ki,ANTAGONIST,[H][C@@]12CCCC[C@]1([H])C(=O)N(CCCCN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,
3526,9933,corticotropin,7.06,Ki,AGONIST,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,
3527,6623,ivermectin,6.4000001,EC50,AGONIST,,
3528,6622,ivermectin,6.4000001,EC50,AGONIST,,
3529,1759,ketoconazole,7.1739254,IC50,INHIBITOR,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,
3530,11706,pemetrexed,7.03,Ki,,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,
3531,4998,triparanol,7.96,Ki,,CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC1=CC=C(Cl)C=C1)C1=CC=C(C)C=C1,
3532,4818,sertindole,7.96,Ki,,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,
3533,448,sertindole,8.3,Ki,,FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2,
3534,2292,raltegravir,8.3,Ki,,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,
3535,15370,mitoxantrone,6.28,IC50,,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,
3536,15369,mitoxantrone,6.72,IC50,,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C1=C(O)C=CC(O)=C1C2=O,
3537,6223,gefitinib,8.15,Kd,,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,
3538,9948,aripiprazole,6.11,IC50,,ClC1=CC=CC(N2CCN(CCCCOC3=CC=C4CCC(=O)NC4=C3)CC2)=C1Cl,
3539,9948,verapamil,6.52,Ki,,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,
3540,9727,fumagillin,9.2,IC50,,[H][C@@]1([C@H](OC)[C@@H](CC[C@]11CO1)OC(=O)\C=C\C=C\C=C\C=C\C(O)=O)[C@@]1(C)O[C@@H]1CC=C(C)C,
3541,9837,sorafenib,8.2,Kd,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3542,7243,sorafenib,8.57,Kd,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3543,7831,sorafenib,7.92,IC50,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3544,4368,sorafenib,8.18,Kd,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3545,4573,sorafenib,8.82,Kd,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3546,109,cisapride,6.82,Ki,,[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3547,106,cisapride,6.82,Ki,,[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3548,108,cisapride,6.82,Ki,,[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3549,107,cisapride,6.82,Ki,,[H]C1(CCN(CCCOC2=CC=C(F)C=C2)CC1([H])OC)NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3550,11753,buprenorphine,7.11,Ki,,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]51CC[C@@]2(OC)[C@]([H])(C1)[C@](C)(O)C(C)(C)C)=CC=C3O,
3551,9233,ruboxistaurin,8.6,Kd,,[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,
3552,12878,ruboxistaurin,7.92,Kd,,[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,
3553,9303,ruboxistaurin,7.96,Kd,,[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,
3554,9302,ruboxistaurin,8.33,IC50,,[H][C@@]1(CN(C)C)CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,
3555,16886,dibrompropamidine,6.27,Ki,,NC(=N)C1=CC(Br)=C(OCCCOC2=C(Br)C=C(C=C2)C(N)=N)C=C1,
3556,4652,enoxolone,8.91,IC50,,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,
3557,14098,stallimycin,6.7,IC50,,CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC=O)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N,
3558,14489,dasatinib,7.51,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3559,10735,dasatinib,7.2,IC50,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3560,5652,dasatinib,9.47,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3561,6223,dasatinib,8.59,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3562,10331,dasatinib,8.48,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3563,5359,dasatinib,8.39,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3564,6391,dasatinib,9.3,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3565,6348,dasatinib,9.51,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3566,5360,dasatinib,9.62,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3567,5648,dasatinib,10.03,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3568,3965,dasatinib,9.0,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3569,18401,dasatinib,7.96,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3570,13665,dasatinib,8.11,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3571,1908,dasatinib,8.85,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3572,5650,dasatinib,9.62,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3573,5649,dasatinib,8.92,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3574,5218,dasatinib,9.35,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3575,220,dasatinib,8.25,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3576,136,dasatinib,9.77,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3577,1341,dasatinib,9.68,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3578,5196,dasatinib,7.74,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3579,5653,dasatinib,10.41,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3580,16501,dasatinib,8.19,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3581,16245,dasatinib,7.89,Kd,INHIBITOR,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3582,16502,dasatinib,7.55,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3583,4368,dasatinib,8.52,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3584,4573,dasatinib,9.16,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3585,5133,dasatinib,9.41,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3586,18746,dasatinib,8.68,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3587,5651,dasatinib,8.16,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3588,17115,dasatinib,7.89,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3589,15161,dasatinib,8.41,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3590,10202,dasatinib,7.57,Kd,,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,
3591,12914,vardenafil,6.34,IC50,,CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1,
3592,12624,vardenafil,6.89,IC50,,CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1,
3593,15370,imatinib,6.46,IC50,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3594,15369,imatinib,7.4,IC50,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3595,136,imatinib,8.22,Kd,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3596,4368,imatinib,7.82,Kd,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3597,11613,imatinib,6.4,IC50,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3598,4573,imatinib,9.15,Kd,,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,
3599,401,orlistat,7.1,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3600,4644,orlistat,7.22,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3601,4409,orlistat,8.0,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3602,404,orlistat,7.52,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3603,12526,orlistat,7.3,IC50,,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,
3604,16721,mupirocin,9.1,IC50,,[H][C@@]1(C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O)O[C@@]1([H])[C@@H](C)[C@H](C)O,
3605,13605,dipyridamole,6.11,IC50,,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,
3606,12624,dipyridamole,6.4,Ki,,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,
3607,15330,chlorhexidine,6.39,IC50,,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
3608,15200,chlorhexidine,6.68,IC50,,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
3609,15201,chlorhexidine,6.4,IC50,,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
3610,15370,chlorhexidine,6.3,IC50,,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
3611,15369,chlorhexidine,6.15,IC50,,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1,
3612,4652,acetoxolone,6.7,IC50,,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](OC(C)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O,
3613,996,telmisartan,9.48,IC50,,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O,
3614,2142,gossypol,6.32,Ki,,CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(=C(C)C=C12)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,
3615,9628,gossypol,6.74,Ki,,CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(=C(C)C=C12)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C,
3616,9837,nilotinib,7.96,Kd,,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,
3617,136,nilotinib,7.59,Kd,,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,
3618,4368,nilotinib,8.22,Kd,,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,
3619,4573,nilotinib,8.96,Kd,,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,
3620,110,ergotamine,7.85,Ki,,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O,
3621,7831,fulvestrant,7.59,Ki,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],
3622,5232,fulvestrant,8.7,IC50,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],
3623,9948,reserpine,7.0,Ki,,[H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=C3C=CC(OC)=C1)C2,
3624,19348,tubocurarine,5.2,IC50,,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,
3625,424,tubocurarine,5.51,IC50,,[H][C@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC=C(O)C(OC6=CC1=C(CCN2C)C=C6OC)=C5)=CC(OC)=C4O)C=C3,
3626,259,acarbose,6.0,IC50,,[H][C@]1(N[C@@H]2[C@@H](C)O[C@H](O[C@]3([H])[C@@H](CO)O[C@H](O[C@]4([H])[C@@H](CO)OC(O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,
3627,3874,itraconazole,7.0,IC50,,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,
3628,15369,ritonavir,7.1,IC50,,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,
3629,15128,tacrolimus,7.96,IC50,,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC,
3630,13305,tacrolimus,7.7,Kd,,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC,
3631,5604,tacrolimus,7.1,Ki,,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC,
3632,9948,vinblastine,7.0,Ki,,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@@](CC)([C@@H](OC(C)=O)[C@]2(O)C(=O)OC)[C@@]13[H])[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCC2=C1NC1=CC=CC=C21)C(=O)OC,
3633,4652,glycyrrhizic acid,9.4,IC50,,[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](O)[C@H](O[C@]2([H])O[C@H]2CC[C@@]3(C)[C@@]([H])(CC[C@]4(C)[C@]3([H])C(=O)C=C3[C@]5([H])C[C@](C)(CC[C@]5(C)CC[C@@]43C)C(O)=O)C2(C)C)C(O)=O)O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O,
3634,5126,evans blue,6.08,Ki,,CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O,
3635,996,saralasin,9.82,Ki,,CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O,
3636,7632,sirolimus,9.3,Kd,,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,
3637,12910,sirolimus,7.3,EC50,,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,
3638,5604,sirolimus,8.52,Ki,,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,
3639,11576,eledoisin,9.66,EC50,,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O,
3640,13305,ciclosporin,8.4,Kd,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3641,13495,ciclosporin,8.15,Ki,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3642,13118,ciclosporin,8.01,Kd,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3643,6150,ciclosporin,8.22,Ki,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3644,5858,ciclosporin,7.8,IC50,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3645,15171,suramin,6.52,IC50,,CC1=CC=C(C=C1NC(=O)C1=CC=CC(NC(=O)NC2=CC=CC(=C2)C(=O)NC2=C(C)C=CC(=C2)C(=O)NC2=CC=C(C3=CC(=CC(=C23)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)=C1)C(=O)NC1=CC=C(C2=CC(=CC(=C12)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O,
3646,11154,vorinostat,8.7,Ki,,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,
3647,10838,vorinostat,7.92,Ki,,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,
3648,3718,rimonabant,8.96,Ki,,CC1=C(N(N=C1C(=O)NN1CCCCC1)C1=CC=C(Cl)C=C1Cl)C1=CC=C(Cl)C=C1,
3649,1709,boceprevir,7.4,IC50,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3650,2378,boceprevir,7.12,IC50,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3651,3358,boceprevir,7.49,IC50,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3652,2380,boceprevir,6.92,IC50,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3653,2377,boceprevir,6.12,IC50,,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,
3654,1709,telaprevir,6.2,IC50,,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3655,2303,telaprevir,6.68,IC50,,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3656,2878,telaprevir,7.52,IC50,,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3657,3358,telaprevir,7.59,IC50,,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3658,2380,telaprevir,6.52,IC50,,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1,
3659,16461,linagliptin,7.05,IC50,,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,
3660,14489,vandetanib,8.34,Kd,,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,
3661,4573,vandetanib,7.96,Kd,,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,
3662,16037,crizotinib,7.74,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3663,14730,crizotinib,7.6,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3664,8680,crizotinib,7.51,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3665,14778,crizotinib,8.39,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3666,5653,crizotinib,8.22,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3667,10106,crizotinib,7.92,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3668,18652,crizotinib,8.11,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3669,10456,crizotinib,8.44,Kd,,[H][C@](C)(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,
3670,15442,hydroxyprogesterone caproate,7.0,Kd,,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3671,39,prazosin,9.07,IC50,,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,
3672,11613,prazosin,8.11,IC50,,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1,
3673,13389,axitinib,8.38,Ki,,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,
3674,1297,axitinib,8.89,Kd,,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,
3675,1556,axitinib,7.96,Kd,,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,
3676,15146,vismodegib,7.82,IC50,,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,
3677,15516,dapagliflozin,8.87,IC50,,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1,
3678,15514,dapagliflozin,8.49,IC50,,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1,
3679,15646,dapagliflozin,6.42,IC50,,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC(CC2=CC=C(OCC)C=C2)=C(Cl)C=C1,
3680,16175,bosutinib,8.7,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3681,5652,bosutinib,8.04,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3682,6223,bosutinib,8.89,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3683,10331,bosutinib,8.09,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3684,9698,bosutinib,7.82,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3685,6391,bosutinib,8.2,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3686,6348,bosutinib,8.85,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3687,5360,bosutinib,8.05,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3688,5648,bosutinib,8.24,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3689,16909,bosutinib,8.15,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3690,9699,bosutinib,9.3,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3691,10377,bosutinib,8.49,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3692,17867,bosutinib,7.51,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3693,16037,bosutinib,8.33,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3694,5650,bosutinib,7.57,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3695,5649,bosutinib,7.74,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3696,220,bosutinib,7.54,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3697,9786,bosutinib,8.29,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3698,9782,bosutinib,7.52,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3699,136,bosutinib,8.82,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3700,1341,bosutinib,8.48,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3701,5196,bosutinib,9.11,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3702,16501,bosutinib,7.54,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3703,136,bosutinib,8.96,IC50,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3704,10027,bosutinib,8.09,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3705,9835,bosutinib,7.8,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3706,5133,bosutinib,8.08,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3707,15161,bosutinib,7.52,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3708,9840,bosutinib,8.51,Kd,,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,
3709,8415,dequalinium,5.89,IC50,,CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1,
3710,39,choline theophyllinate,7.85,Ki,ANTAGONIST,C[N+](C)(C)CCO.CN1C2=C(N=C[N-]2)C(=O)N(C)C1=O,
3711,2854,plerixafor,10.4,IC50,,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,
3712,39,bufylline,7.85,Ki,ANTAGONIST,,
3713,5558,choline fenofibrate,6.0,Ki,,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,
3714,9934,tetracosactide,9.19,EC50,,[H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,
3715,4218,diosmetin,7.54,IC50,,COC1=C(O)C=C(C=C1)C1=CC(=O)C2=C(O)C=C(O)C=C2O1,
3716,6012,linolenic acid,8.56,Kd,,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,
3717,7831,regorafenib,9.3,IC50,INHIBITOR,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1,
3718,4325,tofacitinib,8.35,Kd,,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,
3719,1908,ibrutinib,9.1,IC50,,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,
3720,2380,simeprevir,6.1,IC50,,[H][C@@]12C[C@]1(NC(=O)[C@]1([H])C[C@]([H])(C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1,
3721,10331,nintedanib,8.74,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3722,10455,nintedanib,8.31,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3723,9691,nintedanib,8.39,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3724,3775,nintedanib,8.06,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3725,18823,nintedanib,7.66,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3726,16910,nintedanib,7.74,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3727,8497,nintedanib,7.68,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3728,2183,nintedanib,8.66,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3729,2529,nintedanib,7.74,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3730,16697,nintedanib,8.05,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3731,3141,nintedanib,7.68,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3732,16568,nintedanib,7.74,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3733,7199,nintedanib,7.77,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3734,9782,nintedanib,8.03,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3735,13789,nintedanib,8.08,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3736,4573,nintedanib,7.92,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3737,9835,nintedanib,8.28,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3738,18652,nintedanib,7.92,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3739,13247,nintedanib,7.77,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3740,11264,nintedanib,7.72,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3741,11624,nintedanib,7.68,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3742,16150,nintedanib,7.92,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3743,14244,nintedanib,7.64,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3744,8794,nintedanib,7.85,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3745,10456,nintedanib,8.07,Kd,,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,
3746,11653,cangrelor,8.3,IC50,ANTAGONIST,CSCCNC1=NC(SCCC(F)(F)F)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O,
3747,10838,romidepsin,9.81999969,Ki,,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,
3748,4998,tamoxifen,9.0,Kd,,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,
3749,4410,tamoxifen,9.0,Kd,,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,
3750,2336,palbociclib,8.69999981,IC50,,CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O,
3751,2336,palbociclib,8.42000008,IC50,,CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O,
3752,145,nicotine,8.26000023,Ki,,CN1CCC[C@H]1C1=CC=CN=C1,
3753,11154,romidepsin,7.73999977,IC50,,[H][C@]12CC(=O)N[C@]([H])(C(C)C)C(=O)N[C@]([H])(CSSCC\C=C\1)C(=O)N\C(=C/C)C(=O)N[C@@]([H])(C(C)C)C(=O)O2,
3754,543,colforsin daropate,7.38999987,IC50,,[H][C@@]12[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]3(C)O[C@](C)(CC(=O)[C@]3(O)[C@@]1(C)[C@@H](O)CCC2(C)C)C=C,
3755,8671,ibuprofen,7.30000019,IC50,,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,
3756,109,metoclopramide,7.30000019,Kd,,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3757,106,metoclopramide,7.30000019,Kd,,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3758,108,metoclopramide,7.30000019,Kd,,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3759,107,metoclopramide,7.30000019,Kd,,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1,
3760,18797,dabigatran etexilate,7.30000019,Ki,,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1,
3761,18798,dabigatran etexilate,7.30000019,Ki,,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1,
3762,4894,glutamic acid,7.28999996,Ki,,N[C@@H](CCC(O)=O)C(O)=O,
3763,145,nicotine,7.1500001,Ki,,CN1CCC[C@H]1C1=CC=CN=C1,
3764,40,nicotine,7.07000017,IC50,,CN1CCC[C@H]1C1=CC=CN=C1,
3765,423,nicotine,7.07000017,IC50,,CN1CCC[C@H]1C1=CC=CN=C1,
3766,728,pecazine,7.01000023,AC50,,CN1CCCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1,
3767,14461,retinol acetate,6.73999977,Kd,,CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,
3768,15442,estriol succinate,6.63000011,Kd,,[H][C@@]12C[C@@H](OC(=O)CCC(O)=O)[C@H](OC(=O)CCC(O)=O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3CC[C@@]21[H],
3769,6595,aminobutyric acid,6.57000017,EC50,,NCCCC(O)=O,
3770,17464,tannic acid,6.48999977,IC50,,,
3771,728,promethazine,6.44000006,AC50,,CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C,
3772,728,olanzapine,6.42999983,AC50,,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,
3773,728,pyrithione,6.36000013,AC50,,[O-][N+]1=C(S)C=CC=C1,
3774,13127,lansoprazole,6.36000013,IC50,,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,
3775,16901,digitoxin,6.1500001,IC50,,[H][C@@]1(C[C@H](O)[C@H](O[C@@]2([H])C[C@H](O)[C@H](O[C@@]3([H])C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)O[C@H]1CC[C@@]2(C)[C@]([H])(CC[C@]3([H])[C@]2([H])CC[C@]2(C)[C@H](CC[C@]32O)C2=CC(=O)OC2)C1,
3776,4217,tannic acid,6.03999996,IC50,,,
3777,3413,bicalutamide,6.0,IC50,,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,
3778,145,mecamylamine,5.51000023,IC50,,[H]C12CCC([H])(C1)C(C)(NC)C2(C)C,
3779,8207,rilonacept,11.8538723,Kd,INHIBITOR,,
3780,8046,rilonacept,11.21467018,Kd,INHIBITOR,,
3781,6420,methotrexate,6.94000006,IC50,,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3782,7447,dabigatran etexilate,6.07999992,Ki,,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1,
3783,15195,pemetrexed,6.86000013,IC50,,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,
3784,15195,raltitrexed,8.19999981,IC50,,CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3785,6915,zinc chloride,8.43999958,EC50,,,
3786,16644,migalastat,6.59000015,IC50,,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,
3787,6150,sirolimus,9.69999981,Kd,,[H][C@@](C)(C[C@]1([H])CC[C@@]([H])(O)[C@@]([H])(C1)OC)[C@]1([H])CC(=O)[C@]([H])(C)\C=C(C)\[C@@]([H])(O)[C@@]([H])(OC)C(=O)[C@]([H])(C)C[C@]([H])(C)\C=C\C=C\C=C(C)\[C@]([H])(C[C@]2([H])CC[C@@]([H])(C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@@]2([H])C(=O)O1)OC,
3788,6150,tacrolimus,9.39999962,Kd,,[H][C@]12O[C@](O)([C@H](C)C[C@@H]1OC)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@H]([C@@H](C)[C@@H](O)CC(=O)[C@H](CC=C)\C=C(C)\C[C@H](C)C[C@@H]2OC)C(\C)=C\[C@@H]1CC[C@@H](O)[C@@H](C1)OC,
3789,1054,flufenamic acid,6.11999989,IC50,,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,
3790,11706,methotrexate,6.92000008,IC50,,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3791,11706,raltitrexed,7.0,IC50,,CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3792,1218,eosin,6.0,IC50,,OC1=C(Br)C2=C(C=C1Br)C1(OC(=O)C3=C1C=CC=C3)C1=CC(Br)=C(O)C(Br)=C1O2,
3793,6421,methotrexate,6.96999979,IC50,,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3794,6421,pemetrexed,7.21999979,IC50,,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,
3795,6421,raltitrexed,7.65999985,IC50,,CN(CC1=CC2=C(C=C1)N=C(C)NC2=O)C1=CC=C(S1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,
3796,16886,nafamostat,10.69999981,Ki,,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,
3797,132,ciclosporin,6.30000019,IC50,,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3798,132,pioglitazone,6.51999998,IC50,,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,
3799,4818,haloperidol decanoate,8.23999977,Ki,,CCCCCCCCCC(=O)OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,
3800,14461,vitamin A palmitate,6.74,Kd,,CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,
3801,2820,progesterone,7.38,Ki,,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3802,2820,hydroxyprogesterone caproate,7.74,Ki,,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3803,2820,hydrocortisone acetate,7.55,Ki,,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3804,2820,cortisone acetate,6.89,Ki,,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3805,2820,prednisolone,7.51,Ki,,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
3806,2820,desoxycortone,7.65,Ki,,[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3807,2820,aldosterone,6.28,Ki,,[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O,
3808,2820,testosterone,6.72,Ki,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,
3809,2820,nandrolone,6.14,Ki,,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3810,36,Florbetapir F-18,8.54,Ki,,CNC1=CC=C(\C=C\C2=CN=C(OCCOCCOCC[18F])C=C2)C=C1,
3811,36,methylthioninium chloride,6.26,IC50,,CN(C)C1=CC2=[S+]C3=CC(=CC=C3N=C2C=C1)N(C)C,
3812,36,florbetaben F18,8.65,Ki,,CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1,
3813,7620,lifitegrast,8.53,IC50,,[H][C@@](CC1=CC(=CC=C1)S(C)(=O)=O)(NC(=O)C1=C(Cl)C=C2CN(CCC2=C1Cl)C(=O)C1=CC=C2C=COC2=C1)C(O)=O,
3814,7610,triclocarban,6.92,IC50,,ClC1=CC=C(NC(=O)NC2=CC(Cl)=C(Cl)C=C2)C=C1,
3815,648,dabrafenib,7.59,IC50,,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,
3816,10302,sorafenib,7.74,IC50,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,
3817,5179,racecadotril,8.1,IC50,,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,
3818,61,prednisolone,7.83,IC50,,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
3819,6902,obeticholic acid,7.0,EC50,,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)[C@]([H])(CC)[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])CC[C@]12C,
3820,16357,ciclosporin,7.29,Ki,INHIBITOR,[H][C@]1(NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC(=O)[C@]([H])([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@]([H])(C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C1=O)C(C)C,
3821,16361,erlotinib,6.28,Ki,INHIBITOR,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,
3822,8174,flufenamic acid,8.85,EC50,ACTIVATOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,
3823,8331,loxapine,5.36,EC50,ACTIVATOR,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,
3824,8174,niflumic acid,8.68,EC50,ACTIVATOR,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1,
3825,2125,nimodipine,6.0,IC50,GATING INHIBITOR,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,
3826,2125,nitrendipine,6.0,IC50,GATING INHIBITOR,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,
3827,4222,ticlopidine,6.7,IC50,INHIBITOR,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1,
3828,3711,dequalinium,6.7,IC50,BLOCKER,CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1,
3829,2783,ponatinib,8.17,Kd,INHIBITOR,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,
3830,3004,ponatinib,7.92,Kd,INHIBITOR,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,
3831,14778,brigatinib,8.72124672,IC50,INHIBITOR,COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1,
3832,1341,ibrutinib,10.0,IC50,INHIBITOR,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,
3833,6391,ibrutinib,8.481486,IC50,INHIBITOR,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,
3834,17115,ibrutinib,8.154902,IC50,INHIBITOR,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,
3835,18746,ibrutinib,8.69897,IC50,INHIBITOR,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,
3836,996,angiotensin II,10.2,Kd,AGONIST,[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,
3837,424,cytisine,5.85,Ki,,[H][C@@]12CNC[C@@]([H])(C1)C1=CC=CC(=O)N1C2,
3838,6851,prednisolone tebutate,7.5,EC50,,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
3839,2820,nandrolone decanoate,6.14,Ki,,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3840,2820,prednisolone tebutate,7.51,Ki,,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CC(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,
3841,39,esatenolol,8.75,IC50,,CC(C)NC[C@H](O)COC1=CC=C(CC(N)=O)C=C1,
3842,15442,nandrolone decanoate,6.3,Kd,,[H][C@@]12CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3843,15442,norethindrone acetate,7.97,Kd,,[H][C@@]12CC[C@@](OC(C)=O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],
3844,13545,midostaurin,6.02,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3845,9871,midostaurin,7.68,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3846,16697,midostaurin,7.77,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3847,8771,midostaurin,7.7,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3848,9604,midostaurin,7.82,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3849,9685,midostaurin,7.77,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3850,13082,midostaurin,8.03,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3851,13213,midostaurin,7.82,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3852,17724,niraparib,6.24,IC50,,[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1,
3853,12888,niraparib,6.48,IC50,,[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(N)=O)C2=N1,
3854,13790,midostaurin,7.26,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3855,17495,midostaurin,8.03,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3856,18404,midostaurin,6.92,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3857,9835,midostaurin,7.82,Kd,,[H][C@]12C[C@]([H])([C@@H](OC)[C@](C)(O1)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,
3858,15516,ertugliflozin,9.06,IC50,,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,
3859,16909,neratinib,7.89,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3860,16694,neratinib,7.92,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3861,9699,neratinib,9.19,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3862,16174,neratinib,8.13,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3863,9835,neratinib,7.8,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3864,10377,neratinib,7.54,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3865,5196,neratinib,8.11,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3866,16693,neratinib,8.19,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
3867,9786,neratinib,8.11,Kd,,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,
